Drug Formulary 2013

HOSPITAL PAKAR SULTANAH FATIMAH, MUAR
MESRA BERSAMA MEMBINA KEUNGGULAN
HOSPITAL PAKAR SULTANAH FATIMAH

MUAR, JOHOR
HOSPITAL
DRUG FORMULARY
Drug Information Unit

Pharmacy Department
Hospital Pakar Sultanah Fatimah
Hospital Drug Formulary, Hospital Pakar Sultanah Fatimah 2013
Foreword
With the exponential advancement in the medical technologies, there is a
challenging need for all healthcare professional to equip themselves with
adequate and updated drug information in order to deliver safe, appropriate and
cost-effective healthcare services to patients.
In conjunction with this, Hospital Pakar Sultanah Fatimah has published its own
Hospital Drugs Formulary with the purpose of achieving the objective above as a
handy reference and to encourage an effective and efficient prescribing practice
in Hospital Pakar Sultanah Fatimah.
The category of prescribers that are authorized to initiate the prescription for the
drug in this formulary is listed as:
A*
= Consultant / Specialist for specific indication only
= Consultant / Specialist
A/KK
= Consultant / Specialist / Family Physicians Specialist
= Medical Officer
= Paramedical Staff
I hope that this Hospital Drugs Formulary will not only serve to improve the
standards of medication prescribing in Hospital Pakar Sultanah Fatimah but also
as an educational reference for new doctors and pharmacists.
Lastly, I would like to express my appreciation to the Drug Information Unit of the
Pharmacy Department HPSF for their time and continuing efforts undertaken in
producing this Hospital Drug Formulary.
DR. SELAHUDDEEN BIN ABD. AZIZ

Director of Hospital Pakar Sultanah Fatimah
Foreword
The Ministry of Health (MOH) Drug Formulary contains a list of drugs approved
for use in all hospitals or institutions under the Ministry. The Formulary is to
promote rational, cost effective use of drugs whereby newer and more expensive
drugs were introduced in a controlled manner so as to minimize wastage. The
use of the Formulary promotes optimal utilization of funds to purchase drugs.
This Hospital Drug Formulary is adapted from the latest MOH Drug Formulary.
With the large number of new drugs and formulations listed in the Drug
Formulary of the Health Ministry, it is appropriate and timely that guidance is
provided to assist doctors in Hospital Pakar Sultanah Fatimah, Muar in selecting
drugs and formulation that is available in this hospital. A review and update of
this hospital formulary will be done periodically to keep up with the changes in
the availability of drugs, treatment guideline and feedback from the clinical head
of departments. For this Formulary to be successfull, it must be acceptable in our
hospital and used wisely among hospital staff. We welcome feedback from all
hospital staff to improve the quality of this Hospital Drug Formulary.
This Formulary depends heavily on contribution from the Drug Information Unit of
the Pharmacy Department, who generously spend their time and effort to collate
a brief but important document, for the benefit of this hospital. I congratulate
them for their effort.
Last but not least, our sincere appreciation is extended to our Hospital Director,
Dr Selahuddeen Bin Abd. Aziz for his continuous support.
KAMALIAH BT MD SAMAN
Chief Pharmacist
Hospital Pakar Sultanah Fatimah, Muar
ii
Pharmacy Telephone Directory

Chief Pharmacist
594
Pharmacist U52
639
Outpatient Department
- Counter
105
- Pharmacist
104
Drive Through Pharmacy
636
Inpatient Department
- Counter
616
- Pharmacist
618
Satelit Pharmacy
306
Store
- Hunting line
611
- Pharmacist
593
Cytotoxic Drug Reconstitution (CDR)
617
Total Parenteral Nutrition (TPN)
642
Therapeutic Drug Monitoring (TDM)
481
Ward Pharmacist
615
Drug Information Service (DIS)
638
Manufacturing Unit
634
iii
Table of Contents
Foreword
Pharmacy Telephone Directory
iii
Table of Contents
iv
ALIMENTARY TRACT AND METABOLISM

A01
Stomatological Preparations
A02
Drugs For Acid Related Disorders
A03
Drugs For Functional Gastrointestinal Disorders
A04
Antiemetics and Antinauseants
A05
Bile And Liver Therapy
A06
Laxatives
A07
Antidiarrheals, Intestinal
A10
Drugs Used In Diabetes
A11
Vitamins
A12
Mineral Supplements
1
2
3
3
4
4
4
5
6
8
BLOOD
B01
B02
B03
B05
9
11
12
13
AND BLOOD FORMING ORGANS

Antithrombotic Agents
Antihaemorrhagics
Antianaemic Preparations
Blood Substitutes and Perfusion Solutions
CARDIOVASCULAR SYSTEM
C01
Cardiac Therapy
C02
Antihypertensives
C03
Diuretics
C04
Peripheral Vasodilators
C05
Vasoprotectives
C07
Beta Blockers
C08
Calcium Channel Blockers
C09
Agents Acting On The Renin-Angiotensin System
C10
Serum Lipid Reducing Agents
16
17
18
18
18
19
20
20
22
DERMATOLOGICALS
D01
Antifungals for Dermatological Use
D02
Emollients and Protectives
D03
Preparations For Treatment Of Wounds And Ulcers
D04
Antipruritics, Incl. Antihistamines, Anaesthetics, etc.
D05
Antipsoriatics
D06
Antibiotics and Chemotherapeutics For Dermatological Use
D07
Corticosteroids, Dermatological Preparations
D08
Antiseptics and Disinfectants
D10
Anti-Acne Preparations
D11
Other Dermatological Preparations
23
23
24
24
24
24
25
26
27
27
GENITO URINARY SYSTEM AND SEX HORMONES

G01
Gynaecological Antiinfectives and Antiseptics
G02
Other Gynaecologicals
G03
Sex Hormones and Modulators of the Genital System
G04
Urologicals
iv
28
28
28
30
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

H01
Pituitary and Hypothalamic Hormones and Analogues
31
H02
Corticosteroids for Systemic Use
31
H03
Thyroid Therapy
32
H05
Calcium Homeostasis
33
ANTIINFECTIVES FOR SYSTEMIC USE

J01
Antibacterial for Systemic Use
J02
Antimycotics For Systemic Use
J04
Antimycobacterials
J05
Antivirals for Systemic Use
J06
Immune Sera and Immunoglobulins
J07
Vaccines
34
40
41
42
45
46
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

L01
Antineoplastic Agents
L02
Endocrine Therapy
L03
Immunostimulants
L04
Immunosuppressive Agents
47
54
54
55
MUSCULO-SKELETAL SYSTEM
M01
Antiinflammatory and Antirheumatic Products
M02
Topical Products for Joint And Muscular Pain
M03
Muscle Relaxants
M04
Antigout Preparations
M05
Drugs for Treatment of Bone Diseases
M09
Other Drugs For Disorders Of The Musculo-Skeletal System
56
57
57
58
58
58
NERVOUS SYSTEM
N01
Anaesthetics
N02
Analgesics
N03
Antiepileptics
N04
Anti-Parkinson Drugs
N05
Psycholeptics
N06
Psychoanaleptics
N07
Other Nervous System Drugs
59
61
62
65
66
70
73
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

P01
Antiprotozoals
P02
Antihelmintics
P03
Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents
74
74
75
RESPIRATORY SYSTEM
R01
Nasal Preparations
R02
Throat Preparations
R03
Drugs for Obstructive Airway Diseases
R05
Cough and Cold Preparations
R06
Antihistamines for Systemic Use
R07
Other Respiratory System Products
76
76
77
80
80
81
SENSORY ORGANS
S01
Ophtalmologicals
S02
Otologicals
S03
Ophthalmological and Otological Preparations
82
85
85
VARIOUS
V03
All Other Therapeutic Products
V04
Diagnostic Agents
V07
All Other Non-Therapeutic Products
86
88
88
INDEX
89
APPENDIX
1. Adverse Drug Reactions (ADR) Reporting Form
97
2. Drug Allergy Card Request Form
98
Disclaimer: The Pharmacy Department, Hospital Pakar Sultanah Fatimah shall not be liable for any
loss, damage, death, personal injury or other consequences caused by the use of any information
obtained from this formulary. This information shown is correct at the point of printing.
vi
ALIMENTARY TRACT AND METABOLISM
A01 Stomatological Preparations

No Generic Name
Cat Indications
1 Triamcinolone Acetonide
B Oral and perioral lesions
0.1 % In Dental Paste
Dosage
Remark
Apply a thin layer to affected area bd - RM2.90/tube
qid
Benzydamine HCl 0.15 %

Solution (Difflam)
For relief of painful condition Used as a 30 seconds gargle or rinse, RM11.05/

100ml
of the oral cavity
undiluted. ADULT 15 ml.
CHILD < 12 yr 5-15 ml.
ENT, Dental
Uninterrupted treatment should not be
more than 7 days
Thymol Compound
Gargle
For sore throat and minor

mouth inflammation
A02 Drugs For Acid Related Disorders

No Generic Name
Cat Indications
1 Magnesium Trisilicate
C Heartburn, dyspepsia
Mixture
To be gargled tds - qid
RM1.45/ 60ml
Dosage Form
Remark
10-20 ml 3-4 times daily before meals RM0.67/60ml
ADULT 1-2 tablet to be chewed up to RM0.13/tab
6 times a day before meals. CHILD
over 6 years one tablet to be taken bd qid
Magnesium Trisilicate
Tablet
Heartburn, dyspepsia
Sodium Bicarbonate,
Magnesium Carbonate,
Tincture Cardamom
Compound Mixture
(Carminative)
Heartburn, for rapid relief of ADULT 10-20 ml tds

dyspepsia
RM4.87/
120ml
Ranitidine 50 mg/2 ml
Injection
i) Benign gastric/ duodenal

ulceration, reflux
oesophagitis, Zollinger
Ellison Syndrome ii) Stress
ulcer prophylaxis in postoperative and high risk
patients
i) ADULT: Slow IV injection of 50 mg

diluted to 20 ml and given over at least
2 min. May be repeated every 6-8 hrs
or IV infusion at rate of 25 mg/hr for 2
hrs, may be repeated at 6-8 hrs
intervals or IM. CHILD: 1 mg/kg/dose
6-8 hrly. ii) Initial slow IV injection of
50 mg, then continuous infusion of
125-250 mcg/kg/hr
RM0.32/amp
Ranitidine 150 mg Tablet
Ranitidine 300 mg Tablet
i) 150 mg bd (om & on) or 300 mg on

for 4-8 weeks. Maintenance: 150-300
mg on ii) 150 mg bd or 300 mg on for
8-12 weeks iii) 150 mg od or bd iv)
150 mg and may be increased as
necessary to 6 g/day
RM0.13/tab
i) Benign gastric and

duodenal ulcer ii) Reflux
oesophagitis iii) Non-ulcer
dyspepsia iv) ZollingerEllison Syndrome
Omeprazole 20 mg
Capsule
Only for : i)Reflux

oesophagitis
ii)For eradication of
Helicobacter pylori infection
iii)Benign peptic ulcer not
responding to conventional
therapy
iv)Zollinger-Ellison
Syndrome
i)20 - 80 mg od - bd up to 8 - 12 weeks
ii)20 mg bd in combination with any of
the 2 antibiotics (clarithromycin 500
mg bd, amoxicillin 1 g bd or
metronidazole 400 mg bd) for 1 - 2
weeks iii) 20 mg od for 4 - 6 weeks iv)
ADULT: 20 - 120 mg od adjusted
according to the patient's response.
CHILD 0.4 - 0.8 mg/kg/day
RM0.50/caps
Omeprazole 40 mg
Injection
A*
i) Reflux oesophagitis,
i) 40 mg IV once daily when oral
eradication of H. Pylori
therapy is inappropriate ii) 40- 160 mg
infection, benign peptic
by IV in single or divided doses
ulcer not responding to
conventional therapy,
Zollinger-Ellison Syndrome
ii) Endoscopically confirmed
peptic ulcer
RM0.47/tab
RM6.88/vial
No Generic Name
9 Pantoprazole 40 mg
Injection
Cat Indications
A* Bleeding peptic ulcer and
acute stress ulceration
Dosage
Remark
40 mg bd until oral administration can RM12.40/vial
be resumed. CHILD not recommended
10
Pantoprazole 40 mg
Tablet
A*
i) Helicobacter pylori
eradication ii) Peptic ulcer
disease iii) Erosive and nonerosive reflux oesophagitis
(GERD and NERD) iv)
Zollinger-Ellison Syndrome
v) Prevention of NSAID
induced gastropathy
i) 40 mg bd in combination with any of

the 2 antibiotics (Clarithromycin 500
mg bd, Amoxicillin 1 g bd or
Metronidazole 400 mg bd) for 1-2
weeks ii) 40 mg od for 2 - 4 weeks iii)
20 - 40 mg om for 4 weeks iv) 40 mg
bd. Maximum: 240 mg daily v) 20 mg
daily. CHILD not recommended
11
Esomeprazole 40 mg
Tablet (Nexium)
A*
i)Gastro-oesophageal reflux i)20mg daily for 4-8 weeks ii)40mg

disease ii)H. pylori
daily for 10 days in combination with
eradication
amoxicillin 1g bd or clarithromycin
500mg bd
RM1.81/tab
Sucralfate 1 g Tablet
i) Benign gastric and

duodenal ulceration ii)
Stress ulcer prophylaxis
RM0.43/tab
12
A03 Drugs For Functional Gastrointestinal Disorders

No Generic Name
Cat Indications
1 Mebeverine HCL 135mg
B Irritable bowel syndrome
Tablet (Duspatalin)
i) 2 g bd or 1 g qid for 4-6 weeks or in

resistant cases up to 12 weeks (max 8
g daily) ii) 1 g 6 times dly (max 8 g
dly). CHILD not recommended
Dosage
135 mg tds
RM0.48/tab
For in-patient
on Ryles
Tube only
Remark
RM0.33/tab
Atropine Sulphate
1mg/ml Injection
i) Reduce vagal
inhibition,salivary and
bronchiol secretion in
anaesthesia
ii) Reversal of excessive
bradycardia
iii) Reversal of effect of
competitive muscle
relaxants
iv) Overdosage with other
compounds having
muscarinic action
v) Organophosphate
poisoning
i) ADULT 300-600 mcg IM/SC 30-60

minutes before anaesthesia or 300600 mcg IV immediately before
induction of anaesthesia
ii) ADULT 0.5-1 mg repeated, every 35 minutes. Max Dosage: 0.04 mg/kg
body weight
iii) ADULT 0.6-1.2 mg before or with
anticholinesterase
iv) ADULT 0.5-1 mg IV/SC, repeated
every 2 hour
v) ADULT 2 mg IV/IM, every 30
minutes according to clinical
response. Cholinesterase reactivator
should be given at the earliest
possible time
RM1.57/amp
Hyoscine N-Butylbromide
20 mg/ml Injection
ADULT 20 - 40 mg.
Max : 40 mg tds - qid.
CHILD 0.5 mg/kg/dose
RM0.69/amp
Hyoscine N-Butylbromide
10 mg Tablet
Gastrointestinal tract and

genito-urinary tract spasm,
dyskinesia of the biliary
system
ADULT 10-20 mg tds.

CHILD 6-12 years: 10 mg tds
RM0.30/tab
Itopride HCl 50 mg Tablet

(Ganaton)
A*
Treatment of
50 mg tds before meal
gastrointestinal symptoms
of functional, non-ulcer
dyspepsia (chronic gastritis)
i.e sensation of bloating,
early satiety, upper
abdominal pain or
discomfort, anorexia,
heartburn, nausea and
vomiting
RM1.14/tab
Borang E
No Generic Name
6 Metoclopramide HCl 10
mg/2 ml Injection
Metoclopramide HCl 10
mg Tablet
Domperidone 10mg
Tablet
Cat Indications
B i) Dyspepsia, flatulence,
hiatus hernia, peptic
ulceration, reflux
oesophagitis, gastritis,
duodenitis, cholelithiasis,
B
nausea, vomiting
ii) Promote bowel transit
during diagnostic
procedures
B Nausea, vomiting,
dyspepsia, gastroesophageal reflux
A04 Antiemetics and Antinauseants

No Generic Name
Cat Indications
1 Granisetron HCl 3 mg/3
A i) Prevention and treatment
ml Injection
of nausea and vomiting
(Kytril)
associated with
chemotherapy and
radiotherapy
ii) Post-operative nausea
and vomiting
A05 Bile And Liver Therapy

No Generic Name
1 Ursodeoxycholic Acid
250 mg Capsule
(Ursofalk)
Essential Phospholipids
Capsule (Livovid)
A06 Laxatives
No Generic Name
1 Liquid Paraffin
Cat Indications
A Cholestatic liver diseases
(eg. primary biliary cirrhosis,
primary cholangitis etc)
A/KK Nutritional supplement in

liver disorders
Cat Indications
C Constipation
Dosage
Remark
i) ADULT > 20 yr: 10 mg tds. ADULT RM0.35/amp
12 - 20 yr: 5 mg tds. CHILD < 12 yr:
0.12 mg/kg/dose bd - qid
ii) Single dose 5 - 10 minutes before
examination; ADULT and CHILD >
RM0.02/tab
15yr: 10 - 20 mg; CHILD < 15 yr: 0.12
mg/kg/dose bd - qid
Chronic dyspepsia ADULT 10 mg 3

times daily. Acute and subacute
conditions (particularly nausea and
vomiting):ADULT 20 mg 3-4 times
daily
RM0.07/tab
Dosage
Remark
RM62.67/amp
i) ADULT 1-3 mg as an IV bolus not
not less than 30 seconds; maximum 9
mg/day. CHILD over 2 years; single
dose of 10-40 mcg/kg as an IV
infusion; maximum 3 mg/day ii)
ADULT 1 mg by slow IV injection over
30 seconds prior to induction of
anaesthesia
Dosage
Remark
RM2.59/caps
10-15 mg/kg daily in 2 to 4 divided
doses usually for 3 months to 2 years.
If there is no decrease in stone size
after 18 months, further treatment
seems not to be useful
ADULT 1-2 capsules tds with meals
RM0.19/caps
Dosage
Remark
ADULT 10-30 ml on but should not be RM9.28 /kg
taken immediately before going to
bed. CHILD not recommended
Bisacodyl 10 mg
Suppository
i) Constipation ii) Bowel

preparation for radiological
procedures and surgery
i) ADULT and CHILD > 10 yr: 10 mg,

CHILD < 10 yr 5 mg insert rectally ii)
ADULT 10-20 mg, CHILD > 4 yr 5 mg
the following morning before
procedures insert rectally
RM0.27/supp
Bisacodyl 5 mg Tablet
i) Constipation ii) Bowel

preparation for radiological
procedures and surgery
i) ADULT and CHILD > 10 yr 5-10 mg,

CHILD 4-10 yr 5 mg. To be taken at
night for effect on the following
morning ii) ADULT 10-20 mg the night
before procedures, CHILD > 4 yr 5 mg
the night before procedures
RM0.03/tab
Lactulose 3.35 g/5 ml

Liquid
i) Constipation ii) Hepatic

encephalopathy
i) ADULT 15 ml bd adjusted to
patient's need. CHILD 0.5 ml/kg/dose
od or bd ii) 30-50 ml tds-qid, dose
adjusted to produce 2-3 soft stools
daily. CHILD 1 ml/kg/dose tds - qid
RM3.28/
100ml
No Generic Name
5 Polyethylene Glycol
/Macrogol 4000 Powder
(Fortrans)
Cat Indications
A Bowel cleansing prior to
colonoscopy, radiological
examination or colonic
surgery. Suitable for
patients with heart failure or
renal failure
Dosage
Remark
1 sachet dissolved in 1 L of water. 2-3 RM8.53/ea
L of oral solution are required. When
Borang E
morning surgery is planned, the oral
solution is given in the late afternoon (Nefro)
the day prior. If surgery is scheduled in
afternoon, the oral solution should be
given on the same day for ingestion to
be completed three hours before
surgery
Sodium Biphosphate
16% & Sodium
Phosphate 6% Enema
(Fleet Enema)
Bowel cleansing before

ADULT 133 ml (1 bottle) administered
colonic surgery,
rectally. CHILD more than 2 years half
colonoscopy or radiological the adult dose
examination to ensure the
bowel is free of solid
contents. It is not to be used
for treatment of constipation
RM5.25/
133ml
Monobasic Sodium
Phosphate 48 %, Dibasic
Sodium Phosphate 18%
(Colclean)
Bowel cleansing prior to

colonoscopy, radiological
examination or bowel
surgery
45 ml diluted with half a glass (120 ml)

of water, followed by one full glass
(240 ml) of water to be taken
depending on the time of the
procedure. For morning procedure, 45
ml dilute with half glass of water
should be taken at 7 am and the
second 45 ml at 7 pm on the day
before the procedure. For afternoon
procedure, the first dose should be
taken at 7 pm on the day before and
the second dose at 7 am on the day of
the procedure. Solid food must not be
taken during the preparation period;
clear fluids or water can be taken
liberally. Not recommended for use in
children
RM5.10/90ml
Glycerin 25% & Sodium

Chloride15% Disposable
Enema (Ravin Enema)
Constipation
1 enema as required
RM0.78/ea
Glycerin
As a lubricant and osmotic

dehydrating agent
Apply to area when required
RM8.58/kg
A07 Antidiarrheals, Intestinal

No Generic Name
Cat Indications
1 Nystatin 100,000 units/ml
B Prevention and treatment of
Suspension
candidiasis of the skin and
mucous membranes,
protection against candidas
overgrowth during
antimicrobial /corticosteroid
therapy and as selective
decontamination regimens
Dosage
Remark
RM7.60/ 60ml
NEWBORN: 50,000-100,000 units
daily. CHILD up to 5 years: 100,000 500,000 units qid. CHILD up to 6-12
years and ADULT: 500,000-1,000,000
units tds - qid
Oral Rehydration Salt
Replacement of fluid and

electrolytes loss in
diarrhoea
ADULT: 200-400 ml ( 1-2 sachets ) for

every loose motion. CHILD: 200 ml (1
sachet) for every loose motion. In
severe dehydration 100 ml/kg for 3-4
hrs. INFANT: 1-1.5 times their usual
feed volume (50 ml per stool for small
infant)
RM0.09/sac
Diphenoxylate with
Atropine Sulphate Tablet
(Lomotil)
Acute diarrhoea
ADULT initially 4 tablet followed by 2

tablet qid until diarrhoea is controlled
RM0.08/tab
No Generic Name
4 Charcoal, Activated 250
mg Tablet
Cat Indications
C i) Diarrhoea and food
poisoning
ii) Reduce absorption of
drugs, plant, inorganic
poison and chemicals in
poisoning cases
Charcoal, Activated 50 g
Granules
Emergency treatment of
acute oral poisoning and
drug overdose
Hydrocortisone Enema
0.1%
Adjunctive treatment for

ulcerative colitis and
proctitis
Salicylazosulphapyridine
(Sulphasalazine) 500 mg
Tablet (Salazopyrin)
A10 Drugs Used In Diabetes

No Generic Name
1 Insulin Recombinant
Synthetic Human, shortacting 100 IU/ml Penfill
and Refill (Humulin R)
A/KK i) Treatment of inflammatory

bowel disease of ulcerative
colitis and Crohn's disease
ii) Rheumatoid arthritis
ADULT 100 mg 1-2 times/day for 2-3

wks. If used for longer than 3 wks,
taper treatment over 2-3 wks
Borang E
i) ADULT, acute attack 1-2 g qid until

remission occurs (if necessary
corticosteroids may also be given),
reducing to a maintenance dose of
500 mg qid, CHILD > 2 yr, acute
attack 40-60 mg/kg daily, maintenance
dose 20-30 mg/kg daily
ii) ADULT, initially; 0.5-1 g/day,
increase weekly to maintenance dose
of 2 g/day in 2 divided doses,
maximun 3 g/day. CHILD > 6 yr,
juvenile rheumatoid arthritis: 30-50
mg/kg/day in 2 divided doses up to a
maximum of 2 g/day
RM0.38/tab
Cat Indications
B Insulin dependent diabetes
mellitus, non insulin
dependent diabetes
unresponsive to treatment to
diet or oral hypoglycaemics,
B
hyperkalaemia to assure
proper utilisation of glucose
and reduce glucosuria in
non diabetic patients
receiving parenteral nutrition
B
Dosage
Dose to be individualised. The
average daily insulin requirement is
between 0.5-1.0 units/kg body weight
Dose to be individualised. The

average daily insulin requirement is
between 0.5 to 1.0 units/kg body
weight
Insulin Recombinant
Synthetic Human,
Intermediate-acting 100
IU/ml Penfill and Refill
(Humulin N)
Insulin Recombinant
Synthetic Human, premixed 100 IU/ml Penfill
and Refill (Humulin 30/70
@ Mixtard)
Insulin Aspart 100 IU/ml

Injection (Novorapid)
A*
Insulin Glargine 300

IU/3ml Injection (Lantus)
A*
Dosage
Remark
RM0.06/tab
i) ADULT 0.5-1 g given tds - qid.
CHILD half adult dose.
ii) Need to be dissolved in liquid (slurry
consistency). ADULT and CHILD > 12
yr: initial 30-100 g or 1-2 g/kg; repeat
initial dose as soon as possible or 2050 g every 2-6 hrs. CHILD > 1-12 yr,
25-50 g or 1-2 g/kg; may repeat half
the initial dose every 2-6 hr as
needed. CHILD to 1 year of age, 1
g/kg; may repeat half the initial dose
every 2-6 hrs as needed. For max.
efficacy administer within 1 hr after
ingestion of toxic compound
RM5.15/50gm
ADULT:Acute poisoning: 50-100g in
suspension. Severe poisoning: 50100g as an initial dose followed by
20g every 4-6 hrs. CHILD: 1g/kg/dose
Diabetic Type 1 and 2 in

patients that still
experienced hypoglycaemia
with use of human insulin
Remark
RM7.79/ea
RM7.79/ea
RM8.25/ea
(Humulin
30/70),
RM6.79/ea
(Mixtard)
RM27.95/ea
Borang E
RM40.74/ea
i) Diabetes mellitus type I in ADULT and CHILD > 6 yr:
adults and child over 6
individualised dose given by SC, od at
KBUK
years ii) Diabetes mellitus
the same time every day
type II in adult
No Generic Name
6 Metformin HCl 500 mg
Tablet
Cat Indications
B Diabetes mellitus
Glibenclamide 5 mg
Tablet
Gliclazide 80 mg Tablet
Gliclazide 60mg Modified

Release Tablet
10
Metformin 500mg &

Glibenclamide 2.5mg
Tablet (Glucovance)
11
Metformin 500mg &

Glibenclamide 5mg
Tablet (Glucovance)
12
Acarbose 50 mg Tablet
A11 Vitamins
No Generic Name
1 Multivitamin Syrup
Multivitamin Injection
(Parentrovite)
Alfacalcidol 0.25 mcg

Capsule
Alfacalcidol 1 mcg
Capsule
Dosage
500 mg tds or 850 mg bd with food,
max: 3 g dly in 3 divided doses
Range: 2.5 - 15 mg dly (with or

immediately after breakfast). Initially
2.5 mg dly increasing by 2.5 mg
required for metabolic control. Max: 15
mg dly
Diabetes mellitus type 2
Initially 40-80 mg dly. Total daily dose
may vary from 80- 320 mg orally.
Adjust dose according to patient's
individual response
As monotherapy or in
Initially 30 mg daily, adjusted
combination with other oral according to response every 4 wks
antidiabetic agents in type 2 (after 2 wks if no decrease in blood
diabetes in adults when
glucose). Max. 120 mg daily
dietary measures, physical
exercise and weight loss
alone are not sufficient to
control blood glucose
RM0.05/tab
As second-line therapy
1 tablet bd, titrate up to a maximum
when diet, exercise and
daily dose of 2000 mg metformin/20
initial treatment with
mg glibenclamide
sulphonylurea or metformin
do not result in adequate
glycemic control in patients
with type 2 diabetes mellitus
RM0.10/tab
Diabetes mellitus type 2
A/KK Only for treatment of: i) Non Initially 50 mg od, increase to tds up to
insulin dependent diabetes 100 mg tds.
mellitus (NIDDM) when diet Max 200 mg tds
therapy is insufficient ii) Non
insulin dependent diabetes
mellitus (NIDDM) in
combination with existing
conventional oral therapy
where glycaemic control is
inadequate
Cat Indications
C For prevention and
treatment of vitamin
deficiencies
B
Remark
RM0.08/tab
For prevention and

treatment of vitamin
deficiencies
A/KK Treatment of: i) Renal

osteodystrophy in patients
on haemodialysis ii)
Hypoparathyroidism and
pseudohypoparathyroidism
iii) Adjunct to the
A/KK
management of tertiary
hyperparathyroidism iv)
Rickets and osteomalacia v)
Osteoporosis
Dosage
CHILD 5 ml daily or based on
manufacturer
RM0.13/tab
RM0.11/ tab
RM0.11/tab
RM0.15/tab
Remark
RM2.11/
100ml
Initially 2 - 4 pairs IV 4 - 8 hrly,

reducing to 1 pair IV daily. For less
serious cases, 1 pair IV 1 - 2 times
daily or based on individual
requirements
RM32.48/pair
Initial dose ADULT and CHILD > 20kg:

1 mcg dly;
CHILD < 20kg: 0.05 mcg/kg/day.
Maintenance dose : 0.25 mcg to 2
mcg dly
RM0.24/cap
RM1.11/cap
No Generic Name
5 Alfacalcidol 2 mcg/ml
Drops
Cat Indications
A* Treatment of: i) Renal
on haemodialysis ii)
A* Hypoparathyroidism and
pseudohypoparathyroidism
iii) Adjunct to the
management of tertiary
hyperparathyroidism iv)
Rickets and osteomalacia v)
Osteoporosis
Dosage
NEONATES : 0.1 mcg/kg/day
Remark
RM199.80/
bottle
Initial dose : 1 mcg per haemodialysis.

Maximum dose 6 mcg per
haemodialysis and not more than 12
mcg per week
RM11.40/vial
i) 0.25 mcg bd ii) Initial dose 0.25 mcg.

In patients with normal or only slightly
reduced serum calcium levels, doses
of 0.25 mcg eod is sufficient iii) 0.25
mcg/day om iv) ADULT and CHILD 3
years and older : Initially 0.25 mcg/ml.
CHILD less than 3 years : 10 to 15
ng/kg/day
RM0.29/ cap
i) For the prevention or

treatment of Vitamin B1
deficiency syndromes
including beri-beri and
peripheral neuritis
associated with pellagra ii)
Wernicke-Korsakoff
Syndrome
i) Mild to chronic deficiency: 10-25 mg

dly. Severe deficiency: 200- 300 mg
dly ii) 500 mg every 8 hrs for 2 days,
followed by 100 mg bd until patient
can take oral dose
RM0.03/tab
For deficiency or raised

requirement of Vitamin B1,
B6, B12
1 - 3 tablets tds swallowed unchewed
RM0.05/tab
Vitamin B Complex
Tablet
Prophylaxis and treatment

of vitamin B deficiency
1-2 tablets daily
RM0.01/tab
11
Ascorbic Acid 100 mg

Tablet (Vitamin C)
Vitamin C deficiency
ADULT: 100-250 mg od or bd. CHILD:

100 mg tds for 1 week followed by 100
mg daily until symptoms abate
RM0.06/tab
12
Pyridoxine HCl 10 mg
(Vitamin B6)Tablet
i) Pyridoxine-dependent
i) INFANT 4 mg/kg daily for short
convulsions in infancy ii)
periods ii) 100 - 400 mg daily in
Sideroblastic anaemia iii) B6- divided doses iii) ADULT 20 - 50 mg
deficient anaemia in adult
up to 3 times daily iv) Prophylaxis 10
iv) Prophylaxis to peripheral mg daily, therapeutic 50 mg tds v) 20 neuritis in isoniazid therapy 100 mg daily
v) Nausea and vomiting of
pregnancy and irradiation
sickness
RM0.02/tab
13
Riboflavine 3 mg Tablet
For prevention and

treatment of riboflavine
deficiency
RM0.02/tab
Alfacalcidol 2 mcg/ml
Injection
Calcitriol 0.25 mcg

Capsule
Thiamine Mononitrate 10
mg Tablet
Vitamin B1, B6, B12

Tablet (Neurobion)
10
A/KK Treatment of: i)

Postmenopausal
osteoporosis ii) Renal
on haemodialysis iii)
Hypoparathyroidism and
rickets iv) Secondary
hyperparathyroidism in renal
failure
CHILD: 2.5-10 mg/day in divided

doses. ADULT: 5-30 mg/day in divided
doses
A12 Mineral Supplements

No Generic Name
1 Calcium Gluconate 10%
Injection
Cat Indications
B i) Acute hypocalcaemia
ii) Hypocalcaemic tetany
iii) Cardiac resuscitation
Dosage
i) 1-2 g (2.25-4.5 mmol). CHILD 50
mg/kg
ii) ADULT 1g (2.2 mmol) by slow IV
injection followed by continuous
infusion of 4 g (8.8 mmol) daily
iii) IV or intracardiac injection, 10 ml
A/KK To be used only for

Initial 2.5 g daily and increased up to
elemental calcium
17 g daily
supplementation and
phosphate binding activity in
patients with chronic renal
failure
Remark
RM8.65/amp
RM0.04/tab
Calcium Carbonate 500

mg Tablet
Calcium Lactate 300mg

Tablet
For prophylaxis of calcium

deficiency and treatment of
chronic hypocalcaemia
ADULT 1-5 g dly in divided doses
RM0.15/tab
Potassium Chloride
1g/10 ml Mixture
Potassium depletion
1 g od or bd until serum potassium is

restored
RM13.67/kg
Potassium Chloride SR
600 mg Tablet (Slow-K)
For the treatment and

specific prevention of
hypokalaemia
ADULT: 2-3 tablets dly. Severe

deficiency: 9-12 tablets dly or
according to the needs of the patient
RM0.02/tab
Potassium Citrate 3g/10

ml & Citric Acid Mixture
For systemic or urine

alkalinization
ADULT: 10 ml tds well diluted with

water.
CHILD up to 1 year: 2.5 ml tds;
1-5 years: 5 ml tds;
6 - 12 years: 10 ml tds.
To be taken well diluted with water
RM4.17/
120ml
BLOOD AND BLOOD FORMING ORGANS
B01 Antithrombotic Agents

No Generic Name
1 Warfarin Sodium 1 mg
Tablet
Cat Indications
Dosage
B Treatment and prophylaxis Initially 10 mg daily for 2 days.
of thromboembolic disorders Maintenance dose, 3-9 mg daily
according to the INR (taken at the
B
same time each day)
Remark
RM0.40/tab
RM0.42 /tab
Warfarin Sodium 2 mg
Tablet
Tablet
RM0.32 /tab
Tablet
RM0.34 /tab
Heparin 5000 units/ml

Injection
i) Prophylaxis and treatment

of venous thrombosis and
pulmonary embolism.
ii) Treatment of myocardial
infarction and arterial
embolism.
iii) Prevention of clotting in
arterial and heart surgery
and for prevention of
cerebral thrombosis
Heparin Sodium 50 units

in Sodium Chloride
Injection
To maintain patency of
Flush with 5 ml (50 units) every 4
peripheral venous catheters hours or as required
RM0.66 /5ml
Enoxaparin Sodium 20
mg Injection (Clexane)
A*
RM14.65/
0.2ml
A*
i) Prevention of Deep Vein

Thrombosis(DVT) especially
in perioperative and high
risk surgical cases
ii) Treatment of DVT
iii) Unstable angina and non
Q wave Myocardial
Infarction
A*
10
Clopidogrel 75mg Tablet

(Plavix)
A*
i) By IV inj, LD of 5000 units (10,000

units in severe pulmonary embolism)
followed by continuous infusion of 1525 units/kg/hr. By SC injection (for
DVT) of 15,000 units bd. Small adult
or child, lower LD then, 15-25
units/kg/hr by IV infusion, or 250
units/kg bd by SC injection.
ii) As i), for unstable angina and acute
peripheral arterial occlusion.
iii) Prophylaxis in general surgery, by
SC injection, 5000 units 2 hr before
surgery, then every bd -tds for 7 days
or until patient is ambulant, during
pregnancy (with monitoring), 500010000 units bd. An adjusted dose
regimen may be used for major
orthopaedic surgery or low molecular
weight heparin may be selected
i) Prophylaxis fo DVT especially in

surgical patients: moderate risk, 20 mg
SC approximately 2 hours before
surgery then 20 mg every 24 hours for
minimum 7 - 10 days, high risk (eg
orthopaedic surgery, medical patients,
40mg every 24 hours for at least 6
days until patient ambulant, max 14
days.
ii) Treatment of DVT or pulmonary
embolism, 1.5 mg/kg every 24 hours,
usually for 5 days and until adequate
oral anticoagulation established.
iii) Unstable angina and non-STsegment-elevation myocardial
infarction 1 mg/kg every 12 hours,
usually for 2 - 8 days
Prevention of myocardial
75 mg od
infarct, stroke or established
peripheral arterial disease.
As second/third line
treatment in patients who
are sensitive to
Acetylsalicylic Acid &
intolerant to Ticlopidine
RM12.76/vial
RM19.79/
0.4ml
RM23.95/
0.6ml
RM0.60/tab
No Generic Name
11 Ticlopidine HCl 250 mg
Tablet
Cat Indications
Dosage
A/KK i) Prevention of thrombotic 250 mg bd to be taken with food
stroke for patients who are
sensitive /intolerant to
Acetysalicylic Acid ii)
Maintenance of coronary
bypass surgery or
angioplasty iii) Maintenance
of patency of access in
patients on chronic
haemodialysis
RM0.07/tab
12
Acetylsalicylic Acid 100

mg, Glycine 45 mg Tablet
(Cardiprin)
Prevention of myocardial
infarct, stroke, vascular
occlusion and deep vein
thrombosis. Transient
ischaemic attacks
13
Dipyridamole 75 mg
Tablet
As an adjunct to oral
75-150 mg tds to be taken 1 hour
anticoagulation/ antiplatelet before meals
therapy in the prophylaxis of
cerebrovascular events
RM0.21/tab
14
Streptokinase 1,500,000
IU Injection
A*
Acute myocardial infarction, Myocardial infarction: 1,500,000 units

acute pulmonary embolism over 30-60 min. Pulmonary embolism:
250,000 units by IV infusion over 30
mins, then 100,000 units every hour
for up to 12-72 hours with monitoring
of clotting factors
RM693.68/
vial
15
Urokinase 6000 IU
Injection
A*
Treatment of
thromboembolic disease
such as mycocardial
infarction, peripheral artery
occlusion, pulmonary
embolism, retinal artery
thrombosis and other
ophthalmologic use
ADULT: Acute pulmonary embolism:

IV loading dose 4400 iu/kg over 10
mins, maintenance 4400 iu/kg/hour for
12 hours. Peripheral vascular
occlusion: infuse 2500 iu/ml into clot at
a rate of 4000 iu/min for 2 hours. This
may be repeated up to 4 times.
Hyphaema: 5000 IU in 2 ml saline
solution is injected and withdrawn
repeatedly over the iris. If residual clot
remains, leave 0.3ml in the anterior
chambers for 24-48 hours to facilitate
futher dissolution
RM38.65/ vial
16
Tenecteplase 10,000 unit

(50 mg) Injection
(Metalyse)
A*
Acute myocardial
reinfarction where
streptokinase is
contraindicated due to
previous streptokinase
induced antibodies.
[Indicated when antibodies
was given > 5 days and <
12 mths]
< 60 kg: 30 mg,

60 - 69 kg: 35 mg,
70 - 79 kg: 40 mg;
80 -90 kg: 45 mg,
90 kg or above: 50 mg.
Administer single IV bolus over 5-10
seconds
RM3352.80/
vial
Dabigatran Etexilate 75
mg Capsule
(Pradaxa)
A*
A*
Following total knee replacement:

Initially ADULT 110 mg (ELDERLY, 75
mg) within 1- 4 hrs after surgery, then
220 mg (ELDERLY, 150 mg) OD
thereafter for 6-10 days Following total
hip replacement: Initially ADULT 110
mg (ELDERLY, 75 mg) within 1- 4
hours after surgery, then 220 mg
(ELDERLY, 150 mg) OD thereafter for
28-35 days
RM4.37/ tab
Dabigatran Etexilate 110

mg Capsule
(Pradaxa)
Prevention of venous
thromboembolic events in
patients who have
undergone total knee
replacement or total hip
replacement surgery
17
18
10
1 tablet dy
Remark
RM0.20/tab
A&E
Orthopedic
(4 pts/mth)
RM4.37/ tab
Orthopedic
(4 pts/mth)
No Generic Name
19 Dabigatran Etexilate150
mg Capsule
(Pradaxa)
Cat Indications
A* Reduction of the risk of
stroke and systemic
embolism in patients with
non-valvular atrial fibrillation
(AF)
Dosage
Recommended daily dose is 150mg
bd. Therapy should be continued
lifelong. Patients aged > 80 years:
110mg bd. For renal impairment:
150mg bd, no dose adjustment
necessary
20
A*
i) 2.5 mg once daily given by SC,

administered 6 hr following surgical
closure provided homeostasis has
been established. Usual duration of
therapy is 5 to 9 days; for hip fracture
patients, an extended course of up to
24 days is recommended.
ii) ADULT > 18 yr: 2.5 mg od given by
SC, initiated as soon as possible after
diagnosis and continued for up to 8
days or until hospital discharge. If
patient needs to undergo PCI,
unfractionated heparin to be admin as
per local practice protocol, taking into
account the patient's bleeding risk and
time of last dose of fondaparinux.
Fondaparinux may be restarted no
earlier than 2 hr after sheath removal.
Fondaparinux Sodium 2.5

mg/0.5 ml Injection
(Arixtra)
B02 Antihaemorrhagics
No Generic Name
1 Tranexamic Acid 250 mg
Capsule
i) Prevention of venous
thromboembolic events
(VTE) in orthopedic surgery
(e.g. hip fracture, major
knee or hip replacement
surgery), abdominal surgery
in patients at risk of
thromboembolic
complication.
ii) Treatment of unstable
angina or non-ST segment
elevation myocardial
infarction [UA/NSTEMI] in
patients for whom urgent
invasive management (PCI)
is not indicated.
iii) Treatment of ST segment
elevation myocardial
infarction (STEMI) in
patients managed with
thrombolytics or are not
receiving other forms of
reperfusion therapy
Cat Indications
B Haemorrhage associated
with excessive fibrinolysis
Remark
RM4.37/ tab
KBUK
(2 pts)
RM19.55/ea
iii) ADULT > 18 yr: 2.5 mg od; first

dose to be given IV (directly through
an existing IV line or as infusion in 25
or 50 ml of 0.9% saline over 1-2 min),
subsequent doses to be given SC.
Treatment to be initiated as soon as
diagnosis is made and continued up to
a max of 8 days or until hospital
discharge, whichever comes earlier. If
patient needs to undergo non-primary
PCI, unfractionated heparin to be
admin as per local practice protocol,
taking into account the patient's
bleeding risk and time of last dose of
fondaparinux. Fondaparinux may be
restarted no earlier than 3 hr after
sheath removal
Dosage
ADULT: 1-1.5 g (15-25 mg/kg) bd qid. CHILD: 25 mg/kg/day bd - tds.
Menorrhagia (initiated when
menstruation has started), 1 g tds for
up to 4 days; maximum 4 g daily
Remark
RM0.29/cap
Haemorrhage associated
with excessive fibrinolysis
ADULT: Slow IV 0.5-1 g (10 - 15

mg/kg) tds. Continuous infusion at a
rate of 25 - 50 mg/kg daily. CHILD:
slow IV 10 mg/kg/day bd - tds
RM2.77 /amp
Vitamin K deficiency in
neonates
1 mg given by IM or IV
RM1.74/amp
Synthetic Vitamin K1 10
mg/ml Injection
Haemorrhage associated
0.5 - 20 mg by very slow IV at a rate
with hypoprothrombinaemia not exceeding 1 mg per minute
caused by overdose of
anticoagulants
Tranexamic Acid 100

mg/ml Injection
Synthetic Vitamin K1
mg/ml Injection
11
RM 2.08/amp
No Generic Name
5 Factor VIII Injection
Cat Indications
A Prevention and control of
bleeding in patients with
factor VIII deficiency due to
classical haemophilia A
Dosage
Remark
RM187.50/
Dose varies according to the patient
and the circumstances of the bleeding. vial
i) Mild to moderate: Usually a single
dose of 10-15units/kg. ii) More serious
haemorrhage/minor surgery:Initially 1525 units/kg followed by 10-15 units/kg
every 8 - 12 hrs if required iii) Severe
haemorrhage/major surgery: Initial : 4050 units/kg followed by 20-25 units/kg
every 8-12 hrs.
B03 Antianaemic Preparations

No Generic Name
1 Ferrous Fumarate 200
mg Tablet
Cat Indications
Dosage
Remark
RM0.17/tab
C Prevention and treatment of Prophylactic 200 mg daily.
iron-deficiency anaemias
Therapeutic 200 mg bd. CHILD up to 6
years 80-140 mg bd
Ferric Ammonium Citrate

800 mg/10ml Paed
Mixture
Prevention and treatment of CHILD up to 1 year 5 ml, 1 - 5 years

iron-deficiency anaemias
10 ml, taken well diluted with water
RM66.00/kg
Iron Dextran 50 mg Fe/ml

Injection
Severe iron deficiency

anaemia
An initial test dose of 0.5 ml should be

given over the desired route. For
severe iron deficiency anaemia, 1-2 ml
dly given by deep IM. Dosage is
individualized according to total iron
deficit
RM13.92/amp
Cyanocobalamin 0.1 mg
Injection
i) Prophylaxis of anaemia ii)

Uncomplicated pernicious
anaemia or Vitamin B12
malabsorption
i) Prophylaxis of anaemia: 250-1000

mcg IM every month
ii) Uncomplicated pernicious anaemia
or Vitamin B12 malabsorption: Initial
100 mcg dly for 5-10 days followed by
100-200 mcg mthly until complete
remission is achieved. Maintenance:
100 mcg mthly. CHILD 30-50 mcg
daily for 2 or more wks (to a total dose
of 1-5mg). Maintenance: 100 mcg
mthly to sustain remission
RM1.90/amp
Cyanocobalamin 50 mcg
Tablet
Vitamin B12 deficiency of

dietary origin
ADULT 50-150 mcg daily. CHILD 50105 mcg daily in 1-3 divided doses
RM0.03/tab
Folic Acid 5 mg Tablet
i) For the prevention and

treatment of folate
deficiency states ii) For the
prevention of neural tube
defect in the foetus
i) ADULT initially 5 mg dly for 4 mths

or until haematopoietic response
obtained. Maintenance: 5 mg every 1 7 days depending on underlying
disease CHILD up to 1 yr, 500 mcg/kg
dly; over 1 yr, as adult dose ii) 5 mg
dly starting before pregnancy and
continued through the first trimester
RM0.02/tab
12
No Generic Name
7 Erythropoietin Human
Recombinant 2000 units
Prefilled Syringes (Eprex)
Cat Indications
A i) Treatment of anaemia
associated with chronic
renal failure. Dialysis
patients who are
haemoglobin less than 8 g
or exhibiting symptoms of
anaemia although
haemoglobin more than 8 g
and pre-transplant cases ii)
Anaemia in cancer (nonmyeloid malignancies) with
concomitant chemotherapy
B05 Blood Substitutes and Perfusion Solutions

No Generic Name
Cat Indications
1 Human Albumin 20%
B i) Acute hypovolemic shock
Injection
ii) Hypoproteinaemia iii)
Neonatal
hyperbilirubinaemia
Dosage
Remark
RM26.80/ea
i) ADULT by IV injection over 1-5
mins, initially 50 units/kg 3 times wkly
adjusted according to response in step
of 25 units/kg 3 times wkly at interval
of at least 4 wks. CHILD initially as for
adult. Maintenance, bodyweight < 10
kg usually 75-150 units/kg 3 times
wkly, 10-30 kg usually 60-150 units/kg
3 times wkly, > 30 kg usually 30-100
units/kg 3 times wkly
ii) ADULT by SC injection (max. 1 ml
per injection site), initially 150 units/kg
3 times wkly, increased if appropriate
rise in haemoglobin not achieved after
4 wks to 300 units/kg 3 times wkly.
Discontinue if inadequate response
after 4 wks at higher dose
Dosage
Remark
i) ADULT 25 g. CHILD 0.6 g/kg body RM105.18/
weight ii) Maximum daily dose is 2g iii) 50ml
1 g/kg before exchange transfusion.
Dose is given at rate of 1 ml of 25%
solution per minute
Modified Fluid Gelatin 4%

Injection (Gelafusine)
For primary volume

ADULT 500 - 1500 ml given as IV
replacement in
infusion
hypovolaemia, perioperative stabilization of the
circulation, haemodilution,
extracorporeal circulation
(haemodialysis and heartlung machine)
RM17.74/
bottle
Hydroxyethyl Starch 6%
Injection
Therapy and prophylaxis of

hypovolaemia and shock in
connection with surgery
trauma, infections and burns
RM27.68/
bottle
Amino Acids 6.5% with

Taurine Injection
(Vaminolact)
Source of amino acids for

Infants: up to 35ml/kg/day
protein synthesis and of
Taurine in infants & children
requiring IV nutrition
RM51.62/
100ml
Amino Acids Injection

(Glamin)
Source of amino acids in

Dose to be individualised. ADULT
patients needing IV nutrition usually 500-2000 ml by IV. ADULT
usual requirement for amino acid: 1-2
g/kg/day
RM147.10/
500ml
Fat Emulsion 20% for IV

Infusion (Intralipid /
Lipofundin)
Source of lipid in patients

needing IV nutrition
RM56.00/
500ml,
RM44.80/
100ml
13
ADULT dly dose up to 20 ml/kg/day.

Normally 500-1500 ml. The rate of
infusion may approach 20 ml/kg/hour
in acute haemorrhagic shock, slower
rates in burns and septic shock.
CHILD < 10 yr 15 ml /kg/hour. Do not
exceed

usual lipid requirement 2-3 g/kg/day.
INFANT 0.5-1 g/kg/day
No Generic Name
7 Dextrose 50 % Injection
(10ml)
Cat Indications
B For parenteral
replenishment of fluid and
B minimal carbohydrate
calories as required by the
clinical condition of the
B
patient
Dosage
According to the needs of the patient
Remark
RM1.16/amp
RM2.57/ bottle
Dextrose 5 % Injection
(500ml)
Dextrose 10 % Injection
(500ml)
10
Amino Acids 15% with

Electrolytes Injection
(Aminoplasma)
Source of amino acids and

electrolytes in patients
needing IV nutrition

usual requirement for amino acid 1-2
g/kg/day
RM79/ 500ml
11
Mannitol 10% Injection

(10 g/100 ml)
Cerebral oedema
RM5.43/
500ml
12
Mannitol 20 % Injection
(20 g/100 ml)
0.25- 2 g/kg IV of a 15% to 25%

solution over 30-60 minutes. Safety
and efficacy not established in
children under 12 years of age
13
Sodium Citrate, Citric

Acid Mixture 3 g/10 ml
(Mist Sodium Citrate)
Citrates and citric acid

ADULT 10-20 ml. CHILD up to 1 year
solutions are used to correct 2.5 ml; 6-12 years 10 ml. To be taken
the acidosis of certain renal well diluted with water
tubular disorders to treat
metabolic acidosis for longterm urine alkalinization for
prevention and treatment of
uric acid and calcium kidney
stones and as
nonparticulate neutralizing
buffers
RM19.20/kg
14
Balanced Salt Solution

(Ocusol)
For irrigation during ocular

surgery
RM24.50/
500ml
15
Sodium Bicarbonate,
Citric Acid, Sodium
Citrate and Tartaric Acid 4 g per sachet
For relieving of discomfort in 4-8 g (1-2 sachets) dissolved in a

mild urinary tract infection, glass of cold water 4 times daily as
symptomatic relief of
prescribed
dysuria to enchance the
action to certain antibiotics
especially some
sulphonamides. In gout as
urinary alkalinizers to
prevent cystallisation of
urates
RM0.39/
sachet
For chronic renal disease

requiring dialysis and for
acute renal failure
Dose depending on clinical cases
RM9.45/bag
By slow IV infusion depending on the

deficit or the daily maintenance
requirements. 1 g diluted in 500 ml
normal saline or glucose and given
slowly over 2-3 hours
(Ural)
RM2.65/ bottle
Irrigate as directed
16
Peritoneal Dialysis with

1.5% Glucose Solution
17
Peritoneal Dialysis with

4.25% Glucose Solution
18
Potassium Chloride 1
g/10 ml Injection
For the correction of severe

hypokalaemia and when
sufficient potassium cannot
be taken by mouth
19
Sodium Bicarbonate
8.4% (1 mmol/ml)
Injection
For acceleration of excretion According to the needs of the patient.

in drug intoxication (where In severe shock due to cardiac arrest:
excretion of the drug into
50 ml by IV
the urine is accelerated by
elevated urine pH) and for
acidosis
14
RM4.78/
500ml
RM9.66/bag
RM1.47/amp
RM1.47/amp
No Generic Name
20 Sodium Chloride (Half
Strength) 0.45% Injection
(500ml)
21 Sodium Chloride 0.9%
Injection
22
Cat Indications
Dosage
B For replenishing fluid and
100 - 1000 ml by IV or according to
for restoring / maintaining
the needs of the patient
the concentration of sodium
C and chloride ions
RM2.41/500ml
RM2.00/250ml
RM1.48/100ml
RM6.00/
500ml
Sodium Chloride 3%
Injection
Sodium Chloride 0.18%
with Dextrose 10%
Injection
24

with Dextrose 10%
Injection
25

with Dextrose 5%
Injection
RM2.50/
500ml
26

with Dextrose 4.23%
Injection
RM2.49/
500ml
27

with Dextrose 5%
Injection
RM2.20/
500ml
28
Magnesium Sulphate
50% Injection
Treatment and prophylaxis

of hypomagnesaemia.
Prevention and treatment of
life-threatening seizures in
the treatment of toxemias of
pregnancy (pre-eclampsia
and eclampsia)
RM8.65/5ml
ADULT 5-10 ml by IM. CHILD 20-40
mg/kg as a 20% solution by IM.
Hypomagnesaemia: 0.5-1 mmol/kg up
to 160 mmol magnesium over to 5
days. Eclampsia: IV 4 g over up to 20
minutes followed by IV infusion at rate
of 1 g every hour. Recurrent seizures
may require an additional IV bolus of 24 g (4 g if bw > 70 kg)
29
Potassium Dihydrogen
Phosphate Injection
For treatment of
hypophosphataemia or
phosphate replacement in
parenteral nutrition
Parenteral nutrition: 10 - 20 mmoles of

phosphate daily
30
Phosphate Solution
containing Sodium Acid
Phosphate (1.936g/15 ml)
(Phosphate Sandoz)
Sodium Lactate
Compound
(Hartmanns Solution/
Ringer-lactate)
For supplemental ionic

phosphorus for correction of
hypophosphataemia
RM3.00/tab
Replacement of
extracellular losses of fluid
and electrolytes, as an
alkaliniser agent
100-1000 ml by IV or according to the

needs of the patient
RM2.43/bottle
A*
Only to be used to cover

daily loss of electrolyte and
trace elements for patient
on parenteral nutrition
Only to be used to cover
daily loss of electrolyte and
trace elements for patient
on parenteral nutrition
10 ml added to 500-1000 ml solution,

given by IV infusion
RM34.70/amp
According to the needs of the patient.

INFANT and CHILD weighing 15 kg or
less: Basal requirements of the
included trace elements are covered
by 1 ml/kg/day to a maximum dose of
15 ml. CHILD weighing 15 kg or more,
a daily dose of 15 ml, should meet
basic trace element requirements.
However, for patients weighing more
than 40 kg the adult preparation trace
element should be used
RM34.70/amp
23
31
32
33
Trace Elements and

Electrolytes (Adult)
Solution
(Addamel)
Trace Elements and
Electrolytes (Paed)
Solution
A*
Acute dilutional
hyponatraemia
For replenishing fluid and
energy and for restoring or
maintaining the
concentration of sodium and
chloride ions
Remark
RM2.41/
500ml
(Peditrace)
15
RM2.40/
500ml
RM2.40/
500ml
RM8.65/amp
KPK
CARDIOVASCULAR SYSTEM
C01 Cardiac Therapy

No Generic Name
1 Digoxin 500 mcg/2 ml
Injection
Cat Indications
A Heart failure with atrial
fibrillation, supraventricular
arrhythmias (particularly
atrial fibrillation)
Dosage
Remark
Rapid digitilisation: ADULT & CHILD > RM10.87/amp
10 yr, initially 0.75 - 1.5 mg, followed
by 250 mcg 6 hourly until digitilisation
is complete
Rapid digitalisation: 1-1.5 mg in

divided doses over 24 hours; less
urgent digitalisation, 250 - 500 mcg dly
(higher dose may be divided).
Maintenance : 62.5 - 500 mcg dly
(higher dose may be divided)
according to renal function and , in
atrial fibrillation, on heart rate
response; usual range, 125-250 mcg
dly (lower dose may be appropriate in
elderly)
Ventricular tachycardia and 50-100 mg IV as a bolus, repeated
ventricullar fibrillation. To be after 5 minutes if necessary.
diluted before use
Maintenance : 1-4 mg/min by IV
infusion under ECG monitoring
RM0.12/tab
A*
i) Sustained monomorphic
ventricular tachycardias
ii) Preexcited atrial
fibrillation associated with
Wolff-Parkinson White
Syndrome
iii) Reciprocating AtrioVentricular tachycardias
(AVT) associated with WolffParkinson White Syndrome
iv) Supraventricular
tachycardias due to IntraAtrio Ventricular Nodul
Reentry
RM3.70/tab
Amiodarone 150 mg/3 ml

Injection
A*
Arrhythmias when other

Initial infusion of 5mg/kg via large
drugs are contraindicated or venous access over 20-120 mins with
ineffective
ECG monitoring; subsequent infusion
given if necessary according to
response up to a maximum of 1.2 g in
24 hrs
RM13.22/amp
Amiodarone 200 mg
Tablet
A*
Arrhythmias
200 mg tds for 1 week, then reduced

to 200 mg bd for another week.
Maintenance dose, usually 200 mg
daily or the minimum required to
control the arrhythmia
RM0.77/tab
(pack of 30 )
RM0.84
(pack of 50)
Noradrenaline Acid
Tartrate (Norepinephrine
Bitartrate) 4 mg/4 ml
Injection
Septic shock and shock

where peripheral vascular
resistance is low
Infuse and titrate to desired pressure

response. Range: 0.05 - 0.5
mcg/kg/minute
RM7.37/amp
Dopamine HCl 40 mg/ml

Injection
Non-hypovolemic
hypotension
Initial dose 2-5 mcg/kg/min with

incremental changes of 5-10
mcg/kg/min at 10-15 mins intervals
until adequate response is noted. Most
patients are maintained at less than 20
mcg/kg/min. If dosage exceeds
50mcg/kg/min, assess renal function
frequently
RM2.65/amp
Digoxin 0.25 mg Tablet
Lignocaine 100 mg/5ml

Injection
Flecainide Acetate 100

mg Tablet (Trambocor)
Heart failure , with atrial

fibrillation, supraventricular
arrhythmias (particularly,
atrial fibrillation)
16
Ventricular arrhythmias: 100 mg bd,

maximum 400 mg/day (usually
reserved for rapid control or in heavily
built patients), reduced after 3 - 5 days
if possible.
Supraventricular arrhythmias: 50 mg
bd, increased if required to maximum
of 150 mg bd
RM1.16/vial
No Generic Name
9 Dobutamine HCl 250
mg/20 ml Injection
10
Cat Indications
A Hypotension and heart
failure
Dosage
Remark
RM8.35/vial
Initial 0.5-1 mcg/kg/min by IV;
maintenance 2.5-20 mcg/kg/min by IV;
titrate according to response;
maximum dose 40 mcg/kg/min
RM0.89/amp
0.5-1 mg given by SC or IM
Adrenaline Acid
(Epinephrine) Tartrate 1
mg/ml Injection
Glyceryl Trinitrate 25
mg/5 ml Injection
Cardiopulmonary
resuscitation

of angina, left ventricular
failure. Not for direct IV
injection.
12
Glyceryl Trinitrate 0.5 mg

Tablet
RM0.08/tab
13
Isosorbide Dinitrate 10
mg Tablet

of angina and left ventricular
failure
Prophylaxis and treatment i) 30 - 120 mg dly in divided doses
for: i) Angina ii) Left
ii) 40 - 160 mg, up to 240 mg if
ventricular failure
required; in acute episodes: 5 - 10 mg
by sublingually

of angina pectoris
RM0.37/cap
A*
For treatment of congenital 0.05 - 0.1 mcg/kg/min by continuous

heart diseases which are
IV infusion, then decreased to lowest
ductus arteriosus dependent effective dose
RM8510/vial
11
(Isordil)
14
15
Isosorbide Mononitrate
50 mg SR Capsule
(Elantan)
Alprostadil 500 mcg/ml
Injection
(Prostin VR)
Initial 5 mcg/min delivered via infusion

pump. Subsequent titration must be
adjusted to clinical situation with dose
increment becoming more cautious as
partial response is seen.
0.5-1 mg sublingually
50 mg daily
RM9.86/amp
RM0.01/tab
16
Adenosine 3 mg/ml
Injection
Rapid conversion of
ADULT: Initially: 3 mg given as a rapid
paroxysmal supraventricular IV bolus (over 2 seconds). Second
tachycardia to sinus rhythm dose: If the first dose does not result
in elimination of the supraventricular
tachycardia with in 1 or 2 minutes, 6
mg should be given also as a rapid IV
bolus. Third dose: If the second dose
does not result in elimination of the
supraventicular tachycardia with in 1-2
minutes, 12 mg should be given also
as a rapid IV bolus
RM64.08/amp
17
Trimetazidine 20 mg
Tablet (Vasteral)
Prophylactic treatment of
20 mg tds
episodes of angina pectoris
RM0.07/tab
18
Ivabradine 5 mg Tablet
A*
Symptomatic treatment of
chronic stable angina
pectoris in patients with
normal sinus rhythm, who
have a contraindication or
intolerance to beta blockers
RM2.51/tab
(Coralan)
C02 Antihypertensives
No Generic Name
1 Methyldopa 250 mg
Tablet
Cat Indictions
B Hypertension
Prazosin HCl 1 mg Tablet
Initial dose 5 mg BD. May increase

dose after 3-4 wks to 7.5 mg BD
depending on response. ELDERLY,
initial dose 2.5 mg BD and titrate to a
maximum of 7.5 mg BD
KBUK
Dosage
Remark
250 mg bd - tds, gradually increased RM0.21/tab
at intervals of 2 or more days,
maximum; 3 g/day. ELDERLY initially
125 mg bd, increased gradually, max;
2 g dly
Initially 0.5 mg bd - tds, the initial dose RM0.10/tab
on retiring to bed at night; increased to
1 mg bd - tds after 3 - 7 days: further RM0.14/tab
increased if necessary to maximum 20
RM0.34/tab
mg daily
Hypertension
17
No Generic Name
5 Doxazosin Mesylate 4mg
CR Tablet
Cat Indications
A* Benign Prostatic
Hyperplasia
Dosage
4 mg od
Remark
RM0.48/tab
Hydralazine 20mg
Injection
Hypertensive crisis in
pregnancy
i) Slow IV injection, ADULT: 5-10 mg

diluted with 10ml sodium chloride
0.9%. May be repeated after 20-30
minutes if necessary. ii) IV infusion
200-300 mcg/minutes. Maintenance
dose 50-150 mcg/mins
RM12/amp
Minoxidil 5 mg Tablet
A*
Severe hypertension
ADULTS and CHILD > 12 yr: Initially 5

mg dly in single or divided doses
(elderly 2.5 mg). May increase by 5 10 mg dly at intervals of 3 or more
days until optimum control is achieved.
Max: 50 mg dly
RM0.08/tab
C03 Diuretics
No Generic Name
1 Hydrochlorothiazide 50
mg Tablet
Cat Indications
B Diuretic, hypertension
Dosage
Remark
RM0.08/tab
ADULT: Diuretics; 25-200 mg dly.
Hypertension 12.5-25 mg dly CHILD:
Oedema and hypertension; Adjunct; 1
to 2 mg/kg ORALLY dly in single or
two divided doses; Children 2-12 yr
MAX dose, not to exceed 100 mg
ORALLY dly; Infants < 6 mths, may
require doses up to 3 mg/kg ORALLY
dly in two divided doses, Infants up to
2 yrs: MAX dose, not to exceed 37.5
mg ORALLY dly
Frusemide 20 mg/2 ml
Injection
Pulmonary oedema
Initially 20 -40 mg IM or slow IV (rate

not exceeding 4 mg/min). CHILD: 0.5 1.5 mg/kg. Max: 20 mg dly
RM0.29/amp
Frusemide 40 mg Tablet
Pulmonary oedema
ADULT: Initial 40 - 80 mg om if
required, can be increased to a max of
1 g/day in certain cases especially in
chronic renal failure. CHILD : 1 - 3
mg/kg daily
RM0.03/tab
Spironolactone 25 mg
Tablet
i) Diuretic as an adjunct to
the management of
oedematous states
ii) Hypertension
i) Initially 1 - 2 tab dly adjusted

according to response. Max : 4 tabs
daily. ii) 1 -2 tabs dly as a single or
divided dose
RM0.11/tab
C04 Peripheral Vasodilators

No Generic Name
Cat Indications
Dosage
1 Pentoxifylline 400 mg
A/KK Peripheral vascular disease 400 mg bd - tds
Tablet (Trental)
C05 Vasoprotectives
No Generic Name
1 Bismuth Subgallate &
Benzyl Benzoate
Suppository (Anusol)
2
Lignocaine, Aluminium
Acetate, Zinc Oxide &
Hydrocortisone
Suppository (Xyloproct)
Cat Indications
C For relief of pruritus, burning
and soreness in patients
with haemorrhoids and
perianal conditions
B Anorectal pain, pruritis,
inflammation and irritation
18
Remark
RM0.48/tab
Dosage
Remark
Insert 1 suppository night and morning RM0.52/ supp
after bowel movements; do not use for
longer than 7 days
1 suppository to be used od or bd. Not
for prolonged use
RM1.27/supp
No Generic Name
3 Sodium Tetradecyl
Sulphate 3 % Injection
(Trombovar)
Diosmin 450 mg &

Hesperidin 50 mg Tablet
(Daflon)
C07 Beta Blockers

No Generic Name
1 Propranolol HCL 40 mg
Tablet
Cat Indications
A* Sclerotherapy of
oesophageal varices,
haemorrhoids and varicose
veins
A/KK i) Haemorrhoids
ii) Chronic venous
insufficiency
Cat Indications
B i) Hypertension
ii) Angina
iii) Myocardial infarct
iv) Cardiac arrhythmia
v) Portal hypertension
vi) Migraine
vii) Thyrotoxicosis
Dosage
Remark
0.5-2 mL into the submucosal layer at RM17.50/amp
the base of the oesophageal varix or
the haemorrhoid, several injections
may be given at different sites, max.
total injected 10-15 mL of 1% per
treatment
RM0.37/tab
i) Acute attack: 6 tablets dly for the
first 4 days, then 4 tablets dly in 2
divided doses for 3 days and 2 tablets
thereafter. Chronic: 2 tablets dly ii) 2
tab dly with meals
Dosage
Remark
RM0.10/tab
i) Initially 80 mg bd increased as
required to a usual range of 160 - 320
mg dly. CHILD: Initial doses of 1
mg/kg in divided doses, can be
increased to 2 - 4 mg/kg/day in divided
doses ii) Initial dose of 40 mg bd - tds.
Maintenance 120 - 240 mg dly iii)
40mg qid for 2 - 3 days then 80 mg bd,
beginning 5 - 21 days after infarction
iv) 10 - 40 mg tds - qid v) Initially 40
mg bd. The dose may be increased as
required up to 160 mg bd vi) Initial
prophylaxis dose: 40 mg bd tds. The
dose may be increased at weekly
intervals up to 160 mg dly vii) Adjunct:
10 - 40 mg tds - qid. CHILD:
Arrythmias, thyrotoxicosis: 0.25 - 0.5
mg/kg tds - qid as required
Hypertension: Initially 100 mg to max RM0.17/tab
400 mg dly, Angina: 50 - 100 mg bd tds. Myocardial infarction: 200 mg dly
in divided doses. Arrythmias: 50 mg 300 mg in bd - tds
Metoprolol Tartrate 100

mg Tablet
Hypertension, angina,
myocardial infarction,
arrhythmias
Atenolol 50 mg Tablet
Hypertension, angina
pectoris, myocardial
infarction and arrhythmias
Bisoprolol Fumarate 5 mg
Tablet
RM0.16/tab
Bisoprolol Fumarate 2.5

mg Tablet
Treatment of stable
1.25 mg od to 5 - 10 mg dly
moderate to severe
congestive cardiac failure in
addition to ACEI's and
diuretics
Labetalol HCl 100 mg/20

ml Injection
Hypertension crisis
ADULT: Bolus injection 50 mg IV for at

least 1 min. Max: 200 mg. IV infusion,
dilute 2 amps to 200ml with sodium
chloride and dextrose injection or 5%
dextrose IV infusion, Hypertension of
pregnancy; 20mg per hour doubled
every 30 min to max 160 mg/hr
RM12.60/unit
Labetalol HCl 100 mg

Tablet
Hypertension (including in
pregnancy)
ADULT: 100 mg (50 mg in elderly) dly

with food, increased at intervals of 14
days to usual dose of 200 mg bd, up
to 800 mg bd (3 - 4 divided doses if
higher dose). Max: 2.4 g dly
RM0.29/tab
19
Hypertension and arrythmias; 50 - 100

mg dly, Angina; 100 mg dly,
Myocardial infarction; individualised
RM0.05/tab
RM0.16/tab
No Generic Name
8 Carvedilol 6.25 mg Tablet
Carvedilol 25 mg Tablet
Cat Indications
A* Treatment of stable
moderate to severe
congestive cardiac failure in
addition to ACEI's and
A* diuretics
C08 Calcium Channel Blockers

No Generic Name
Cat Indications
1 Amlodipine 5 mg Tablet
B Hypertension
Dosage
Remark
RM0.13/tab
3.125 mg bd for 2 weeks, then 6.25
(pack of 100)
mg bd for 2 weeks, then 12.5 mg bd
RM0.07/tab
for 2 weeks then 25 mg bd (titrated up (pack of 28)
to the highest tolerated level)
RM0.13/tab
Dosage
5 mg od. Max: 10 mg
Remark
RM0.02/tab
RM0.04/tab
Amlodipine 10 mg Tablet
Felodipine 5 mg Tablet
A/KK Hypertension
Felodipine 10 mg Tablet
A/KK
Nifedipine 10 mg Tablet
Verapamil HCl 5 mg/2 ml A/KK Supraventricular tachycardia 5 mg by slow IV. The dose can be
Injection
repeated after 5 - 10 mins.
Recommended max. total dose : 15
mg
Verapamil HCl 40 mg
B i) Supraventricular
ADULT: 40 - 80 mg tds - qid. In oral
Tablet
tachyarrhythmias (SVT)
long term therapy, max: 480 mg dly
prophylaxis
ii) angina
RM11.01/amp
Diltiazem HCl 30 mg
Tablet
RM0.22/tab
Initiate at 5 mg od. Usual dose, 5 - 10

mg om
RM0.27/tab
Hypertension
Initial dose of 10 mg bd. Usual range

10 - 30 mg tds. Maximum: 120 - 180
mg per day
Treatment of angina
pectoris in the following
cases: i) inadequate
response or intolerance to
beta-blockers and
Isosorbide Dinitrate ii)
contraindication to betablockers iii) coronary artery
spasm
C09 Agents Acting On The Renin-Angiotensin System

No Generic Name
Cat Indications
1 Captopril 25 mg Tablet
B i) Hypertension
ii) Congestive heart failure
iii) Post-myocardial
infarction
iv) Diabetic nephropathy
Enalapril 5 mg Tablet
RM0.20/tab
i) Hypertension ii)
Congestive heart failure
20
60 mg tds (elderly initially bd);

increased if necessary to 360 mg dly
RM0.02/tab
RM0.12/tab
Dosage
Remark
i) Initially 12.5 mg bd. Maintenance: 50 RM0.07/tab
mg bd - tds, may be increased to max
450 mg/day ii) Initially 6.25 - 12.5 mg
tds, increase after several days to 25 50 mg tds iii) Initially 6.25 mg dly,
gradually increased to 37.5 mg dly in
divided doses iv) 75 - 100 mg dly in
divided doses
i) Initially 5 mg dly, (ELDERLY 2.5 mg
od), usual maintenance dose 10 - 20
mg dly. Maximum: 40 mg/day in 1 - 2
divided doses ii) Initially 2.5 mg dly,
usual maintenance dose 20 mg dly in
1 - 2 divided doses; maximum: 40
mg/day
RM0.15/tab
RM0.03/tab
RM0.06/tab
No Generic Name
5 Perindopril 4 mg Tablet
Cat Indications
B i) Hypertension ii)
Congestive heart failure iii)
Stable coronary artery
disease
Perindopril 8 mg Tablet
Ramipril 5 mg Tablet
Dosage
Remark
RM0.11/tab
i) 4 mg as single dose, may be
increased to a single 8 mg dose.
ELDERLY: Start treatment with 2 mg
dose. In renal insufficiency, dose
should be adapted according to
creatinine clearance ii) Single starting
oral dose of 2 mg should be increased
to a single 4 mg once BP acceptability RM0.29/tab
has been demonstrated iii) 4 mg od for
2 wks, may be increased to 8 mg od.
ELDERLY: 2 mg od for 1 wk, then 4
mg od for the following wk, may be
increased up to 8 mg od
i) Hypertension and
congestive heart failure
ii) Post-myocardial infarction
iii) Reducing risk of
myocardial infarction, stroke
or cardiovascular death in
diabetics or patients with
increased cardiovascular
risks
i) Initially 2.5 mg od, increased at

intervals of 1-2 wks to MAX 10 mg od
ii) Initially 2.5 mg bd for 2 days then
increased to MAX 5 mg bd
iii) Initially 1.25 - 2.5 mg od, increased
to 5 mg od after 1 wk, MAX: 10 mg od
after 3 wks
RM0.40/tab
Losartan 50 mg Tablet
(Cozaar)
A/KK Patients intolerant of ACE

inhibitors, only in the
treatment of i) Hypertensive
patient with left ventricular
hypertrophy ii) Hypertension
in diabetics with proteinuria
or nephropathy
Hypertension: Usual starting and

maintenance dose: 50 mg od.
Maximum increasing the dose to 100
mg od. Patients with intravascular
volume-depletion starting dose of 25
mg od. Renal protection in Type 2
diabetic patients with proteinuria and
hypertension, starting dose: 50 mg od,
may be increased to 100 mg od based
on blood pressure response
RM1.00/tab
Valsartan 80 mg Tablet
(Diovan)
A/KK Patients intolerant of ACE

inhibitors, only in the
treatment of i) Hypertension
ii) Heart failure iii) Post
myocardial infarction
i) 80 or 160 mg od. May be increased

to 320 mg od ii) 40 mg bd. Uptitration
to 80 and 160 mg bd. Max: 320 mg in
divided dose
RM1.12/tab
10
Irbesartan 300mg Tablet

(Aprovel)
A/KK Hypertension, diabetic

150 mg to 300 mg dly
nephropathy (in patients
who cannot tolerate ACE
inhibitors because of cough)
11
40 - 80 mg a day
Telmisartan 40 mg Tablet A/KK i)Hypertension in patients
(Micardis)
inhibitors because of cough
ii)Reduction of the risk of
myocardial infarction,
stroke, or death from
Telmisartan 80 mg Tablet A/KK cardiovascular causes in
patients > 55 yrs at high risk
(Micardis)
of developing major
cardiovascular events who
are unable to take ACE
inhibitors
12
13
Losartan Potassium 50
mg and
Hydrochlorothiazide 12.5
mg Tablet (Hyzaar)
1 tablet od, may increase to maximum

A/KK Hypertension in patients
dose losartan 100 mg/
inhibitors because of cough, hydrochlorothiazide 25 mg od
hypertensive patient with left
ventricular hypertrophy
21
RM1.36/tab
RM1.03/tab
RM1.22/tab
RM0.98/tab
No Generic Name
14 Valsartan 80 mg &
Hydrochlorothiazide 12.5
mg Tablet (Co-Diovan)
15 Telmisartan 80mg &
Hydrochlorothiazide
12.5mg Tablet
(Micardis Plus)
16
Amlodipine 5 mg and
Valsartan 160 mg Tablet
(Exforge)
17
Telmisartan 80 mg and
Amlodipine 10 mg Tablet
(Twynsta)
Cat Indications
Dosage
1 tablet od
1 tablet dly
A*
Essential hypertension in
patients whose blood
pressure is not adequately
controlled by monotherapy
Remark
RM1.10/tab
RM1.24/tab
Doses range from amlodipine besylate RM1.56/tab

5 mg/Valsartan 160 mg to amlodipine
KBUK
besylate 10 mg/valsartan 320 mg
ORALLY od, with dose titration
occuring every 1 to 2 weeks if
necessary; MAX amlodipione besylate
10 mg/valsartan 320 mg
A/KK Treatment of essential

hypertension in adults:
i) Replacement therapy:
Single-pill combination should be

taken once daily. The maximum
recommendation dose is Telmisartan
Patients receiving telmisartan & 80mg/Amlodipine 10mg one tablet per
amlodipine from separate
day.
RM1.21/tab
tablets may instead receive one

tablet containing the same
component doses
ii) Add on therapy: Patients
who BP is not adequately
controlled on telmisartan or
amlodipine monotherapy
iii) Initial therapy: May also be
used as initial therapy in
patients who are likely to need
multiple drugs to achieve their
BP goals
C10 Serum Lipid Reducing Agents

No Generic Name
Cat Indications
Dosage
Remark
1 Simvastatin 10 mg Tablet A/KK Hypercholesterolaemia and 10 - 20 mg od. Maximum: 80 mg daily RM0.10tab
coronary heart disease
RM0.14/tab
2 Simvastatin 40 mg Tablet A/KK intolerant or not responsive
to other forms of therapy
3
Lovastatin 20 mg Tablet
Hypercholesterolaemia and 20 mg od. Maximum: 80 mg daily

RM0.06/tab
Pravastatin Sodium 20
mg Tablet
Hypercholesterolaemia and 20 mg od. Maximum: 80 mg daily

RM0.42/tab
Atorvastatin 40 mg Tablet
A*
RM0.49/tab
Atorvastatin 20 mg Tablet
A*
Hypercholesterolaemia and 10 mg once daily. Maximum: 80 mg

daily
intolerant or not responsive
to other forms of therapy
Gemfibrozil 300 mg
Capsule
(Lopid)
Ezetimibe 10mg tablet

(Ezetrol)
ADULT: 1200 mg/day in 2 divided

doses, 30 minutes before breakfast
and dinner. Dose range from 0.9-1.5 g
daily
i) Co-administration with statins 10 mg od. Not recommended for
for patients who have chronic
children less than 10 years old
RM0.17/tab
heart disease or are chronic

heart disease equivalent or
familial hypercholesterolaemia
with target LDL-C not achieved
by max dose of statins ii)
Monotherapy in patients with
documented biochemical
intolerance to statins
KBUK
A/KK Treatment of
hyperlipoprotinaemias
(TYPES IIA, IIB, III, IV, V)
A*
RM0.31/tab
22
RM3.16/tab
DERMATOLOGICALS
D01 Antifungals for Dermatological Use

No Generic Name
Cat Indications
1 Nystatin 100,000 units/g
C Prevention and treatment of
Cream
cutaneous infections caused
by Candida albicans
Dosage
Remark
RM4.40/tube
Apply liberally to affected area bd or
(30gm)
as required. After lesion has
disappeared continue treatment for 10
days to prevent relapses. Nail
infection: Cut nails as short as
possible. Apply cream od until growth
of new nail has set in
Clotrimazole 1 % Cream
Cutaneous candidiasis,
Tinea corporis, Tinea cruris,
Tinea pedis and Tinea
versicolor
Rub in gently onto affected and

surrounding skin bd or tds continuing
for about 2 weeks beyond the
dissapearance of all symptoms
RM1.18/tube
(20gm)
Miconazole 2 % Cream
i) Fungal infections: Tinea

pedis, Tinea corporis, Tinea
capitis and other
dermatophyte infections
caused by Trichophyton and
Epidermophyton species ii)
Antifungal agent that has
been in various candida
infections including vaginal
candidiasis
i) Skin Infection: Apply sparingly and

rub gently onto affected area od - bd
continuing for 10 days after lesions
have healed ii) Apply bd continuing for
10 days after lesions have healed
RM1.10/tube
(15gm)
Ketoconazole 2 %
Shampoo
Resistant dandruff only
Apply twice wkly for 2 - 4 wks.

Prophylaxis: Once every 1 - 2 wks
RM9.14/
120ml
Sodium Thiosulphate
10% Solution
Fungicides. For the

treatment of pityriasis
versicolor
Apply to all affected parts of the body

and face with a brush after a bath od bd or tds
RM22.2/kg
Salicylic Acid 2 % Cream
Apply sparingly to the affected area bd

- tds
Salicylic Acid 2 - 5 %
Ointment
Seborrhoeic dermatitis,
scalp psoriasis and
hyperkeratotic skin
conditions
Salicylic Acid 20 %
Ointment
Plantar warts
Apply sparingly to the affected area bd

-tds. Wash with cleanser bd - tds
Benzoic Acid Compound

Ointment (Whitfields)
Apply sparingly to affected area od bd
RM0.05/gm
11
Terbinafine HCL 250mg

Tab
A*
Tinea infections of
thickened skin of palms and
soles
Fungal infections especially
onchomycosis caused by
dermatophytes
250 mg od for 6 wks for fingernails: 12

wks for toenails
RM1.29/tab
D02 Emollients and Protectives

No Generic Name
Cat Indications
1 Zinc Oxide Ointment
C Skin protective in various
skin conditions such as
nappy rash and eczema
Dosage
Apply tds or as required
RM0.57/30gm
Remark
Paraffin, White Soft
Xerosis and ichthyosis
Apply to the affected area
RM0.40/30gm
Emulsificants Ointment
Xerosis and ichthyosis
Use as a soap and emollient
RM0.53/30gm
Urea (Carbamide) 10 %
Cream
Apply sparingly and rub into affected

area bd - tds and when required after
cleansing skin
RM3.21/tube
(20gm)
Aqueous Cream
Contact irritant dermatitis,

infantile eczemas, acute
and chronic allergic
eczemas, icthyosis,
hyperkeratotic
Dry skin
As a soap or apply to the skin as an

emollient cream
RM0.40/30gm
23
D03 Preparations For Treatment Of Wounds And Ulcers

No Generic Name
Cat Indications
1 Protein Free
A Trophic lesions in patients
Haemodialysate 10 %
with arterial occlusive
Jelly (Solcoseryl)
disease and with chronic
venous insufficiency, burn
injuries, impaired wound
healing, decubitus ulcers
and skin ulcer caused by
irradiation
D04 Antipruritics, Incl. Antihistamines, Anaesthetics, etc.
No Generic Name
Cat Indications
1 Calamine Cream
C Prickly heat or insect bites
Dosage
Apply 3 - 5 times daily
Remark
RM18.25/tube
(20gm)
Dosage
Remark
Apply to the affected area as required RM1.33/25gm
Calamine Lotion
Prickly heat or insect bites
Apply to the skin as required and allow

to dry, od - tds
RM5.33/
120ml
Calamine with 5 %
Precipitated Sulphur
Lotion
Acne vulgaris
Apply to the skin as required and allow

to dry, od - tds
RM5.50/ 60ml
D05 Antipsoriatics
No Generic Name
1 Coal Tar 20 % Solution
Cat Indications
Dosage
B Dandruff, seborrhoeic
Use 100 ml in a bath
dermatitis, atopic dermatitis,
eczema and psoriasis
Remark
RM33.06/L
Rub a small amount into the scalp

gently
RM2.90/kg
Massage into wet hair, rinse and

repeat. Use once or twice weekly
RM31.10/
350ml
Only for the treatment of

Psoriasis Vulgaris
Apply to the affected skin lesions bd.

Maintenance therapy may be achieved
with less frequent application. The
wkly dose should not exceed 100 g
RM66.50/
30gm
A*
Resistant plaque psoriasis
Apply once daily up to 4 weeks with

maximum weekly dose of 100g and
maximum treatment area 30% of body
surface
RM94.75/tube
(30gm)
Methoxsalen 10 mg
Capsule
Protection before exposure

to sunlight, psoriasis and
vitiligo
0.2 - 0.6 mg/kg. For repigmentation of

larger lesions (greater than 6 cm sq):
20 mg/day 2 hrs before exposure.
Take with food or milk
RM1.67/cap
Acitretin 10 mg Capsule
A*
Acitretin 25 mg Capsule
A*
Generalised pustular and or ADULT: initially 25-30 mg dly for 2-4

erythrodermic psoriasis,
wks, then adjusted according to
pityriasis rubra pilaris,
response, usually within range 25-50
Darier's Disease,
mg dly for further 6-8 wks (max: 75 mg
Icthyosiform Erythrodermas - dly). CHILD: 500 mcg/kg dly
Bullous and non-bullous
occasionally up to 1 mg/kg dly to a
forms, extensive naevus
MAX 35 mg dly for limited periods
verrucosus, extensive
psoriasis
Cocois Co. Ointment
Tar, Coal Tar and Oleyl

Alcohol Liquid (Polytar)
Calcipotriol 50 mcg/g
Ointment (Daivonex)
A*
Calcipotriol Hydrate 50
mcg/g & Betamethasone
Dipropionate 0.5 mg/g
Ointment (Daivobet)
Scalp psoriasis and severe

seborrhoeic dermatitis
A/KK Dandruff, seborrhoeic

dermatitis and atopic
dermatitis
D06 Antibiotics and Chemotherapeutics For Dermatological Use

No Generic Name
Cat Indications
Dosage
1 Chlortetracycline 3%
B Bacterial skin infections
Apply directly to affected area bd as
Cream (Achromycin)
required for 1 - 2 wks
24
RM3.50/cap
RM7.09/cap
Remark
RM0.50/15gm
No Generic Name
2 Fusidic Acid 2 % Cream
Cat Indications
Dosage
A Skin infections caused by
Apply to affected area bd - tds
staphylococci, streptococci,
corynebacterium
minutissumun and other
sodium fusidate-sensitive
organisms
Remark
RM3.19/15gm
Neomycin 0.5 % Cream
Infections of the skin due to Apply sparingly to affected area up to

susceptible organisms
tds (For short term use, 1 - 2 wks)
RM2.66/30gm
Mupirocin 2 % Ointment
(Bactroban)
For MRSA infections only
RM4.83/ 15gm
Silver Sulphadiazine 1 %
Cream (SSD)
Prevention and treatment of Burns: Apply 3 mm thick layer twice

infections in severe burns, daily with sterile applicator. Leg ulcer:
leg ulcers where infections apply at least 3 times a wk
may prevent healing and for
the prophylaxis of infections
in skin grafting
RM16.33/kg
Acyclovir 5% Cream
A*
Herpes simplex infections of Apply every 4 hrs for 5 - 10 days

the skin, including initial and
recurrent labial and genital
herpes simplex infections
RM4.40/5gm
D07 Corticosteroids, Dermatological Preparations

No Generic Name
Cat Indications
1 Hydrocortisone 1 %
B Inflammatory and pruritic
Cream
manifestations of
2 Hydrocortisone 1 %
B corticosteroid responsive
dermatoses
Ointment
3
4
5
Clobetasone Butyrate
0.05 % Cream
(Eumovate/ U-Closone))
Clobetasone Butyrate
0.05 % Ointment
Betamethasone 17 Valerate 0.01 - 0.05 %
Cream
ADULT and CHILD: Apply up to tds for

3 - 5 days
Dosage
Apply sparingly to affected area bd tds until condition improve, then
reduce frequency
A/KK Eczema and dermatitis of all Apply up to qid until condition

types
improves, then reduce frequency
Remark
RM0.09/gm
RM0.15/gm
RM8.14/15gm
RM5.15/15gm
A
B
Eczemas, prurigo nodularis, Apply sparingly to affected area bd limited psoriasis in

tds then reduced to od when
appropriate in sites
improvement occurs
RM2.00/15gm
Betamethasone 17 Valerate 0.01 - 0.05 %

Ointment
Eczemas, prurigo nodularis, Apply sparingly to affected area bd limited psoriasis in

appropriate in sites
improvement occurs
RM2.00/15gm
Betamethasone 17 Valerate 0.1 % Cream
Eczemas, prurigo nodularis, Apply sparingly to affected area bd psoriasis (excluding

widespread plaque
improvement occurs
psoriasis)
RM22.96/
500gm
Mometasone 0.1%
Cream (Elomet)
A*
Steroid responsive
Apply od to affected areas. Do not use
dermatosis and vitiligo.
in paediatric patients for > 3 wks
Used where a potent steroid
is required for short duration
< 6 wks
RM1.73/15gm
Clobetasol Propionate
0.05 % Cream
(Dermovate)
RM2.22/ 15gm
10
Clobetasol Propionate
0.05 % Ointment
(Dermovate)
Short term treatment only of

more resistant dermatoses
eg. psoriasis, recalcitrant
eczemas, lichen planus,
discoid lupus erythematosus
and other conditions which
do not respond satisfactorily
to less potent steroids
25
Apply sparingly od or bd, changing to

lower potency therapy as soon as
condition is controlled. For mild to
moderate use max for 2 wks. For
moderate to severe Max duration 4
consecutive wks. Max: 50 g/wk
RM3.06/ 15gm
No Generic Name
11 Fusidic Acid 2 % in
Betamethasone Valerate
0.1 % Cream (Fusicort)
Cat Indications
A/KK Inflammatory dermatosis
where bacterial infection is
likely to occur eg atopic
eczema, discoid eczema,
stasis eczema, seborrhoic
dermatitis, contact
dermatitis, lichen simplex
chronicus, psoriasis, discoid
lupus erythematosus
D08 Antiseptics and Disinfectants

No Generic Name
Cat Indications
1 Acriflavine 0.1% Lotion
C Infected skin, lesions, cuts,
(Flavin)
abrasions, wounds and
burns.
Dosage
Uncovered lesion- Apply bd - tds.
Covered lesions- Less frequent
applications may be adequate
Remark
RM5.10/15gm
Dosage
Remark
Apply undiluted tds to the affected part RM2.78/
120ml
.
Chlorhexidine Gluconate
5% Solution
i) Preoperative skin
disinfection ii) Wounds or
burns iii) Emergency
disinfection of instruments
Povidone Iodine 10%

(eqvt. to 1% iodine)
Solution
Skin operation prior to

Paint the area od or bd and allow to
surgery, in cleansing open dry
wounds, as an antiseptic for
operative wounds infections
RM11.79/
100ml
Benzalkonium 0.01%
Cream (Drapolene)
Prevention and treatment of Wash and dry baby's bottom. Apply by

nappy rash
spreading the cream evenly paying
particular attention to the fold of the
skin, after every nappy change
RM6.14/55gm
Cetrimide 2% Lotion
As shampoo and cleansing

agent
RM33.96/kg
Hydrogen Peroxide 20
vol Solution
Skin disinfection, particularly Hydrogen Peroxide 6% (=approx. 20

cleansing and deodorising vol) shall be dispensed. For cleansing
wounds and ulcers
wounds: 1.5% to 6% solution apply 23 times daily or when nescessary. As
a mouthwash: rinse the mouth for 2-3
minutes with 15ml of hydrogen
peroxide 6% diluted in half a
tumblerful of warm water 2-3 times
daily. Disinfecting cleaned equipment:
immersion for 30 minutes in 6%
solution. As ear drop for removal of
wax: hydrogen peroxide 6% diluted
with 3 parts of water preferably just
before use
RM10.90/L
Benzoin Compound
Tincture
Infected skin, lesions, cuts,

abrasions, wounds and
burns
Apply undiluted to the skin od or bd.

Duration of therapy, may be weeks to
months depending on the infection
being treated
RM57.50/L
Potassium
Permanganate 1:10,000
Solution
Cleansing and deodorising

suppurative eczematous
reactions and wounds
As soaks or wet dressing od - tds or

as required
RM67.00/kg
Alcohol 70% Solution
Use as antiseptic and

disinfectant
Apply to the skin undiluted or when

needed
26
i) & iii) 1 : 10 in 70 % Alcohol

ii) 1 : 100
RM5.22/
120ml
Apply to affected area
D10 Anti-Acne Preparations

No Generic Name
1 Tretinoin 0.05 % Cream
(Retin-A)
Cat Indications
A/KK Acne vulgaris and
recalcitrant cases of acne
(comedonal type)
A
Dosage
Remark
Apply thinly to the affected area od or RM5.30/20gm
bd. Avoid exposure to sunlight.
Duration of treatment: 8 - 12 weeks is
RM20.72/
required before any noticeable
15gm
response
Tretinoin 0.01% Gel

(Retin-A)
Benzoyl Peroxide 5 %
Gel
Mild to moderate acne

vulgaris
Isotretinoin 10 mg
Capsule
A*
Isotretinoin 20 mg
Capsule
A*
Only for treatment of i)

Initially: 0.5 mg/kg daily (in one to or
Severe nodulo-cystic acne two divided doses) with food once.
ii) Acne conglobata iii) Acne Maintenance: 0.1 - 1 mg/kg daily
fulminans iv) Severe acne
vulgaris failing conventional
treatment WARNING: THIS
DRUG IS TERATOGENIC
D11 Other Dermatological Preparations

No Generic Name
Cat Indications
1 Selenium Sulphide 2.5% A/KK Dandruff, seborrheic
Shampoo
dermatitis of scalp
(Selsun)
27
Apply sparingly od or bd
RM3.50/tube
RM1.50/tab
RM2.00/tab
Dosage
Remark
Dandruff: apply 5-10 mL topically twice RM9.30/
weekly for 2 weeks, then 1-4 times per 120ml
month, as needed, leave on for 2-3
min, then rinse thoroughly. Seborrheic
dermatitis of scalp: apply 5-10 mL
topically twice weekly for 2 weeks,
then 1-4 times per month, as needed,
leave on for 2-3 min, then rinse
thoroughly
GENITO URINARY SYSTEM AND SEX HORMONES
G01 Gynaecological Antiinfectives and Antiseptics

No Generic Name
Cat Indications
1 Clotrimazole 100mg
B Vaginal candidiasis
vaginal Tablet
G02 Other Gynaecologicals
No Generic Name
1 Oxytocin 5 units &
Ergometrine Maleate
0.5mg/ml Injection
Cat Indications
C+ i) Prevention and treatment
of post partum haemorrhage
ii) Management of third
stage of labour
(Syntometrine)
Dinoprostone
(Prostagladine E2) 3mg
Vaginal Tablet
(Prostin E2)
Gemeprost (Prostagladin
E1 Synthetic Analogue) 1
mg Pessary (Cervagem)
Induction of labour by
vagina
Inducing abortion in the first Cervical dilatation: 1 pessary 3 hrly

trimester
before surgery to a max of 5 pessaries
over 24 hrs
Carboprost
Tromethamine 250 mcg.
Injection (Hemabate)
A*
Postpartum haemorrhage
refractory to oxytocin
Levonorgestrel releasing
intrauterine system
20MCG/24 HOURS
A*
i) Contraception (Initial
release rate of 20 mcg/24
hrs).
ii) Idiopathic menorrhagia
(Mirena)
Bromocriptine Mesylate
2.5 mg Tablet
A/KK i) Hypogonadism or
Galactorrhoea
ii) Acromegaly
G03 Sex Hormones and Modulators of the Genital System

No Generic Name
Cat Indications
1 Testosterone 250 mg/ml
A* Only for treatment of male
Injection
infertility, protein deficiency
during convalescence after
surgery and wasting
disorder. In women,
supplementary therapy of
progressive mammary
carcinoma
2
Estradiol Valerate 2 mg
Tablet (Progynova)
Dosage
Remark
i) 1 ml IM, may be repeated after 2 hrs. RM0.69/amp
Should not exceed 3 ml within 24 hrs
ii) For routine management of third
stage of labour, 1 ml IM following
delivery of the anterior shoulder or
immediately after delivery of the child
Dosage
Remark
200 mg od, preferably at bedtime for 3 RM0.30/tab
consecutive days
A*
Oestrogen replacement
therapy - only those who
cannot tolerate Premarin
28
3 mg vaginal tablet to be inserted high

into the posterior formix. A second 3
mg tablet may be inserted after 6-8 hrs
if labour is not established. Max 6 mg
RM58.15/tab
RM135.88/
supp
RM151.00/
ADULT: by deep IM injection; 250
vial
mcg, may repeat at 15-90 minute,
intervals to a total dose of 2 mg (8
doses), followed by subsequent doses
of 250 mcg at intervals of 1.5 to 3.5
hours. Dosage may be increased to
500 mcg/dose if contractility is
inadequate
RM582.83/
One unit intrauterine device to be
inserted into the uterine cavity within 7 unit
days of the onset of menstruation or
Borang E
immediately after first trimester
abortion. Postpartum insertion should
be postponed until 6 wks after
delivery. 1 unit IUD is effective for 5
yrs
RM0.59/tab
i) Initially 1 - 1.25 mg on increased
gradually, usual dose: 7.5 mg dly in
divided doses. Max 30 mg dly ii) 1.25 2.5 mg at bedtime for 3 days and may
be increased by 1.25 - 2.5 mg every 37 days up to 30 mg a day in divided
doses
Dosage
Remark
RM18.04/amp
By IM only. Hypogonadism 250 mg
every 2-3 wks. To maintain an
Borang E
adequate androgenic effect 250 mg
every 3-6 wks. Potency disorders 250
mg every 4 wks. Male climateric
disorders: 250 mg every 3-4 wks.
Repeated 6-8 wks courses at 2-3
months interval
2 mg dly continuously or 21 day
regimen with 1 wk of tablet free
interval
RM0.71/tab
No Generic Name
3 Conjugated Oestrogens
0.625 mg/g Cream
Cat Indications
A Atrophic vaginitis and post
menopausal atrophic
urethritis
(Premarin)
Conjugated Oestrogens
0.625 mg Tablet
i) Osteoporosis ii) Female

hypoestrogenism iii)
Vasomotor symptoms or
atrophic vaginitis and
urethritis
A*
Complaints resulting from

2.5 - 5mg dly
natural or surgical
menopause and in cases at
high risk for breast
carcinomas where general
hormone replacement
therapy is contraindicated
(Premarin)
5
Tibolone 2.5mg Tablet

(Livial)
Medroxyprogesterone
Acetate 5mg Tablet
(Provera)
Dydrogesterone HCI 10
mg Tablet
(Duphaston)
Estradiol Valerate 2mg &

Norgestrel 0.5mg Tablet
Estradiol 1mg (14 tab) &

Estradiol 1mg with
Dydrogesterone 10mg
(14 tab)
(Femoston 1/10)
i) Secondary amenorrhoea
ii) Abnormal uterine
bleeding due to hormonal
imbalance
A/KK i) Dysmenorrhoea ii)

Endometriosis iii)
Dysfunctional uterine
bleeding (to arrest and to
prevent bleeding) iv)
Threatened abortion v)
Habitual abortion vi) Post
menopausal complaints
(hormone replacement
therapy in combination with
oestrogen)
i) 0.625 mg dly
ii) 0.3 - 1.25 mg dly
iii) 0.3 - 1.25 mg dly
RM0.58/tab
RM2.74/tab
KBUK
RM0.26/tab
i) 5-10 mg dly for 5-10 days. To
produce optimum secretory
transformation 10 mg daily for 10 days
ii) 5-10 mg dly for 5-10 days on day 1521 of menstrual cycle. Optimum
secretory transformation 10 mg dly for
10 days from day 15 of the cycle
i) 10 mg bd from day 5 - 25 of cycle ii)

10 mg bd - tds from day 5 - 25 of the
cycle or continuously iii) To arrest
bleeding :10 mg bd with an oestrogen
once daily for 5 - 7 days, To prevent
bleeding : 10 mg bd with an oestrogen
once daily from day 11 - 25 of the
cycle iv) 40 mg at once, then 10mg
8hrly until symptoms remit v) 10 mg bd
until 20th week of pregnancy vi) 10-20
mg daily during last 12-14 days of
each cycle.
RM1.89/tab
Pre and post menopausal

syndrome, primary and
secondary amenorrhea,
menstrual irregularities.
Deficiency symptoms after
oophorectomy or
radiological castration for
noncarcinomatous disease
Start on the 5th day of menstrual cycle

- 1 tab daily for 21 days then stop for 7
days. If patient forgets dose at usual
time, it should be taken within
following 12 hours
RM1.53/tab
A*
Hormone Replacement
Therapy for women with
disorders due to natural or
surgically induced
menopause with intact uteri
1 tablet daily without pill-free interval,

starting with 1 mg of Estradiol for first
14 days, followed by 1mg Estradiol
with 10 mg Dydrogestrone dly for the
next 14 days
RM1.32/tab
(Progyluton)
Dosage
Remark
RM32.51/
Intravaginally or topically 2 - 4 g dly
14gm
depending on severity of condition.
Total dose not exceeding 4 g.
Administration should be cyclic, with 3
weeks on conjugated oestrogens and
one week off. Oestrogens should be
used for the shortest duration possible
when treating atrophic vaginitis. Every
3 to 6 months attempts should be
made to taper or discontinue therapy
and conjugated oestrogens should be
titrated to give the lowest possible
dosage to control symptoms
29
KBUK
No Generic Name
11 Clomifene Citrate 50 mg
Tablet
12
13
Cat Indications
A Anovulatory infertility
Danazol 200 mg Capsule A/KK i)Endometriosis and

gynaecomastia
ii)Menorrhagia
iii)Prophylaxis of hereditary
angioedema
Raloxifene HCl 60mg
A* Prevention and treatment of
Tablet
post menopausal
(Evista)
osteoporosis
Dosage
Remark
RM0.49/tab
50 mg dly from 2nd - 6th or 5th - 9th
day of menstrual cycle. Increase dose
gradually by increments of 50 mg if
there is no response until a dosage of
200 mg dly is achieved
i)200-800 mg dly for max of 9 months
ii)200 mg dly for 12 wks ii)400 mg dly.
Reduce to 200 mg dly after 2 months
attack free period
RM1.06/cap
1 tablet daily
RM3.89/tab
KBUK
G04 Urologicals
No Generic Name
1 Tolterodine L-Tartrate ER
4mg Capsule
(Detrusitol)
2
Alfuzosin HCI 10mg

Tablet
Cat Indications
A* Treatment of overactive
bladder with symptoms of
urinary, frequency or urge
incontinence
Treatment of functional
10 mg od pre bed
symptoms related with
benign prostatic hypertrophy
(BPH)
RM1.00/tab
A*
Second line treatment of

400 mcg od
functional symptoms of
benign prostatic hyperplasia
(BPH) in patients who do
not tolerate first line drugs
or when first line drugs are
inappropriate or
contraindicated
RM0.96/tab
RM0.17/tab
A*
(Xatral XL)
3
Tamsulosin HCl 400 mcg

Extended Release Tablet
Dosage
Remark
RM4.68/tab
4 mg od. May decrease to 2 mg od
depending on response and tolerability
Borang E
(Harnal)
Terazosin HCl 2 mg
Tablet
i) Treatment of Benign
Prostatic Hyperplasia.
ii)Hypertension
Finasteride 5 mg Tablet
A*
Treatment and control of

5 mg a day as a single dose. Clinical RM3.53/tab
benign prostatic hyperplasia responses occur within 12 wks - 6
mths of initiation of therapy. Long-term Borang E
administration is recommended for
maximal response
Dutasteride 0.5mg
Capsule
(Avodart)
A*
Benign prostatic hyperplasia 0.5 mg dly

in men with an enlarged
prostate gland
RM3.57/cap
Dutasteride 0.5mg and

Tamsulosin 0.4mg
Capsule
(Duodart)
A*
Combination therapy for the One capsule daily

treatment of moderate to
severe symptoms of BPH
with: i) Large prostate
(>30g) ii) Poor risk or not fit
for surgery iii)Those who are
awaiting their turn for
surgery
RM3.62/cap
(Proscar)
30
i)Initially 1 mg on, increased in a

stepwise fashion to 2 mg, 5 mg or 10
mg od. ii)Initial: 1mg od at bedtime,
Maintenance: 1-5mg od (morning or
evening) or bd. Max: 20-40mg/day
Borang E
KBUK
KBUK
(ikut kouta
pesakit
Dutasteride
sediada)
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H01 Pituitary and Hypothalamic Hormones and Analogues

No Generic Name
Cat Indications
Dosage
i) 0.7-1 mg/m2/day or 0.025-0.035
1 Somatropin 8mg (24IU)
A* i) Growth failure due to
inadequate endogenous growth mg/kg/day SC/IM
Injection
Desmopressin 100
mcg/ml Nasal Spray
Desmopressin 0.2mg
Tablet
Oxytocin 10 units/ml
Injection
i) Diabetes Insipidus ii) Primary i) ADULT : 10 - 20 mcg od - bd.

nocturnal enuresis
CHILD: 5 - 10mcg od - bd ii) 10-40 mcg
i)Central diabetes insipidus

ii)Primary nocturnal enuresis
iii)Treatment of nocturia
associated with nocturnal
polyuria in adult
i)ADULT and CHILD: 0.1 mg tds.

RM5.61/tab
Maintenance: 0.3-0.6 mg dly
ii)ADULT and CHILD > 5 yr, 0.2 mg on;
Borang E
withdraw for 1 week for assessment after 3
months iii)Initially 0.1 mg on. May be
increased to 0.2 mg and then to 0.4 mg by
means of weekly increase
Induction of labour
IV: 0.5 - 1 milliunits/minute; gradually

increase dose in increments of 1 - 2
milliunits/minute until desired contraction
pattern is established; dose may be
decreased after desired frequency of
contractions is reached and labor has
progressed to 5 - 6 cm dilation
i) Acromegaly ii) Treatment of

patients with symptoms
associated with gastro-enteropancreatic endocrine tumours
iii) Carcinoid tumours with
features of the carcinoid
syndrome, VIPomas,
glucagonomas,
gastrinomas/Zollinger-Ellison
syndrome, GRFomas,
insulinomas iv) Prevention of
complications following
pancreatic surgery v)
Emergency management of
bleeding gastro-eosophageal
varices in patients with cirrhosis
i, ii and iii) Initially 0.005 - 0.1 mg SC 1 - 2 RM44.77/ amp

times daily, increase gradually up to 0.1 0.2 mg 3 times daily iv) 0.1 mg 3 times
daily for 7 consecutive days, starting on the
day of operation, at least 1 hour before
laparotomy v) 25 mcg/hour for 5 days by
continous IV infusion
(Pitocin)
Octreotide 0.1 mg/ml

Injection
(Sandostatin)
H02 Corticosteroids for Systemic Use

No Generic Name
Cat Indications
1 Fludrocortisone Acetate
A As an adjunct to
0.1 mg Tablet
glucocorticoids in the
management of primary
adrenocortical insufficiency
in Addison's disease and
treatment of salt-losing
adrenogenital syndrome
2
Dexamethasone 0.5 mg
Tablet
RM92.80/
2.5ml
(Minirin)
vial
hormone ii) Growth failure in

ii) 1.4 mg/m2/day or 0.045-0.05 mg/kg/day
girls due to gonadal dysgenesis SC
Borang E
(Turner syndrome) iii) Growth iii) 0.035 mg/kg/day or 1 mg/m2/day SC
failure in short children born
small gestational age (SGA)
(Saizen)
Remark
RM473.50/
Croup, septic shock,

cerebral oedema and
respiratory distress
syndrome including status
asthmaticus
31
RM0.69/amp
Dosage
Remark
Adrenocorticoid insufficiency (chronic): RM1.25/tab
ADULT 1 tablet od. Salt-losing
adrenogenital syndrome: ADULT 1 - 2
tablets dly. CHILD and INFANT 0.5 - 1
tablet dly
0.5 - 9 mg daily, depending upon the

disease being treated. Up to 15 mg
daily in severe disease
RM0.04/tab
No Generic Name
3 Dexamethasone Sodium
Phosphate 8 mg/2 ml
Injection
Methylprednisolone
Sodium Succinate 0.5 g
Injection
Cat Indications
B Croup, septic shock,
cerebral oedema and
syndrome including status
asthmaticus
Dosage
Remark
RM0.69/amp
Initially 0.5 - 9 mg IM, IV or infusion
dly, depending upon the disease being
treated
Suppression of
15 - 30 mg/kg dly. Large doses may
inflammatory and allergic
be repeated 4 - 6 hrly for up to 48 hrs
disorders, cerebral oedema,
immunosuppression
treatment of haematological
and oncological disorders,
treatment of shock states
and endocrine disorders
RM43.90/unit
RM0.13/tab
(Solu-Medrol)
Prednisolone 5 mg Tablet
i) Replacement therapy for

primary and secondary
adrenocortical insufficiency
ii) Adrenogenital syndrome
iii) Other therapy
Triamcinolone Acetonide
10 mg/ml Injection
Inflammation of joints,
Smaller joints: 2.5 - 5 mg and larger
bursae and tendon sheaths joints: 5 - 15 mg. Treatment should be
limited to 1 mg/injection site to prevent
cutaneous atrophy
RM5.80/amp
Hydrocortisone 10 mg
Tablet
Glucocorticoid replacement ADULT: 20-30 mg dly in divided

therapy in primary or
doses.
secondary adrenal
CHILD: 10-30 mg dly in divided doses
insufficiencies and long term
management of congenital
adrenal hyperplasia in
children
RM1.03/tab
Hydrocortisone Sodium
Succinate 100 mg
Injection
Conditions responsive to
systemic or local
glucocorticoid injection
therapy especially in
emergencies
RM1.21/vial
H03 Thyroid Therapy

No Generic Name
1 Levothyroxine Sodium
100mcg Tablet
Levothyroxine Sodium
50mcg Tablet
Propylthiouracil 50 mg
Tablet
Cat Indications
B Hypothyroidism
i) 5 - 25 mg daily in divided doses

ii) 10 - 20 mg/m2 dly in divided doses
iii) ADULT: 5 - 60 mg daily. CHILD: 0.5
- 2 mg/kg/day in divided doses every 6
- 8 hrs or as a single dly
Initially 100 - 500 mg IV over 30

seconds to more than 10 mins. Dose
may be repeated at intervals of 2, 4 or
6 hrs
Dosage
ADULT: 1.7 mcg/kg/day orally in a
single daily dose (usual maintenance
dose is 100 - 125 mcg/day 70 kg
adult). CHILD;
0 - 3 months: 10 - 15 mcg/kg/day;
1 - 5 years: 5 - 6 mcg/kg/day;
6 - 12 years: 4 - 5 mcg/kg/day;
> 12 years: 2 -3 mcg/kg/day
Palliative treatment of
hypothyroidism as an
adjunct to ameliorate
hyperthyrodism in
preparation for surgical
treatment or radioactive
iodine therapy and in the
management of
thyrotoxicosis crisis
32
CHILD: Initial 5 - 7 mg/kg/day in

divided doses every 8 hrs.
Maintenance: 1/3 to 2/3 of the initial
dose in divided doses every 6-8 hrs.
ADULT: Initial dose: 300 - 450 mg dly
in divided doses every 8 hrs.
Maintenance: 100 - 150 mg dly in
divided doses every 8-12 hrs.
Remark
RM0.10/tab
RM0.13/tab
RM0.17/tab
No Generic Name
4 Carbimazole 5 mg Tablet
Iodine & Potassium

Iodide Solution (Lugol's
Solution)
H05 Calcium Homeostasis

No Generic Name
1 Calcitonin (Synthetic
Salmon) 200 IU Nasal
Spray (Miacalcic)
2
Calcitonin (Synthetic
Salmon) 100 IU Injection
Cat Indications
B Hyperthyroidism
Dosage
Remark
RM0.07/tab
ADULT: Initially 10 - 60 mg daily in
divided doses. Maintenance: 5 - 20 mg
daily
i) Pre-operative treatment of i) 1 ml daily in divided doses

thyrotoxicosis
ii) 2 - 3 ml daily
ii) Thyrotoxicosis crisis
Cat Indications
A* Osteoporosis
Dosage
200 units daily
RM255.20/kg
Remark
RM143.2/unit
KBUK
A*
Acute hypercalcaemia
(Miacalcic)
33
5 - 10 IU/kg/day SC/IM (in 1 - 2

divided doses) to 400 units every 6 - 8
hours adjusted according to clinical
and biochemical response (no
additional benefit with over 8 units/kg
every 6 hours. 5 - 10 units/kg slow IV
over at least 6 hours
RM38.24/unit
ANTIINFECTIVES FOR SYSTEMIC USE
J01 Antibacterial for Systemic Use

No Generic Name
Cat Indications
Dosage
1 Doxycycline 100 mg
B Infections due to susceptible ADULT: 200 mg on the first day
Capsule
organisms
followed by 100 mg dly. Severe
infections: 200 mg dly
Remark
RM0.20/cap
Ampicillin Sodium 500

mg Injection
Treatment of susceptible
bacterial infections (non
beta-lactamase-producing
organisms); meningitis
250 - 500 mg IM/IV every 4 - 6 hrs.

Max: 400 mg/kg/day. Meningitis: 2 g 6
hrly. CHILD: 150 mg/kg/daily IV in
divided doses. Usual children dose <
10 yr, half adult dose
RM2.32/vial
Amoxicillin 250 mg
Capsule
Infections caused by
susceptible strains of gram
positive and gram negative
organisms
ADULT: 250 - 500 mg tds. CHILD: 20 40 mg/kg/day tds
RM0.46/cap
Amoxicillin Trihydrate 125

mg/5 ml Syrup
susceptible strains of gram
positive and gram negative
organisms
CHILD less than 10 years: 125 - 250

mg 8 hourly. CHILD less than 20 kg:
20 - 40 mg/kg/day in 3 - 4 divided
doses
RM1.20/ 60ml
Bacampicillin 400 mg
Tablet
(Penglobe)
ampicillin-sensitive gram
positive& gram negative
microorganisms
ADULT: 400 mg bd. Severe infection:

800 mg bd. CHILD > 25 kg: 12.5 - 25
mg/kg bd
RM1.42/tab
Benzylpenicillin 1 mega
unit (600 mg) Injection
i) Infections caused by
ii) Infective endocarditis
RM2.32/vial
Benzylpenicillin 5 mega
units (3 g) Injection
i) ADULT: 600 - 1200 mg IM qid,

increased if necessary in more serious
infections. CHILD: 50 - 100 mg/kg dly
IV in 2 - 4 divided doses
ii) ADULT: 7.2 g dly by slow IV
infusion in 6 divided doses
Phenoxymethyl Penicillin
125 mg/5 ml Syrup
(Penicillin V)
Treatment or prophylaxis of CHILD: Up to 1 year: 62.5 mg qid;

infections caused by
1 - 5 years: 125 mg qid;
6 - 12 years: 250 mg qid
RM3.75/60ml
Phenoxymethyl Penicillin
250 mg Tablet
i) Treatment or prophylaxis
of infections caused by
ii) Prophylactic, rheumatic
fever
RM0.09/tab
(Penicillin V)
i) ADULT: 500 - 750 mg qid. CHILD;

up to 1 yr: 62.5 mg, 1 - 5 yr: 125 mg, 6
- 12 yr: 250 mg qid
ii) ADULT: 125 - 250 mg bd. CHILD:
25 - 50 mg/kg in divided doses every 6
- 8 hrs. Max: 3 g/day
RM4.17/vial
RM5.22/vial
10
Benzathine Penicillin 2.4

mega units Injection (1.8
g)
i) ADULT: 1.2 mega units IM

i) Treatment of mild to
moderately severe
ii) 2.4 mega units wkly for 1 - 3 wks
infections due to Penicillin Gsensitive organisms
ii) Treatment of syphillis
11
Procaine Benzylpenicillin
Aqueous 4 mega units (4
g) Injection
Treatment of infections due ADULT: 300,000 - 900,000 units (300 - RM8.12/vial

to Penicillin G-sensitive
900 mg) IM dly. CHILD: Up to 1 yr:
150 mg IM dly. 1-5 yrs: 300 mg IM dly.
organisms
6-12 yrs: 600 mg IM dly
12
Cloxacillin Sodium 250

mg Capsule
ADULT: 250 - 500 mg qid.

CHILD: 2 - 10 years: 250 mg qid;
< 2 yr: 125 mg qid
RM0.30cap
13

mg/5 ml Suspension
bacterial infections, notably
penicillinase-producing
staphylococci
CHILD 2 - 10 yrs: 250 mg qid,

< 2 yr: 125 mg qid
RM12.76/
100ml
14

mg Injection

mg Injection
ADULT: 250 - 500 mg qid depending

on type and severity of infection.
CHILD < 20 kg: 25 to 50 mg/kg/day in
equally divided doses qid
RM1.75/vial
15
bacterial infections, notably
penicillinase-producing
staphylococci infections
34
RM2.32/vial
No Generic Name
16 Ampicillin & Sulbactam
250 mg/5 ml Suspension
(Unasyn)
Cat Indications
A Treatment of susceptible
bacterial infections
Dosage
ADULT: 375 - 750 mg bd. CHILD >
30kg- adult dose, < 30 kg: 25 - 50
mg/kg/day in 2 divided doses
Remark
RM10.84/
30ml
17
Ampicillin Sodium 1g &

Sulbactam Sodium
500mg Injection (Unasyn)
ADULT: 1.5 - 12 g/day in divided

doses tds-qid. MAX: 4 g Sulbactam.
CHILD: 150-300 mg/kg/day tds-qid.
Prophylaxis of surgical infections: 1.5 3 g at induction of anaesthesia. May
be repeated tds-qid.
NEONATES: First wk of life,
75mg/kg/day in divided doses bd
RM3.25/vial
18
Ampicillin & Sulbactam

375 mg Tablet (Unasyn)
ADULT & CHILD > 30 kg: 375 - 750

mg bd. Max: 3 g daily
RM1.17/tab
19
Amoxicillin & Clavulanate A/KK Infections caused by

228 mg/5 ml Syrup
(Augmentin)
Moderate infections: CHILD 7 - 12

year: 10 ml, 2-6 yr: 5 ml.
Severe infections: 2-6 yr: 10 ml
RM8.14/ 70ml
20
Amoxicillin 1g &
Clavulanate K 200mg
Injection (Augmentin)
21
Amoxicillin 500 mg &

Clavulanate 125 mg Tab
(Augmentin)
22
Piperacillin 4g &
Tazobactam 500mg
Injection (Tazocin)
A*
Febrile neutropenia, lower

respiratory tract infection
and severe sepsis
~Adult and children > 12 yrs: 4.5 g tds

~Renal insufficiency: CrCL 20 - 80
ml/minute: 4.5 g tds. CrCL <
20ml/minute: 4.5 g bd
~Neutropenia adult and children > 12
yrs, > 50 kg: 4.5 g qid in combination
with aminoglycosides
~Children with normal renal function &
< 50kg: 90 mg/kg qid in combination
with aminoglycosides
RM12.43/vial
23
Cephalexin Monohydrate
250 mg Capsule
i) Respiratory tract infection,

urinary tract infection ii)
Complicated, recurrent or
chronic infections, bronchitis
iii) Pneumonia
i) 250 mg qid
ii) 250 - 500 mg qid
iii) 1 - 1.5 g tds or qid.
Max: 6 g/day
RM0.15/tab
24
Cephalexin Monohydrate
125 mg/5 ml Syrup
Respiratory tract infections, CHILD: 25 - 100 mg/kg/day qid.

ear, nose and throat
Max: 4 g dly
infections, urinary tract
infections, obstetric and
gynaecologic infections
RM1.45/60ml
25
Cefuroxime Axetil 125

mg/5 ml Suspension
RM28.36/
50ml
CHILD < 3 mth: 30mg/kg bd.

3 mth - 12 yr: 30mg/kg tds-qid.
susceptible organisms.
Respiratory tract, skin, soft ADULT: 1.2 g by IV or intermittent
infusion tds-qid
tissue, GUT infection,
septicaemia, peritonitis, postoperative infection &
osteomyelitis
A/KK Infections due to betaADULT & CHILD > 12 yr: Mild to

lactamase producing strain moderate infections: 625 mg bd.
where amoxicillin alone is
Severe infections: 1 g bd
not appropriate. Respiratory
tract, skin, soft tissue, GUT
infection, septicaemia,
peritonitis, post-operative
infection & osteomyelitis
35
30 mg/kg/day in 2 divided doses
RM4.36/vial
RM2.72/tab
No Generic Name
Cat Indications
26 Cefuroxime Axetil 125 mg A/KK Upper respiratory tract,
Tablet
GUT, skin & soft tissue
infections, urinary tract
(Zinnat)
infection (UTI),
pyelonephritis
Dosage
ADULT: 250 mg bd ;
UTI: 125 mg bd.
CHILD:125 mg bd.
Max 250 mg/day
27
Cefuroxime Sod 750 mg

Injection
susceptible organisms,
surgical prophylaxis
ADULT: 750 mg tds - qid IM or IV.

Severe infections: 1.5 g tds - qid IV.
CHILD: 30 - 100 mg/kg/day in 3 - 4
divided doses.
Surgical prophylaxis: 1.5 g IV
RM6.26/vial
Infections due to gramnegative bacteria
ADULT: 1 g bd (up to 12 g/day in

severe cases). CHILD: 50 - 180
mg/kg/day in 4 - 6 divided doses
RM6.90/vial
Severe gram negative

RM11.07/vial
ADULT: 1 g tds or 2 g bd.

In severe infections: 2 g tds.
CHILD: 25 - 150 mg/kg/day in 2 - 3
divided doses
ADULT: 1-2 g od. Severe infection: 4 g
bd. INFANT & CHILD, 3 wks - 12 yrs:
20-80 mg/kg dly. CHILD > 50 kg: adult
dose. NEONATE up to 2 wks: 20-50
mg/kg dly, not to exceed 50 mg/kg
Infections due to gramnegative bacteria
ADULT: 1 - 2 g bd IM or IV. By IV,

adult dose may be doubled.
Max: 16 g daily in divided doses.
CHILD & INFANT: 50 - 200 mg/kg/day
in 2 - 4 divided doses.
NEONATE < 8 days: 50 - 200
mg/kg/day bd
RM5.22/vial
i) Treatment of infections
ADULT: 1 - 2 g bd.
due to multi-drug resistance CHILD: 40 - 80 mg/kg/day
pathogens producing Blactamase
ii) Treatment of infections
caused by Acinetobacter
species
RM15.70/vial
A*
Febrile neutropenia,
septicaemia, lower
respiratory tract infection,
urinary tract infection, skin
and skin structure
infections, gynaecologic and
intra-abdominal infections
RM11.51/vial
A*
i) Emperical treatment for

ADULT: 0.5 - 1g tds,
presume infections in
CHILD: 10 - 20 mg/kg tds (except
patients (adult and children) meningitis 40 mg/kg)
with febrile neutropenia,
used as monotherapy or in
combination with anti-virals
or antifungal agent
ii) Septicaemia
iii) Serious infections in
renal impaired patients
(Zinacef)
28
Cefotaxime 1 g Injection
(Claforan)
29
Ceftazidime 1 g Injection
(Fortum)
30
Ceftriaxone 1g Injection
(Rocephin)
31
Cefoperazone Sodium 1
g Injection
(Cefobid)
32
Cefoperazone 500mg &

Sulbactam 500mg
Injection
(Sulperazon)
33
Cefepime 1 g Injection
(Maxipime)
34
Meropenem 1g Injection
Remark
RM0.82/tab
36
ADULT: 1 - 2 g bd for most infections.

For severe infections including febrile
neutropenia: 2 g tds.
CHILD: 25 - 50 mg/kg tds
RM9.04/vial
RM48.60/vial
No Generic Name
35 Imipenem 500 mg &
Cilastatin 500 mg
Injection
(Tienam)
Cat Indications
A* Severe infections caused by
susceptible pathogens
especially useful in
infections involving ESBL
organisms. Not to be used
for prophylaxis
36
Trimethoprim 300 mg
Tablet
37
Sulphamethoxazole 200
mg & Trimethoprim 40
mg/5ml Suspension
(Bactrim)
38
mg Injection
(Bactrim)
39
mg Tablet
Dosage
Remark
Based on type or severity of infection, RM29.23/vial
susceptibility of pathogen(s) and
patient condition including body weight
and renal function.
ADULT: 1-2 g/day in 3-4 divided
doses. Max: 4 g/day or 50 mg/kg/day.
Infusion rate: < 500 mg dose: over 2030 mins, > 500 mg: dose over 40-60
mins.
CHILD: 15 - 30 mg/kg/dose, infusion
at 6-12 hrly intervals depending on
age. Max: 2 g/day
ADULT: 200 mg dly in 1 or 2 divided RM1.66/tab

Treatment of urinary tract
infections due to susceptible doses or 300 mg dly as a single dose.
pathogens
Acute infection: 200 mg bd.
CHILD: 6 - 12 yrs: 100 mg bd;
6 mths - 5 yrs: 50 mg bd.
6 wks - 5 mths: 25mg bd
CHILD < 12 yrs: TM 6 mg & SMZ 30 RM35.65/
susceptible pathogens
mg/kg/day, divided into 2 equal doses. 60ml
CHILD > 12 yrs: Standard dose: 10 ml
diluted and infused bd. Severe
infections: 15 ml diluted and infused
bd
i) Severe or complicated
i) ADULT: 960 mg bd increased to
RM11.60/ea
infections when oral therapy 1.44g bd in severe infections. CHILD:
is not feasible
KPK
36 mg/kg daily in 2 divided doses
ii) Treatment and
increased to 54 mg/kg/day in severe
prophylaxis of pneumocystis infections
carinii pneumonia (PCP) in ii) Treatment: ADULT & CHILD > 4
immunocompromised
wks: 120 mg/kg/day PO/IV infusion in
patients
2 - 4 divided doses for 14 days.
Prophylaxis: ADULT: 960 mg od or
960 mg on alternate days (3 times a
week) or 960 mg bd on alternate days
(3 times a wk).
CHILD 6 wks - 5 mths: 120 mg bd on
3 consecutive days or 7 days per wk;
6 mths - 5 yrs: 240 mg;
6-12 yrs: 480 mg
i) Severe or complicated
infections due to susceptible
infection ii) Treatment and
prophylaxis of pneumocystis
carinii pneumonia (PCP) in
immunocompromised
patients
i) ADULT: 1 - 3 tablets bd ii)

Treatment: ADULT & CHILD > 4 wks:
120 mg/kg/day in 2 - 4 divided doses
for 14 days. Prophylaxis: ADULT: 960
mg od or 960 mg on alternate days (3
times a wk) or 960 mg bd on alternate
days (3 times a wk). CHILD; 6 wks - 5
mths: 120 mg bd on 3 consecutive
days or 7 days per wk; 6 mths - 5 yrs:
240 mg; 6 - 12 yrs: 480 mg
(Bactrim)
RM0.09/tab
40
Erythromycin
Ethylsuccinate 400 mg/5
ml Suspension
CHILD: mild to moderate infection: 30 - RM4.98/60ml

50 mg/kg/day in equally divided doses
every 6 hrs. For more severe infection
this dose may be doubled. Doses may
be given bd - tds a day
41
Erythromycin
Ethylsuccinate 400 mg
Tablet (EES)
ADULT: 400-800 mg bd.

CHILD: 30-50 mg/kg/day in 2-4
divided doses
37
RM0.26/tab
No Generic Name
42 Erythromycin
Lactobionate 500 mg
Injection
Cat Indications
A* Only for treatment of i)
certain forms of meningitis
ii) septicaemia not
responding to usual
antibiotics iii) mycoplasma
pneumonia iv) infection with
gram-positive organisms
(e.g. tetanus, streptococcal
infection) associated with
Penicillin allergy, only when
oral erythromycin cannot be
given
43
Clarithromycin 250 mg
Tablet
A*
Only for i) treatment of

i) 250-500 mg bd. Up to 6-14 days
complicated respiratory tract ii) 500 mg bd with omeprazole &
infection not responding to amoxicillin. Up to 2 wks
standard macrolides
ii) eradication of
Helicobacter pylori infection
RM2.12/tab
(pack of 30)
RM0.45/tab
(pack of 100)
44
Azithromycin 500mg
Injection
A*
RM49.70/vial
45
Azithromycin 250 mg
Tablet
A*
Only for treatment of severe 500 mg IV as a single dly dose for a

atypical pneumonia
minimum of 2 days followed by 500
mg oral dose as a single dly dose to
complete a 7-10 days course
i) Treatment of complicated i) 500 mg dly for 3 days
respiratory tract infection not ii) 1 g as a single dose
responding to standard
iii) 1 g wkly
macrolides
ii) Adult treatment of
uncomplicated genital
infections due to Chlamydia
trichomatis or susceptible
Neisseria gonorrhoea
iii) Prophylaxis against
Mycobacterium avium
complex in patients with
advanced HIV
46
Clindamycin HCl 300 mg

Capsule
A*
i) Skin and soft tissue

infections, bone& joint
infections
ii) Cerebral toxoplasmosis
iii) Children less than 8
years old:Treatment and
prophylaxis of malaria in
combination with quinine, as
an alternative to doxycline
i) ADULT: 150-300 mg qid; up to 450

mg qid in severe infections;
CHILD: 3 - 6 mg/kg qid
ii) 600 mg qid for 6 wks
iii) 10mg/kg bd, in combination with
quinine. The combination to be given
for 7 days
RM0.62/cap
47
Clindamycin Phosphate
150 mg/ml Injection
A*
i) Skin and soft tissue

infections, bone & joint
infections
ii) Cerebral toxoplasmosis
RM27.50/ea
48
Streptomycin Sulphate
1 g Injection
Tuberculosis
i) ADULT: 0.6 - 2.7 g dly (in 2 - 4

divided doses); up to 4.8 g dly; CHILD
> 1 mth, 15 - 25 mg/kg/day or 350
mg/m2/day in 3 - 4 divided doses ii)
1200 mg qid for 3 wks followed by 300
mg orally qid for another 3 wks
0.5 - 1 g IM of Streptomycin base daily
or at longer intervals, cumulative dose
should not exceed 100 g
49
Gentamicin 7.5 mg
Beads
Treatment of chronic
7.5 - 22.5 mg chains to fill affected
osteomyelitis of postcavity
traumatic, post-operative or
hematogenous origin
38
Dosage
Remark
ADULT& CHILD: 15 - 20 mg/kg/day in RM13/vial
divided doses by IV infusion or
intermittently by slow IV over 1 hr at
intervals not more than 6 hrly.
Max: 4 g/day
RM1.17/tab
RM1.04/vial
RM35/unit
KPK
No Generic Name
50 Gentamicin Sulphate
80 mg/2 ml Injection
Cat Indications
Dosage
B Infections due to susceptible ADULT: 3 - 5 mg/kg/day tds IM or IV.
organisms
CHILD up to 2 wks: 3mg/kg bd;
2 wks - 12 yrs: 2 mg/kg tds
51
Amikacin 500 mg/2 ml

Injection
52
Ofloxacin 100 mg Tablet
(Tarivid)
53
54
Ciprofloxacin 250 mg
Tablet
(Ciprobay)
Ciprofloxacin 200 mg /
100 ml Injection
Remark
RM0.52/amp
Infections due to susceptible ADULT: (IM or IV): 15 mg/kg/day bdorganisms

tds for 7 - 10 days. Max: 1.5 g/day.
CHILD: 15 mg/kg/day bd - tds. Max:
1.5 g/day. Neonates: Initial LD of 10
mg/kg followed by 7.5 mg/kg/day bd.
Max: 15mg/kg/day
i) As second-line treatment i) 400 mg/day
of leprosy
ii) 400 mg bd
ii) As second-line treatment iii) 200 mg bd
for tuberculosis and
multidrug resistant
tuberculosis (MDR-TB)
iii) Sequential therapy for
UTI and pyelonephritis
RM6.72/amp
Treatment of infections due

to susceptible bacterial
strains
Treatment of infections due
to susceptible bacterial
strains
ADULT: 125-750 mg bd. Acute

gonorrhoea: a single dose of 250 mg
RM0.06/tab
ADULT uncomplicated infections:200

mg/day; acute gonorrhoea and acute
uncomplicated cystitis in women can
be treated with a single infusion of 100
mg.Other infections: 400-800 mg/day
RM10.80/vial
(Ciprobay)
RM0.22/tab
55
Vancomycin HCl 500 mg

Injection
A*

Slow IV infusion, ADULT: 500 mg over
MRSA and CAPD peritonitis at least 60 mins qid or 1 g over at least
100 mins bd.
NEONATE up to 1 wk, 15 mg/kg
initially, then 10 mg/kg bd.
INFANT 1 - 4 wks, 15 mg/kg initially
then 10 mg/kg tds.
CHILD > 1 mth, 10 mg/kg qid
RM8.70/vial
56
Fusidic Acid 500 mg

Injection
A*
Treatment of severe
staphylococcal infections
especially Methicillin
Resistant Staphylococcus
aureus (MRSA). To be used
in combination therapy only
ADULT : 500 mg tds diluted to 250 500 ml infused slowly over 2 hrs.
Max: 2 g dly.
CHILD and INFANT : 20 mg/kg/day
divided into 3 equal doses infused
slowly over 2 - 4 hrs
RM60.32/vial
57
Fusidic Acid 250 mg

Tablet
A*
ADULT: 500 mg tds, skin and soft

tissue infection: 250 - 500 mg bd
RM1.49/tab
58
Metronidazole 500
mg/100 ml Injection
(Flagyl)
Treatment of infections
caused by susceptible
organisms especially
Staphylococcal infections
including Methicillin
Resistant Staphylococcus
aureus (MRSA)
Anaerobic infections
ADULT: 500 mg IV infusion tds.

CHILD: 7.5 mg/kg tds
RM2.52/bottle
59
Colistin (Polymyxin E)
1,000,000 unit Injection
Adults > 60kg: 1-2 million units tds.

Max: 6 million units in 24 hrs.
Children < 60 kg : 50 000 to 75 000
units/kg/day in 3 divided dose.
Dosage adjustment required in renal
impairment.
RM18.08/vial
Acinetobacter CBC sepsis

multiresistant (even to
sulperazone)
(Colistimethate)
39
KPK
J02 Antimycotics For Systemic Use

No Generic Name
Cat Indications
1 Amphotericin B 50 mg for
A Systemic fungal infections
Injection
Ketoconazole 200 mg
Tablet
Fluconazole 50 mg
Capsule
Fluconazole 2 mg/ml
Injection
Itraconazole 100 mg
Capsule
A*
Dosage
Remark
RM22.02/vial
ADULT: 0.25 mg/kg/day by IV
infusion, gradually increase if tolerated
to 1 mg/kg/day. Max in severe cases:
1.5 mg/kg dly or on alternate days. For
neonates, lower doses are
recommended
i) 200 mg with meal od for 10 days
ii) 200 - 400 mg dly for 4 wks - 6 mths
iii) 200 - 400 mg dly for 6 - 12 mths.
Max 400 mg dly
RM0.24/tab
i) Oropharyngeal
candidiasis, atrophic oral
candidiasis associated with
dentures, other candidal
infections of mucosa
ii) Tinea pedis, corporis,
cruris, versicolor and dermal
candidiasis
iii) Invasive candidal &
cryptococcal infections
(including meningitis)
iv) Prevention of relapse of
cryptococcal meningitis in
AIDS patients after
completion of primary
therapy
v) Prevention of fungal
infections in
immunocompromised
patients considered at risk
as a consequence of HIV
infections or neutropenia
following cytotoxic
chemotherapy, radiotherapy
or bone marrow transplant
i) Oropharyngeal candidiasis: 50-100

mg dly for 7-14 days (Max 14 days)
except in severely
immunocompromised patients,
treatment can be continued for longer
periods.
Atrophic oral candidiasis associated
with dentures: 50 mg dly for 14 days.
Other candidal infections of mucosa:
50-100 mg dly for 14-30 days.
CHILD: 3-6 mg/kg on first day then 3
mg/kg dly (every 72 hrs in NEONATE
up to 2 wks old, every 48 hrs in
NEONATE 2-4 wks old)
ii) 50 mg daily for 2-4 wks, max 6 wks
iii) 400 mg initially then 200-400 mg
dly for 6 - 8 wks.
CHILD: 6-12 mg/kg daily (every 72 hrs
in NEONATE up to 2 wks old, every
48 hrs in NEONATE 2-4 wks old)
iv) 100 -200 mg dly
v) 50-400 mg daily. CHILD: 3-12
mg/kg dly (every 72 hours in
NEONATE up to 2 wks old, every 48
hrs in NEONATE 2-4 wks old)
RM1.29/cap
i) Dermatomycosis including
pityriasis versicolor
ii) Oral candidiasis
iii) Palmar tinea manus and
plantar tinea pedis
iv) Fingernail
onychomycosis
v) Toenail onychomycosis
vi) Vulvovaginal candidiasis
i) 200 mg od for 7 days

ii) 100 mg dly for 15 days
iii) 200 mg bd for 7 days
iv) 200 mg bd for 1 wk/mth
v) 200 mg bd for 1 wk/mth for 3 mths
vi) 200 mg morning and evening for 1
day or 200 mg od for 3 days
RM0.74/cap
A/KK i) Pityriasis versicolor

ii) Systemic mycosis (other
skin mycoses)
iii) Nail infections
40
RM19.80/vial
No Generic Name
7 Caspofungin Acetate
50mg Injection
(Cancidas)
J04 Antimycobacterials
No Generic Name
1 Rifampicin 150 mg
Capsule
Cat Indications
A* i) Confirmed systemic fungal
infection in patients who are
refractory or intolerant to
other fungal therapies. ii)
For pediatric patient (12 mth
and older) for the following
indications:
a) Empirical therapy for
presumed fungal infections
in febrile, neutropenic
patients
b) Treatment of invasive
candidiasis, including
candidemia and the
following Candida infections
; intra-abdominal
abscesses, peritonitis and
pleural space infections
c) Treatment of esophageal
candidiasis d) Treatment of
invasive Aspergillosis in
patients who are refractory
to or intolerant of others
therapy (eg: Amphotericin
B)
Dosage
Remark
RM573.40/
i) Invasive aspergillosis & invasive
vial
candidiasis: ADULT: Initially, 70 mg
infused over 1 hr followed by
Borang E
subsequent doses of 50 mg/day.
Oesophageal candidiasis: ADULT: 50
mg by slow IV infusion over
approximately 1 hr
ii) For all indications, a loading dose of
70mg/m2 on D1 followed by
maintenance dose of 50mg/m2 od.
Cat Indications
B i) Tuberculosis
ii) Leprosy
iii) Prophylaxis for
meningococcal meningitis
B
Dosage
Remark
RM0.17/cap
i) ADULT: 450 - 600 mg as a single
morning dose. CHILD: 10 - 20 mg/kg
dly in 1-2 doses. Directly observed
therapy (DOT): 10 mg/kg twice wkly or
RM0.29/cap
3 times/wk. Max: 600 mg
ii) 600 mg/day
iii) 600 mg bd for 2 days
Rifampicin 300 mg
Capsule
Isoniazid 100 mg Tablet
i) Tuberculosis
ii)Tuberculous meningitis
i) ADULT and CHILD 5 mg/kg (4-6

mg/kg) daily,max 300 mg daily) or 10
mg/kg 3 times wkly
ii) 15 - 20 mg/kg dly
RM0.02/cap
Pyrazinamide 500 mg
Tablet
Tuberculosis
ADULT & CHILD : 25 mg/kg dly or 35

mg/kg 3 times wkly
RM0.16/tab
Ethambutol HCl 400 mg

Tablet
Tuberculosis
ADULT & CHILD > 13 yrs: Initial

treatment: 15 mg/kg as a single dly
dose 24 hrly. Retreatment: 25
mg/kg/day as a single dose 24 hrly.
Concurrent anti-TB drug required.
After 60 days, decrease to 15 mg/kg
as single dose 24 hrly
RM0.28/tab
Dapsone 100 mg Tablet
i) Leprosy
ii) Dermatitis herpetiformis
i) ADULT: 6 - 10 mg/kg wkly (around

50 - 100 mg dly). CHILD: 1 - 2
mg/kg/day. Max: 100 mg/day
ii) ADULT: 50 - 300 mg dly
RM0.06/tab
41
J05 Antivirals for Systemic Use

No Generic Name
Cat Indications
1 Acyclovir 250 mg
A* Treatment and prophylaxis of
herpes simplex in
Injection
immunocompromised, severe
initial genital herpes and
Varicella -Zoster
Acyclovir 200 mg Tablet
Acyclovir 800 mg Tablet
Ganciclovir Sodium 500

mg/10 ml Injection
A/KK i) Mucocutaneous Herpes

Simplex infection in
immunocompromised and
AIDS patients ii) Primary
and recurrent Varicella
Zoster infection in
immunocompromised and
AIDS patients iii) Severe
Kaposi Varicella Eruption
(Eczema herpeticum) iv)
Severe primary HSV
infections (eg. Neonatal
herpes, encephalitis,
eczema herpeticum, genital
A herpes, gingival stomatitis,
vaginal delivery with
maternal vulva herpes) v)
Severe and complicated
varicella infection (eg.
Encephalitis, purpura
fulminans) vi) Severe zoster
infection in paediatrics (eg.
Encephalitis, purpura
fulminans,
immunocompromised
patients and facial, sacral
and motor zoster)
A*
Treatment of
cytomegalovirus (CMV)
disease in
immunocompromised
patients, prevention of CMV
disease during
immunosuppressive therapy
following organ
transplantation
42
Dosage
Remark
ADULT: 5 mg/kg by IV infusion tds for RM5.80/vial
5 days, doubled to 10mg/kg tds in
varicella-zoster in the
immunocompromised and in simplex
encephalitis (usually given for at least
10 days in encephalitis; possibly for 14
- 21 days). Neonate & Infant up to 3
mths with disseminated herpes
simplex: 20mg/kg tds for 14 days (21
days in CNS involvement), varicellazoster 10-20mg/kg tds usually for 7
days. CHILD, 3 mths -12 yrs: Herpes
simplex or Varicella Zoster: 250
mg/m2 tds for 5 days, doubled to 500
mg/m2 tds for varicella-zoster in the
immunocompromised and in simplex
encephalitis (usually given for 10 days
in encephalitis)
i) ADULT: initially 400 mg 5 times dly
for 7-14 days.
CHILD < 2 yrs: 200 mg 4 times dly,
CHILD > 2 yrs: 400 mg 4 times dly
ii), iii) and iv) ADULT: 200 - 400 mg 4
times dly.
CHILD: < 2 yrs, half adult dose;
> 2 yrs, adult dose
v) ADULT: 800 mg 5 times dly for 7
days
vi) ADULT: 20 mg/kg (max: 800 mg) 4
times dly for 5 days,
CHILD 6 yrs: 800 mg 4 times dly.
CHILD l< 2 yrs; 400mg 4 times dly,
> 2 yrs; 800mg 4 times dly
RM0.55/tab
RM0.57/tab
Initial: 5 mg/kg infused over 1 hr bd for RM146/unit

14-21 days (CMV retinitis treatment) or
7-14 days (CMV disease prevention). Borang E
Long term maintenance: 6 mg/kg dly
for 5 days/wk or 5 mg/kg dly for 7
days/wk
No Generic Name
5 Indinavir Sulphate 400
mg Capsule
Cat Indications
Dosage
Remark
RM1.90/cap
A* i) Post-exposure prophylaxis ADULT: 800 mg tds.
(PEP) among healthcare
CHILD (investigational): 500 mg/m2
workers in high-risk HIV
tds (patients with smaller body surface
occupational exposure
area (BSA) may require lower doses
ii) For therapy as part of
of 300 - 400 mg/m2 tds)
combination antiretroviral
treatment on adult HIV
patients ie Highly Active AntiRetroviral Therapy (HAART)
Ritonavir 100 mg
Capsule
A*
Progressive or advanced
HIV infection in combination
with other antiretroviral
agents. Criteria for use: a)
Clinical AIDS b) CD4 < 350
cells or c) Viral load >
10,000 copies/ml
ADULT: initially 300 mg bd, increase

by 100 mg bd increments to 600 mg
bd. For older child who can swallow
soft gelatin capsule; 250 mg/m2 bd for
2 days, if tolerate 400 mg/m2 bd
onwards
RM3.18/cap
Lopinavir/Ritonavir Oral
Solution
Management of patients
with asymptomatic and
symptomatic (early or
advanced) HIV Infection
with CD4 cell counts
12 mg/kg bd for those 7 - 15 kg and

10mg/kg twice daily for those 15 - 40
kg taken with food, up to a maximum
dose of 533 mg Lopinavir/13.3mg
Ritonavir in children > 45 kg (5 ml) bd.
Dose may varies depending on types
of combination used
RM795.50/
160ml
A*
As second line protease

ADULT and CHILD with BSA > 1.4 m2 RM7.79/tab
inhibitor if intolerant to
or > 40kg: 2 tablets bd
Borang E
indinavir/ ritonavir as part of
HAART regimen
(Kaletra)
Lopinavir 200 mg and

Ritonavir 50 mg capsule
(Kaletra)
Zidovudine 100 mg
Capsule
10
Zidovudine 10 mg/ml
Syrup
11
Zidovudine 1% Injection
12
Stavudine 30 mg Tablet
A/KK i) Management of patients

with asymptomatic and
symptomatic (early or
advanced) HIV infections
A* with CD4 cell counts less
than 500 cu. mm
ii) Neonatal prophylaxis
A
To reduce the rate of

maternal-foetal transmission
of HIV in: i) HIV-positive
pregnant women over 14
weeks of gestation ii) Their
newborn infants
A/KK HIV infection, in

combination with other
antiretrovirals
43
i) Adult: 500-600 mg/day in 2-3 divided

doses.
Child > 3 mths: 360-480 mg/m2 dly in
3-4 divided doses; max 200 mg qid
ii) 2 mg/kg qid within 12 hrs after birth
up to 6 wks
RM1.02/cap
i) 200 mg tds or 300 mg bd until start

of labor. During labour, by IV infusion
initially 2 mg/kg over 1 hr followed by
continuous IV infusion at 1 mg/kg/hr
until delivery ii) 2 mg/kg orally qid
within 12 hrs after birth. If unable to
receive oral dose: FULL TERM: 1.5
mg/kg/dose qid, INFANTS 30 wks and
< 35 wks gestation at birth: 1.5
mg/kg/dose bd; at 2 wks of age,
advance to 1.5 mg/kg/dose tds,
INFANTS < 30 wks gestation at birth:
1.5 mg/kg/dose bd; at 4 wks of age,
advance to 1.5 mg/kg/dose tds
RM735.60/
vial
ADULT > 60 kg: 40 mg bd; < 60 kg: 30

mg bd. CHILD < 30 kg: 30 mg bd; < 30
kg: 15 mg bd
RM0.67/tab
RM50.80/ vial
No Generic Name
13 Lamivudine 10 mg/ml
Oral Solution
(3TC)
Cat Indications
A* HIV infection in combination
agents
14
A*
Lamivudine 100 mg
Tablet
(Zeffix)
15
Lamivudine 150 mg
Tablet
(3TC)
16
Adefovir Dipivoxil 10 mg
Tablet
(Hepsera)
17
Nevirapine 200 mg Tablet
18
Efavirenz 200 mg
Capsule
(Stocrin)
19
Efavirenz 600 mg Tablet

(Stocrin)
Dosage
Remark
RM231.40/
ADULT: 150 mg bd or 300 mg od.
INFANT < 1 mth: 2 mg/kg bd. CHILD 1 240ml
month or over: 4 mg/kg bd. Max: 300
mg dly
RM7.33/tab
Management of chronic
ADOLESCENTS > 16 yrs and
hepatitis B infection
ADULTS: 100 mg/dose od
Borang E
associated with evidence of
hepatitis B viral replication
and active liver inflammation
A/KK HIV infection in combination ADULT: 150 mg bd or 300 mg od.

INFANT < 1 mth: 2 mg/kg bd. CHILD 1
agents
month or over: 4 mg/kg bd. Max: 300
mg dly
A* i) Treatment of chronic
Adult over 18 years: 10mg once daily
HBeAg positive and HBeAg
negative hepatitis B
infection in adults with
compensated liver function
(lamivudine should be tried
first)
ii) Lamivudine-resistant
chronic hepatitis B virus
infection with either
compensated or
decompensated hepatitis
function
A*
Treatment of HIV-1 infection 200 mg od for first 14 days then 200

in combination with other
mg bd
antiretroviral agents
RM2.60/tab
RM8.42/tab
(Only by
hepatologist
and
gastroenterolo
gist for
approved
indications)
RM0.67/tab
RM2.86/cap
ADULT: 600 mg od.
CHILD < 17 yrs, > 40 kg: 600 mg od,
32.5 - 40 kg: 400 mg od, 25 - 32.5 kg:
350 mg od, 20 - 25 kg: 300 mg od, 15 20 kg: 250 mg od, 13 - 15 kg: 200 mg RM6.51/tab
od. No studies in children < 3 yrs or <
13 kg. Tablet formulation unsuitable
for children < 40 kg
RM3.03/tab
A/KK HIV infection in combination ADULT and CHILD > 12 years: 1
with at least one other
tablet bd
antiretroviral drug
A*
Combination therapy for HIV

infections with a protease
inhibitor and or Nucleoside
Reverse Transcriptase
A/KK Inhibitors (NRTIs)
20
Zidovudine 300 mg
Tablet & Lamivudine 150
mg Tablet (Combivir)
21
Tenofovir Disoproxil
Fumarate 300 mg &
Emricitabine 200 mg
Tablet
(Tenvir EM)
22
Stavudine 30mg &

A/KK Fixed dose triple therapy for 1 tablet bd for patients < 60 kg
Lamivudine 150mg &
treatment of HIV infection in
Nevirapine 200mg Tablet
adults once patients have
(SLN 30)
been stabilized on the
maintenance regimen of
nevirapine 200 mg bd and
have demonstrated
adequate tolerability to
nevirapine
A*
Treatment of HIV-1 infection 1 tablet once daily.

in adults in combination with
other antiretroviral agents
(such as non-nucleoside
reverse transcriptase
inhibitors or protease
inhibitors).
44
RM5.33/tab
RM2.82/tab
J06 Immune Sera and Immunoglobulins

No Generic Name
Cat Indications
1 Antivenene Malaysian Pit
B Bitten by pit viper
Viper Injection
Dosage
Remark
Reconstitute content for the vial with 5 RM344.77/
ml sterile pyrogen-free distilled water. vial
Administer by IV infusion 200 ml of
normal saline over a period of 1 - 2 hrs
Antivenene Serum
(Cobra) Injection
Treatment for cobra bites
Antivenene Serum (Sea

snake) 1000 units/26.3ml
Injection
Treatment for sea snake

bites
Antivene Serum Snake

polyvalent Injection
Antidote for snake bites
Recommended initial dose is 20ml by RM148.20/

vial
intravenous infusion. The injection
should be given very slowly as 5 mins
KPK
by direct slow IV route or 1hr by
infusion. If symptoms continue, further
doses are administered as required
until symptoms completely disappear
Anti RhD Gamma

Globulin 250 mcg/2 ml
Injection (500 units=100
mcg)
(Rhogram)
Prevention of Rh(D)
sensitisation by IM injection
to rhesus-negative woman
after delivery of rhesuspositive infant
50 - 100 mcg within 72 hours after

incompatible blood transfusion: 25
mcg (125 units) per ml transfused
blood, up to 1000 mcg
RM331.76/
vial
Tetanus Immunoglobulin,
Human 250 Units/Vial
Injection
Passive immunization
against tetanus
Prophylaxis of tetanus: IM 250 units.

Treatment of tetanus: IM 30 - 300
units/kg
RM63.91/ea
Hepatitis B
Immunoglobulin (Human)
Injection
i) For post-exposure
prophylaxis of hepatitis B
ii) Prophylaxis against
recurrence of hepatitis B
infection in chronic hepatitis
B post liver transplantation
i) ADULT and CHILD > 10 yrs: A

single dose of 500 units IM within 48
hrs and not > 1 wk after exposure
ii) Different regimens depending on
hepatitis B virus (HBV) DNA positivity
RM128.50/ea
(Hepa-big)
45
The reconstituted antivenin should be

given by slow IV infusion,
approximately 2ml/min.Subsequent
dose can be given bd according to the
clinical symptoms
1000 units by IV infusion over 1/2 to 1
hr. In severe cases 3000 -10000 units
may be required
RM344.77/
vial
RM13224.0/
vial
J07 Vaccines
No Generic Name
1 Haemophilus Influenzae
Type B Conjugate 10
mcg Vaccine
Cat Indications
C Immunisation of infants
against Haemophilus
Influenzae Type B
Dosage
0.5 ml IM
Remark
RM31.66/vial
Meningococcal A, C, Y,
W135 Vaccine Injection
Immunisation against
Prophylaxis: 0.5 ml SC
meningococcal diseases
caused by Neisseria
meningitis Group A, Group
C, Group Y or Group W-135
RM55.00/vial
(1 dose),
RM290.00/
vial (10 dose)
Pneumococcal Vaccine
(Polyvalent)
Prevention of pneumococcal
infections in high risk
subjects from the age of 2
years including patient with
a history of splenectomy or
scheduled splenectomy
Primary injection: 1 single injection

(0.5 ml) only. Booster: Must not be
given within 5 yrs except in very high
risk patient who received the vaccine
while under immunosuppressive
treatment
RM49.30/vial
Tetanus Toxoid Injection
Immunization against
tetanus infection
0.5 ml at 2 mths followed by second

dose after 4 wks and third dose after
another 4 wks. Booster every 10 yrs
RM5.84/vial
BCG.Freeze-dried
Vaccine Injection
For the prevention of

tuberculosis
0.1 ml by intradermal injection.

INFANT < 12 mths: 0.05 ml
RM13.07/vial
Typhoid Vaccine Injection
Active immunization against 0.5 ml single IM injection into the

typhoid fever in adult and
deltoid or vastus lateralis, may
child more than 2 years
reimmunize with 0.5 ml IM every 2 yrs
if needed
RM13.92/vial
Hepatitis B Vaccine
Injection
Immunisation against
infections caused by
Hepatitis B virus
ADULTS > 20 yrs: 10 mcg/dose.

ADOLESCENT 11 - 19 years: 5
mcg/dose.
NEWBORN and CHILD up to 10
years: 2.5 mcg/dose.
INFANTS born to HBsAg positive
mothers: 3 doses of 0.5 ml each.
Second dose to be given after 1 mth
and booster dose after 6 mths
RM4.87/vial
(Adult - 1
dose),
RM2.43/vial
(Paed 10mcg/0.5ml)
Rabies Human Diploid

Cell Vaccine
(Lyophilised) Injection
Pre-exposure and postexposure vaccination

against rabies
Prophylaxis: 3 dose (1 ml each)

schedule on days 0, 7 and 28. Booster
dose after every 2 - 3 yrs.
Post exposure prophylaxis: use after
attack of a potential rabid animal: 1
dose on days 0, 3, 7, 14 and 30. In
previously vaccinated individuals 2
doses on day 0 and 3
RM310.35/
vial
46
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 Antineoplastic Agents

No Generic Name
1 Cyclophosphamide 1g
Injection
Cyclophosphamide
mg Tablet
50
Cat Indications
A i) Solid tumours (adult and
paediatric), leukaemia, nonHodgkin's lymphoma,
multiple myeloma
ii) Severe lupus nephritis
(Class III and IV)
iii) Other systemic vasculitis
iv) Systemic lupus
erythematosus, rheumatoid
arthritis, polyarteritis
nodosa, wegener
granulomatosis
v) Pemphigus vulgaris
Dosage
Remark
RM19.73/vial
i) ADULT: 600 - 750 mg/m2 IV once
every 3 wks as part of combination
Care with pre
regime. CHILD: Dose variable
and postdepending on disease and protocol.
hydration.
Range 600 mg/m2 to 2 g/m2 infusion Mesna to be
given with
over 1 - 6 hrs (lower doses can be
doses > 1
given as bolus). Higher doses are
g/m2.
used in haematopoetic stem cell
transplant-refer to specific protocols
ii) 750 mg/m2 BSA mthly for 18 mths
iii) 750 mg/m2 BSA mthly for 6 mths.
Dose can be adjusted up to 1,000
mg/m2 BSA to achieve adequate
leucocyte suppression
iv) 500 - 1000 mg IV (Regime varies
according to indication). Starting dose
may be given fortnightly then at mthly
intervals followed by 3 mthly intervals
v) 500 mg infusion on the 2nd day of
the dexamethasonecyclophosphamide pulsed regime, the
cycle is repeated every 4 wks up to 6
cycles or till remission followed by oral
cyclophosphamide
i) Solid tumours, leukaemia,

lymphoma, autoimmune
disorders, autoimmune
bullous diseases,
connective tissue disease,
pyoderma gangrenosum
ii) For severe lupus nephritis
(Class III & IV), systemic
vasculitis and steroid
resistant/dependent
nephrotic syndrome
iii) Systemic lupus
erythematosus (SLE),
rheumatoid arthritis,
polyarteritis nodosa,
wegener granulomatosis
i) ADULT: 50 - 100 mg/day. Monitor

full blood count (FBC), liver function,
urine microscopy and renal function.
CHILD, up to 1 yr: 10-20 mg dly,
1-5 yrs: 30-50 mg dly,
6-12 yrs: 50-100 mg dly
ii) 2 mg/kg/day for 3-4 mths
iii) 1 - 1.5 mg/kg/day orally in divided
doses
RM7.68/tab
RM2.62/tab
Borang E
Chlorambucil 2mg Tablet
Low grade lymphoma,

chronic lymphocytic
leukaemia. Ovarian cancer
200 mcg/kg dly for 4 - 8 wks
Ifosfamide 1 g Injection
A*
i) Solid tumours
ii) Leukaemia
iii) Lymphoma
i) 1.2 - 2.4 g/m2/day for 3 - 7 days as a RM69.60/vial

30-120 mins infusion. Alternatively,
can also be given as a single high
dose, eg. 5 g/m2 in a 24 hr infusion.
Cycles may be repeated every 3-4 wks
ii) CHILD: 400 - 3000 mg/m2/day for 3 5 days according to protocol
iii) Refer to protocols
47
No Generic Name
5 Dacarbazine 100 mg
Injection
Cat Indications
A* i) Malignant melanoma,
sarcomas, neuroblastomas
and other childhood solid
tumours
ii) Hodgkin's Disease
Dosage
i) 250 mg/m2 for 5 days, may be
repeated every 3 wks
ii) 375 mg/m2 IV every 2 wks
Remark
RM36.30/ea
Methotrexate 50 mg
Injection
i) Solid tumours
ii) Gestational trophoblastic
disease
iii) Acute
leukaemia/lymphomas
iv) Rheumatoid arthritis,
psoriatic arthropathy,
severe/erythrodermic
psoriasis
i) 50 mg/m2 once every 2 - 3 wks in

combination with other drugs
ii) 50 mg IV Day 1, 3, 5, 9 every 3 wks.
For high risk gestational trophoblastic
disease, use 100 mg/m2 as part of
EMA-CO regime
iii) High dose regimes: 500 - 3000
mg/m2 per dose may be used,
employing the 500 mg preparations.
CHILD: CNS prophylaxis for acute
leukaemia 2 gm/m2 over 24 hrs with
folinic acid rescue, 3 doses for B-cell
lineage. 4 doses for T-lineage all every
3 wks. Relapse ALL: 1 gm/m2 over 36
hrs with folinic acid rescue every 3
wks for 9 doses, maintenance: 50
mg/m2 every 2 wks. B-cell lymphoma:
3 gm/m2 over 3 hrs with folinic acid
rescue for three doses. Dosage for
intrathecal treatment and prophylaxis
in leukaemia: less than 1 year: 5 mg, 1
- 2 years: 7.5 mg, 2 - 3 years: 10 mg,
more than 3 years: 12.5 mg.
iv) Dose used by rheumatologist: 10 15 mg IM injection or oral wkly. Dose
used by dermatologist: 10 - 25 mg IM
injection wkly
RM8.70/vial
Methotrexate Sod 2.5 mg

Tablet
i) Acute lymphoblastic
leukaemia and acute
promyelocytic leukemia
(maintenance)
ii) Extensive plaque
psoriasis, erythrodermic
psoriasis, pustular psoriasis,
Reiter's syndrome,
connective tissue disease
i) ADULT: 20 mg/m2 wkly. CHILD: 2030 mg/m2 wkly according to protocol

ii) Relapsed acute lymphoblastic
leukaemia (ALL): 100 mg/m2/day for 5
days 6 wkly according to protocol
iii) Dose used by dermatologist: 5-25
mg wkly. Liver biopsy after cumulative
dose of 1.5 g and repeat liver biopsy
with additional gram received. Max
cumulative dose is 4g. Monitor full
blood count (FBC), renal and liver
function
iv) Rheumatoid arthritis, psoriatic
arthropathy: dose used by
rheumatologist: 2.5 mg/wk orally
starting dose, increasing to 7.5 - 20
mg/wkly
RM0.32/tab
Fluorouracil 1 g/20 ml
Injection
A*
Cancers of gastro-intestinal
tract, breast and pancreas,
head and neck.
Ophtalmological indication:
trabeculectomy
500-600 mg/m2 IV in combination with

other cytotoxic agents, repeated every
3 wks or 300-450 mg/m2 IV slow bolus
dly for 5 days in combination with
biological response modifiers,
repeated every 4 wks or 3000-3750
mg/m2 as a continuous infusion over 5
days in combination with a platinum
compound every 3 to 4 wks
RM98.80/ vial
(5-FU)
48
No Generic Name
9 Cytarabine (Cytosine
Arabinoside) 100 mg
Injection
Cat Indications
A i) Central nervous system
lymphoma
ii) Meningeal leukemia
iii) Non Hodgkin's
Lymphoma
iv) High dose cytarabine as
conditioning to cytoreduce
the disease before stem cell
transplant for relapsed or
refractory leukemia
v) As salvage for acute
lymphocytic leukemia
vi) As salvage for acute
myeloid leukemia
vii) As palliative
chemotherapy in elderly
acute myeloid leukemia/
myelodysplastic syndrome
Dosage
Remark
RM1.50/ea
Standard doses 100-200 mg/m2 dly
over 5-10 days. Higher doses for
intensification/consolidation: 1000 3000 mg/m2 dly over 3-5 days
depending on specific protocols.
CHILD: Dose variable depending on
disease and protocol. Range from 100
mg/m2 to 3 g/m2 bd. May be given as
SC, IV bolus or infusion.
Intrathecal dose: < 1 yr: 15 mg, 1-2
yrs: 20 mg, 2-3 yrs: 25 mg, > 3 yrs: 30
mg. (ENSURE THAT PREPARATION
IS SUITABLE FOR INTRATHECAL
USE)
10
A*
i) Locally advanced or
metastatic non-small cell
lung cancer
ii) Locally advanced or
metastatic pancreatic
cancer
iii) In combination with
carboplatin in the treatment
of patients with recurrent
epithelial ovarian
carcinoma, who have
relapsed more than six
months,
following
i) Metastatic
breastplatinumcancer
i) Alone or with cisplatin: 1000 mg/m2

day 1 & 8 every 3 wks or 1000 mg/m2
day 1, day 8, day 15 every 4 wks
ii) Initially 1000 mg/m2 wkly for 7 wks
followed by 1 wk rest. Subsequent
cycles 1000 mg/ m2 wkly for 3 wks
followed by 1 wk rest
iii) Gemcitabine 1000 mg/m2 as 30
minutes IV infusion day 1 & 8 of each
21-day cycle followed by carboplatin
on day 1 to attain a target AUC of 4
mg/ml/min
iv)
mg/m2
on days
1 and 8and
of
i) &1250
ii) 1250
mg/m2
bd (morning
in elderly and poor

performance status patients
and refractory to taxanes.
ii) Metastatic colon cancer,
first line in elderly and poor
performance status patients
iii) Colon cancer, adjuvant
therapy for stage III (Duke's
Satage C) following surgery
iv) First line treatment of
patients with advanced
gastric cancer in
combination with a platinumbased regimen
evening) for 2 wks, every 21 days

iii) Recommended for a total of 24 wks Borang E
(8 cycles of 2 wks of drug
administration and 1 wk rest period)
iv) In combination with a platinum on
day 1, give capecitabine 1250 mg/m2
bd for 14 days. Repeated every 3 wks
for 8 cycles or optimum number of
cycles
Gemcitabine HCl 1g
Injection
(Gemzar)
11
Capecitabine 500 mg
Tablet
A*
(Xeloda)
RM151.50/
vial
RM10.33/tab
12
Vinblastine Sulphate 10
mg Injection
Hodgkin's disease,
choriocarcinoma resistant to
other chemotherapeutic
agents, non-small cell lung
cancer, Langerhans cell
histiocytosis
ADULT: Lung cancer - 6 mg/m2 (max:

10 mg) on Day 1. Hodgkin's diseaserefer to protocol.
CHILD: Usual wkly dose: 6 mg/m2
wkly or 3 wkly depending on protocol
RM90.65/vial
13
Vincristine Sulphate 1mg

Inj
i) Solid tumours
ii) Gestational trophoblastic
disease
iii) Non-Hodgkin's
lymphoma
iv) Multiple myeloma
v) Acute lymphoblastic
leukemia
i) ADULT: 1.4 mg/m2 wkly (max: 2 mg

wkly)
ii) Refer to protocol
iii) 1.4 mg/m2 wkly (max: 2 mg wkly)
iv) 0.4 mg/m2 IV continuous infusion
on days 1-4
v) Refer to protocol. CHILD: 1-2
mg/m2 wkly according to protocol
(0.05 mg/kg for infants < 10kg)
RM25.52/vial
(1mg/1ml),
RM8.60/vial
(2mg/2ml)
49
No Generic Name
14 Vinorelbine 10mg Inj
Cat Indications
A* i) First line treatment in nonsmall cell lung cancer in
combination with
A* cisplatin/ifosfomide
ii) Metastatic breast cancer
Dosage
Strictly IV 25 - 30 mg/m2 diluted in
saline solution, infused over 6-10
mins, administered wkly or day 1, 8
every 3 wks
Remark
RM66/vial
RM325.9/vial
15
Vinorelbine 50mg Inj
16
Etoposide 100 mg/5 mg

Injection
A*
i) For treatment of children

with solid tumours, juvenile
myelomonocytic leukemia
(JMML) and Langerhan cell
histiocytosis
ii) Leukaemia, lymphoma
iii) Testicular cancer, lung
cancer, gestational
trophoblastic disease,
gastric cancer, sarcoma
i) CHILD: 60-120 mg/m2/day by IV for

3-5 days every 3-6 wks depending on
protocols
ii) Maintenance or palliative
chemotherapy for elderly acute
myeloid leukemia, consolidation
therapy for acute lymphoblastic
leukemia, stem cell mobilization (Refer
to protocol)
iii) 100 mg/m2 by IV every other day
for 3 doses repeated every 3-4 wks
RM17/vial
17
Paclitaxel 300 mg
Injection
A*
i) Treatment of recurrent
breast cancer, after failure
of anthracycline-based
chemotherapy
ii) Primary adjuvant therapy
in advanced ovarian cancer
in combination with cisplatin
iii) Treatment of locally
advanced or metastatic nonsmall cell lung cancer
(NSCLC) in chemonaive
patients in combination with
platinum compounds
i) 175 mg/m2 IV over 3 hours every 3

weeks ii) 175 mg/m2 IV over 3 hour
followed by cisplatin 75 mg/m2 in
every 3 weeks or 135 mg/m2 IV over
24 hours followed by cisplatin 75
mg/m2 every 3 weeks iii) 135 mg/m2
IV over 24 hours followed by cisplatin
75 mg/m2 every 3 weeks
RM235/vial
18
Docetaxel 20mg/0.5ml
Injection
A*
Docetaxel 80mg/2ml
Injection
A*
i) 75 mg/m2 IV over 1 hr after

doxorubicin 50 mg/m2 and
cyclophosphamide 500 mg/m2 every 3
wk for 6 cycles
ii) 75 mg/m2 IV over 1 hr every 3 wk in
combination with doxorubicin 50
mg/m2
iii) Administer IV over 1 hr IV every 3
wks. Chemotherapy-naive patients 75
mg/m2 immediately followed by 75
mg/m2 cisplatin over 30-60 mins or
carboplatin (AUC 6 mg/mL/min) over
30-60 minutes. Monotherapy of non
small cell lung cancer (NSCLC) after
failure of prior platinum-based
chemotherapy 75 mg/m2
iv) 100 mg/m2 over 1 hr every 3 wks
v) 60-75 mg/m2 IV over 1 hr every 3
wks, administer with oral prednisone 5
mg bd given continuosly
RM684.66/
vial
19
i) Adjuvant treatment of
patients with high risk nodepositive breast cancer in
combination with
doxorubicin and
cyclophosphamide,
ii) Breast cancer, locally
advanced or metastatic, not
previously on cytotoxic
therapy, in combination with
doxorubicin,
iii) First line therapy in non
small cell lung cancer in
stage 3-4 and performance
status 0-1, in combination
with cisplatin,
iv) Inoperable locally
advanced squamous cell
carcinoma of head and
neck, in combination with
cisplatin and 5-FU for
induction treatment,
v) Prostate cancer, in
combination with
prednisolone
20
Actinomycin D
(Dactinomycin) 500
mcg/3ml Injection
i) For solid tumours

i) ADULT: 500 mcg IV dly for max of 5
ii) Gestational trophoblastic days. CHILD: 1.5 mg/m2 once every 3
disease
wks (if < 10 kg, 50 mcg/kg)
ii) 500 mcg IV on Days 2, 4, 6, 8, 10,
repeat every 7-10 days or 500 mcg IV
bolus on Days 1 and 2, repeat every
15 days
50
RM1215.97/
vial
RM45.00/vial
No Generic Name
21 Doxorubicin HCl 50 mg
Injection
Cat Indications
A i) Solid tumours, leukaemia,
non-Hodgkin's lymphoma
ii) Leukaemia (ALL
induction)
iii) Multiple myeloma
Dosage
Remark
i) 30 - 75 mg/m2 IV as a single dose at RM29.45/vial
21 day intervals
ii) 25 - 45 mg/m2 once a wk for the
first 4 wks during induction or reinduction phase (refer to specific
protocol. Caution: Total cumulative
dose of doxorubicin must not exceed
550 mg/m2 due to risk of
cardiotoxicity. CHILD: 30 mg/m2/dose RM11.60/vial
over 6-24 hrs for 1-2 days. Need to
check cardiac function closely by
echocardiography every cumulative
dose of 100 mg/m2 to max: 360
mg/m2
iii) 9 mg/m2 over 24 hrs infusion for 4
days at mthly intervals
22
Doxorubicin HCl 10 mg
Injection
23
Epirubicin 50 mg Injection
A*
Breast cancer, NonHodgkin's lymphoma,

Leukaemia (ALL induction),
gastric cancer, ovarian
cancer
60-100 mg/m2 injected IV in 3-5 min,

repeated at 21 day intervals.
CHILD: 50 mg/m2 over 6 hrs.
Schedule depends on protocol
RM114.84/
vial
24
Bleomycin HCl 15 mg
Injection
Squamous cell carcinoma,

germ cell tumours,
lymphomas. Routes: SC,
IM, IV (either as bolus or as
infusion over 24 hrs), intraarterial, intra-pleural
15 - 60 mg wkly in divided doses or 10

- 20 mg/m2 once or twice wkly or 10
mg/m2 slow bolus in 15 mins D1 and
D15. Max: 400 mg. CHILD: 10-15
mg/m2 over 6 hrs every 3-4 wks
RM158.92/
vial
25
Mitomycin-C 10 mg
Injection
A*
i) Gastrointestinal, lung,
breast, cervical cancers
ii) Bladder tumours
iii) Opthalmological
conditions: conjunctival
squamous neoplasia,
squamous cell carcinoma of
conjunctiva, trabeculectomy
chronic lymphocytic
leukaemia, chronic
myelogenous leukaemia.
Gastric, colorectal, lung
cancer
i) 10 - 20 mg/m2 given as a single

dose through a running IV infusion
repeated every 6-8 wks. The whole
schedule may be repeated depending
on the bone marrow
ii) 10-40 mg dly or every other day
(intravesical)
iii) 0.4 mg topically as a single
application for opthalmological
conditions, duration: 1 to 3 mins
RM208.80/
vial
26
Cisplatin (Cis-Platinum)
50 mg Injection
Germ cell tumours, ovarian

tumours, adult solid
tumours, lymphomas
Germ cell tumours: 20 mg/m2 dly for 5

days every 3 wks for 3-4 courses.
Ovarian tumours: 75 mg/m2 once
every 3 wks as part of combination
therapy or 100 mg/m2 IV once every 3
wks as a single agent. Baseline
creatinine clearance, pretreatment
hydration and forced diuresis are
mandatory. CHILD: 100mg/m2 over 6
hrs once every 3 wks. Lymphomas:
Refer to protocols
RM18.56/vial
27
Carboplatin 450 mg
Injection
A*
Adult solid tumours,

360 - 400 mg/m2, by IV infusion over
paediatric tumours. Salvage 15 mins to 1 hr on Day 1 every 4 wks.
therapy for lymphoma
Alternatively, prescription may be
based on Area Under Curve (AUC)
calculations. CHILD: 500-600 mg/m2
over 1 hr once every 3 wks. Salvage
regimes in lymphomas - refer to
specific protocols
51
RM86.70/ vial
No Generic Name
28 Oxaliplatin 100mg/50ml
Injection
Cat Indications
Dosage
A* Only for patients with
85 mg/m2 IV repeated every 2 wks
colorectal cancer who: i)
have relapsed within 6
months after the end of
adjuvant chemotherapy with
5-fluorouracil-based regime
ii) have progressive disease
despite 5-fluorouracil
chemotherapy for advanced
disease iii) good
performance status (WHO
of 2 or less). The treatment
must be given in a tertiary
oncology centre or have
clearance in writing by an
oncologist
29
L-Asparaginase 10,000
IU Injection
A*
i) Acute lymphoblastic
i) 5,000 iu/m2 for 10 days during
leukemia
induction, 10,000 iu/m2 also used with
ii) Non-hodgkin's lymphoma high dose methotrexate rescue in
consolidation phase of acute
lymphoblastic leukemia
ii) CHILD: 5,000 - 25,000 iu/m2 per
dose depending on protocol
30
Gefitinib 250 mg tablet
A*
For the treatment of patients 250mg tablet once a day, taken with or RM214.50/tab
with locally advanced or
without food
Borang E
metastatic non-small cell
lung cancer (NSCLC) who
have previously failed
chemotherapy, and who
have activating mutation of
epidermal growth factor
receptor (EGFR). Restricted
to non-smoker, female,
EGFR positive and Asian
patients only.
A*
i) As monotherapy for
maintenance treatment in
patients with locally
advanced or metastatic nonsmall cell lung cancer
(NSCLC) with stable
disease after 4 cycles of
standard platinum-based
first-line chemotherapy.
ii) For the treatment of
patients with locally
advanced or metastatic
NSCLC after failure of at
least one prior
chemotherapy regimen.
Restricted to non-smoker,
female, epidermal growth
factor receptor (EGFR)
positive and Asian patients
only
(Iressa)
31
Erlotinib 150 mg Tablet

(Tarceva)
32
Erlotinib 100 mg Tablet

(Tarceva)
A*
52
Remark
RM110/vial
RM330.60/
vial
150 mg taken at least one hour before RM177.33/tab

or two hours after the ingestion of
food. Reduce in steps of 50 mg when Borang E
necessary. Continue treatment until
disease progression or unacceptable
toxicity occurs. May require dose
modifications when coadministered
with strong CYP3A4 inhibitors or
inducers; or in cigarette smoking
patients.
RM143.23/tab
Borang E
No Generic Name
33 Lapatinib 250 mg Tablet
(Tykerb)
Cat Indications
A* In combination with:
i) capecitabine, for the
treatment of patients with
advanced or metastatic
breast cancer whose tumors
overexpress HER2 and who
have received prior therapy
including an anthracycline, a
taxane, and trastuzumab.
ii) letrozole for the treatment
of postmenopausal women
with hormone receptor
positive metastatic breast
cancer that overexpresses
the HER2 receptor for whom
hormonal therapy is
indicated.
Dosage
i) 1,250 mg (5 tablets) once daily on
Days 1-21 continuously in combination
with capecitabine 2,000 mg/m2/day
(administered orally in 2 doses
approximately 12 hours apart) on
Days 1-14 in a repeating 21 day cycle.
ii) 1500 mg (6 tablets) once daily
continuously in combination with
letrozole. When TYKERB is
coadministered with letrozole, the
recommended dose of letrozole is
2.5mg once daily.
Remark
RM28.36/tab
KPK
(Patient
basis)
34
Hydroxyurea 500 mg
Capsule
i)Solid tumours
ii) Chronic myelocytic
leukaemia and
myeloproliferative disease
iii)Severe psoriasis eg.
Extensive plaque psoriasis,
erythrodermic psoriasis,
pustular psoriasis -as third
line therapy.
i) Intermittent therapy : 80 mg/kg orally

as a single dose every 3rd day.
Continuous therapy : 20-30 mg/kg
orally as a single dose dly.
Concomitant therapy with irradiation :
80 mg/kg orally as a single dose every
3rd day.(administration of hydroxyurea
should be started at least 7 days
before initiation of irradiation and
continued during radiotherapy as well).
ii) Continuous therapy (20 - 30 mg/kg
orally as a single dose daily, therapy
should be interrupted if the white
blood cell count drops below
2500/mm3, or the platelet count below
100,000/mm3.
iii) 500 mg tds.
RM1.07/cap
35
Irinotecan HCl Trihydrate

100mg/5ml Injection
A*
Only for patients with

colorectal cancer who:
i) have relapsed within 6
mths after the end of
adjuvant chemotherapy with
5-fluorouracil-based regime
ii) have progressive disease
despite 5-fluorouracil
chemotherapy for advanced
disease
iii) good performance status
(WHO of 2 or less) The
treatment must be given in a
tertiary oncology centre or
have clearance in writing by
an oncologist
In combination therapy (for previously

untreated patients): 180 mg/m2 once
every 2 wks as an IV infusion over 90
mins followed by infusion with folinic
acid and 5-fluorouracil.
In monotherapy (for previously treated
patients): 350 mg/m2 administered as
an intravenous infusion over 90 mins
period once every 3 wks
RM150/vial
53
L02 Endocrine Therapy

No Generic Name
1 Leuprolide Acetate 3.75
mg Injection
(Lucrin)
2
Cat Indications
A* i) Endometriosis
ii) Hormonal therapy in
advanced prostate cancer
Goserelin 3.6 mg Depot

Injection
(Zoladex)
Goserelin 10.8 mg Depot

Injection
(Zoladex)
Triptorelin 3.75 mg
Injection
(Decapeptyl)
Prostate cancer,
endometriosis, leiomyoma
uteri and assissted
reproduction, breast cancer
in premenopausal and
perimenopausal women
suitable for hormonal
manipulation
Dosage
i) 3.75 mg mthly for 3 - 6 mths
ii) 3.75 mg IM or SC injection mthly
RM292.50/ea
Remark
3.6 mg depot injection every 28 days
RM270.00/ea
Borang E
One 10.8mg depot injected
subcutaneously into the anterior
abdominal wall, every 12 weeks.
RM911.80/ea
Treatment of confirmed
central precocious puberty
(preterm sexual
development) in girls < 9
yrs, boys < 10 yrs
3.75 mg IM injection every 4 wks.

Period of treatment should not exceed
6 mths
RM309.00/ea
20-40 mg dly
RM0.37/tab
Borang E
Tamoxifen Citrate 20 mg
Tablet
Breast cancer
Bicalutamide 50 mg
Tablet
(Casodex)
A*
RM6.78/tab
Advanced prostate cancer 50 mg once daily. (morning or
in combination with LHRH
evening), with or without food. Take on
Borang E
analogue therapy or surgical the same time each day.
castration.
Anastrozole 1 mg Tablet
A*
Treatment of hormone
responsive metastatic or
locally advanced breast
cancer after failure of
tamoxifen
1 mg dly
Treatment of hormone
responsive metastatic or
locally advance breast
cancer after failure of
tamoxifen
2.5 mg od
(Arimidex)
Letrozole 2.5 mg Tablet
A*
(Femara)
Exemestane 25 mg
Tablet
(Aromasin)
L03 Immunostimulants
No Generic Name
1 Filgrastim (G-CSF) 30
MU/ml Injection
(Neupogen)
A*
Borang E
54
RM17.83/tab
Borang E
Treatment of post25 mg once daily

menopausal women with
advanced breast cancer
whose disease has
progressed following
tamoxifen and non-steroidal
aromatase inhibitors
Cat Indications
A* i) Reduction in the duration
of neutropenia and
incidence of febrile
neutropenia in cytotoxic
chemotherapy for
malignancy except chronic
myeloid leukemia and
myelodysplastic syndrome
ii) Haemopoeitic stem cell
transplantation (HSCT)/
stem cell harvesting
RM1.90/tab
RM20.60/tab
1 patient
Dosage
Remark
RM168.20/
i) Adult: SC or IV 5 mcg/kg/day.
vial
Initiation: 24 - 72 hrs after
chemotherapy.
Duration: Until a clinically adequate
neutrophil recovery is achieved
(absolute neutrophil count of at least 1
x 109/L on 2 consecutive days)
ii) Refer to protocol
L04 Immunosuppressive Agents

No Generic Name
Cat Indications
1 Mycophenolate Mofetil
A* i) Prophylaxis of acute
500 mg tablet (Cellcept)
organ rejection in patients
receiving allogenic renal,
cardiac and hepatic
transplant
ii) Used with steroids for
induction and maintenance
of severe lupus nephritis
resistant or intolerant to
cyclophosphamide therapy
2
Mycophenolate Sodium
180mg Tablet (Myfortic)
A*
Mycophenolate Sodium
360mg Tablet (Myfortic)
A*
Ciclosporin 25 mg
Capsule Microemulsion
A*
(Sandimmun Neoral)
Ciclosporin 100 mg
Capsule Microemulsion
A*
(Sandimmun Neoral)
Tacrolimus 1 mg Capsule
(Prograf)
A*
Tacrolimus 5 mg Capsule
(Prograf)
A*
Azathioprine 50 mg
Tablet (Imuran)
Dosage
Remark
i) Renal transplant rejection:
RM6.64/tab
ADULT: 1 g bd.
CHILD (3 mths and older): 600
Borang E
mg/m(2)/dose, bd; max: 2 g/10
mL/day.
Cardiac transplant rejection: 1.5 g bd.
Hepatic transplant rejection: 1.5 g bd
ii) Induction phase: 2-3 g/day for up to
6 mths. Maintenance phase: dose
gradually tapers to 1 g/day
Prophylaxis of acute
720 mg bd
transplant rejection in adult
patients receiving allogenic
renal transplant in
combination with ciclosporin
and corticosteroids
RM3.27/tab
Only for: i) Patients in whom

donor specific
transplantation cannot be
carried out and in young
children to minimise sideeffects of steroids.
ii) Follow-up cases of bone
marrow transplant
iii) Patients with severe
rheumatoid arthritis not
responding to other second
line drugs.
iv) Patients with idiopathic
nephrotic syndrome who are
steroid toxic or poor
response to
cyclophosphamide.
v) Severe aplastic anemia,
pure red cell aplasia
vi) Cases of recalcitrant
psoriasis and atopic eczema
vii) Treatment of chronic
ocular inflammatory
disorders/uveitis
i & ii) Initially 12.5 - 15 mg/kg/day,

beginning on the day before
transplant. Maintenance approx 12.5
mg/kg/day for 3-6 mths before being
tapered off to zero by 1 yr of
transplantation.
iii) 3 mg/kg/day in 2 divided doses for
first 6 wks. May increased gradually to
max 5 mg/kg. Treatment withdrawn if
no response after 3 mths.
iv) ADULT: 5 mg/kg/day in 2 divided
doses. PAED: 6 mg/kg/day in 2
divided doses. Patients with permitted
levels of kidney failure, the starting
dose must < 2.5 mg/kg/day.
v) 12 mg/kg/day.
vi) 2.5 mg/kg/day in 2 divided doses
increasing if there is no improvement
after 4 wks by 0.5 -1 mg/kg/mth up to
max 5 mg/kg/day.
vii) 5 mg/kg/day in 2 divided doses,
may increase to 7 mg/kg/day in
resistant cases. Maintenance: < 5
mg/kg/day especially during remission
RM3.24/cap
i) Primary
immunosuppressant agent
for all solid organ
transplantation
ii) Rescue therapy for
rejection
i) 0.2 mg/kg/day in 2 divided doses

ii) 0.3 mg/kg/day in 2 divided doses
RM8.99/cap
i)Acute leukaemia
i) 1-4 mg/kg/day
ii)Immunosuppressive agent ii) 1.5-2 mg/kg/day
55
Borang E
RM6.55/tab
Borang E
RM12.94/cap
Borang E
RM45.19/cap
Borang E
RM1.24/tab
MUSCULO-SKELETAL SYSTEM
M01 Antiinflammatory and Antirheumatic Products

No Generic Name
Cat Indications
1 Indomethacin 25 mg
B Pain and inflammation in
Capsule (Indocid)
rheumatic disease
Dosage
Remark
50 - 200 mg dly in divided doses, with RM0.05/tab
food. Child not recommended.
RM0.38/amp
Diclofenac Sodium
75mg/3ml Injection
(Voltaren)
Pain and inflammation in

rheumatic disease
75 mg od (bd in severe cases) for < 2

days
Diclofenac Sodium 50 mg
Tablet
(Voltaren)

rheumatic disease and
juvenile arthritis
RM0.02/tab
75 - 150 mg dly in divided doses.
CHILD 1-12 yrs, Juvenile arthritis; 12.525 mg dly
Meloxicam 7.5mg Tablet

(Mobic)
i) initially 7.5 mg dly. May be increased

to 15 mg dly
ii) initially 15 mg dly. May be reduced
to 7.5 mg dly. Max: 5 mg dly. Child <
12 yrs not recommended
RM0.08/tab

rheumatic disease
ADULT : 200-400 mg tds after food,

max: 2.4 g dly CHILD : 20-30 mg/kg
dly in divided doses
RM0.07/tab
A/KK i) Rheumatic arthritis,

osteoarthritis and
ankylosing spondylitis
ii) Acute gout
iii) Muscular skeletal
disorder, dysmenorrhoea
i) 0.5 - 1 g dly in 2 divided doses

ii) 750 mg initially then 250 mg tds
iii) 500 mg initially then 250 mg tds qid as required
RM0.07/tab
A/KK Only for patients not

responding to other NSAIDs
in the treatment of
i) painful osteoarthritis
ii) rheumatoid arthritis
Ibuprofen 200 mg Tablet

(Brufen)
Naproxen 250 mg Tablet
Mefenamic Acid 250 mg

Capsule
(Ponstan)
Mild to moderate pain
ADULT: 250-500 mg tds after meals.

CHILD > 6 mths: 6.5 - 25 mg/kg dly
tds - qid for not longer than 7 days
except in juvenile arthritis
RM0.14/cap
Celecoxib 200 mg
Capsule
A*
i) Osteoarthritis
ii) Rheumatoid Arthritis
iii) Acute pain
iv) Ankylosing Spondylitis
i) ADULTS : 200 mg od.

ii) 100 mg bd, increased if necessary
to 200 mg bd; CHILD not
recommended
iii) 400 mg as a single dose on first
day followed by 200 mg od on
subsequent days,
iv) Initial, 200 mg od or 100 mg bd; if
no effect after 6 wks, may increase to
max. 400 mg dly in 1-2 divided doses.
If no response following 2 wks of
treatmetn with 400 mg/day, consider
discontinuation and alternative
treatment
RM1.74/cap
(Celebrex)
Celecoxib 400 mg
Capsule
A*
(Celebrex)
Parecoxib Sodium 40mg

Injection
RM2.99/cap
A*
Management of post
operative pain in the
immediate post operative
setting only
40 mg followed by 20 or 40 mg every 6
to 12 hrs, as required. Use limited to 2
days only with a max: 80 mg/day.
Reduce the initial dose by 50% in
elderly < 50 kg
RM23.25/ea
i) Acute and chronic

treatment of signs and
symptoms of osteoarthritis
(OA) and rheumatoid
arthritis (RA)
ii) Acute gouty arthritis
iii) Acute pain
i) OA: 60 mg od. RA: 90 mg od

ii) & iii) Acute gouty arthritis and acute
pain: 120 mg od (Given the exposure
to COX-2 inhibitors, doctors are
advised to use the lowest effective
dose for the shortest possible duration
of treatment)
RM1.87/tab
(Dynastat)
10
Etoricoxib 90 mg Tablet
(Arcoxia)
A*
11
Etoricoxib 120 mg Tablet

(Arcoxia)
A*
56
RM3.32/tab
M02 Topical Products for Joint And Muscular Pain

No Generic Name
Cat Indications
Dosage
1 Diclofenac 1% Emulgel
A Post-traumatic inflammation Apply tds - qid and gently rubbed in
of the tendons,ligaments &
joints. Localised forms of
soft tissue rheumatism and
degenerative rheumatism
2
Methyl Salicylate 25%

Ointment
M03 Muscle Relaxants

No Generic Name
1 Suxamethonium Chloride
50 mg/ml lnj
Relief of pain associated

with musculoskeletal
discomfort
To be applied to affected area
Remark
RM1.45/ea
RM20.41/
500gm
Cat Indications
B Muscle relaxant as an
adjunct to anaesthesia
Dosage
Remark
Initial test dose 5-10 mg may be given. RM4.43/amp
Usual single dose 0.3 - 1.1 mg/kg IV.
Max: 100 mg according to the depth
and duration of relaxation required. 2.5
- 4 mg/kg IM, max: 150 mg
ADULT: 80-100 mcg/kg IV.
Maintenance 20-30 mcg/kg acording
to response.
NEONATE and INFANT up to 4 mths:
Initially 10-20 mcg/kg, then
incremental dose to achieve response
RM24.75/ vial
RM6.12/amp
(Scoline)
Vecuronium Bromide 10
mg/10 ml Injection
A*
Vecuronium Bromide 4
mg/ml Injection
A*
Atracurium Besylate 50
mg/5 ml Injection
A*
Muscle relaxation
ADULT and CHILD > 1 mth: Initially

300 - 600 mcg/kg IV injection.
Subsequent doses of 80 - 200 mcg/kg
may be given as necessary. IV
infusion: 5 - 10 mcg/kg/min (300 - 600
mcg/kg/hr)
Rocuronium Bromide 10
mg/ml Injection
A*
As an adjunct to general
anaesthesia to facilitate
endotracheal intubation, to
provide skeletal muscle
relaxation during surgery
and to facilitate mechanical
ventilation in adults, children
and infants from 3 mths of
age
RM18.83/ea
ADULT (usual) : Intubation: (rapid
sequence intubation) initial, 0.6-1.2
mg/kg IV Intubation: (tracheal
intubation) initial, 0.6 mg/kg IV
Intubation: maintenance, 0.1-0.2
mg/kg IV repeated as needed.
Intubation: maintenance, 0.01-0.012
mg/kg/minute continuous IV infusion.
Skeletal muscle relaxation: initial, 0.6
mg/kg IV, maintenance, 0.1-0.2 mg/kg
IV repeated as needed or 0.01-0.012
mg/kg/minute continuous IV infusion.
CHILD: (usual) Intubation: (age 3 mths12 yr) initial, 0.6 mg/kg/dose IV,
maintenance, 0.075-0.125 mg/kg IV as
needed or 0.012 mg/kg/min
continuous IV infusion. Skeletal
muscle relaxation: (age 3 mths-12 yr)
initial, 0.6 mg/kg/dose IV,
maintenance, 0.075-0.125 mg/kg IV as
needed or 0.012 mg/kg/min
continuous IV infusion
Myotonic symptoms
associated with cervical
syndrome, periarthritis of
shoulder and lumbago
spastic paralysis
50 mg tds
RM0.72/tab
Spasticity of the skeletal

muscle
ADULT: 5 mg tds. Max: 80 mg dly.

CHILD: 0.75 - 2 mg/kg dly (> 10 yrs,
max: 2.5 mg/kg dly)
RM0.68/tab
(Esmeron)
Eperisone HCl 50 mg
Tablet
(Myonal)
Baclofen 10 mg Tablet
As an adjunct in
anaesthesia to produce
skeletal muscle relaxation
57
RM5.80/amp
M04 Antigout Preparations

No Generic Name
Cat Indications
1 Allopurinol 300 mg Tablet A/KK i) Frequent and disabling
attacks of gouty arthritis (3
or more attacks/year).
ii) Clinical or radiographic
signs of erosive gouty
arthritis. iii) The presence of
tophaceous deposits.
iii) Urate nephropathy.
iv) Urate nephrolithiasis.
v) Impending cytotoxic
chemotherapy or
radiotherapy for lymphoma
or leukaemia
2
Colchicine 0.5 mg Tablet
i) Acute gout and

prophylaxis of recurrent
gout. ii) Leucocytoclastic
Vasculitis either cutaneous
or systemic involvement,
Behcet's syndrome,
Urticarial vasculitis,
Systemic sclerosis, Sweet's
syndrome and severe
recalcitrant aphthous
stomatitis
M05 Drugs for Treatment of Bone Diseases

No Generic Name
Cat Indications
1 Pamidronate Disodium
A* Hypercalcaemia of
30 mg Injection
malignancy (tumour induced hypercalcaemia)
2
Ibandronic Acid 150 mg

Tablet
(Bonviva)
A*
Zoledronic Acid 4 mg
Injection
Alendronate Sodium
70mg and Cholecalciferol
5600 IU Tablet
(Fosamax Plus)
i)Initial dose, 0.5-1.2 mg, then 0.5-0.6

mg every hr until relief of pain is
obtained or vomiting or diarrhoea
occurs (Max : 8 mg). The course
should not be repeated within 3 days.
Prevention of attacks during initial
treatment with allopurinol or uricosuric
drugs: 0.5 mg od - tds.
ii) 0.5 mg od - tds depends on disease
and severity, up to a max: 3 mg/day
Dosage
Dose depends on the initial serum
calcium levels. Doses range from a
single infusion of 30 - 90 mg
Mecobalamin 500 mcg

Tablet (Methylcobal)
RM0.07/tab
Remark
RM89.00/ea
RM86.28/tab
150 mg once monthly
A*
i) Treatment of
hypercalcaemia of
malignancy
ii) Prevention of skeletal
related events in patients
with multiple myeloma
involving multiple bone
lesion
RM800.00/ea
4 mg reconstituted and should be
given as a 15 mins IV infusion every 3Borang E
4 wks
A*
Osteoporosis in post
menopausal women with a
history of vertebral fracture
and whom oestrogen
replacement therapy is
contraindicated
1 tablet once wkly [contains

cholecalciferol 2800 units in a wkly
dose, equivalent to 400 units dly].
KBUK
M09 Other Drugs For Disorders Of The Musculo-Skeletal System

No Generic Name
Cat Indications
Dosage
1 Prolase Tablet
B Oedema and inflammation 2 tablet tds
(Papese)
in conjunction with other
physical or
chemotherapeutic measures
2
Remark
RM0.14/tab
Treatment of
postmenopausal
osteoporosis to reduce the
risk of fracture.
(Zometa)
Dosage
Initial dose : 100-300 mg dly.
Maintenance : 300-600 mg dly.
Max: 900 mg dly
Peripheral neuropathies
58
1 tablet tds.
RM21.25/tab
KBUK
Remark
RM0.03/tab
RM0.11/tab
NERVOUS SYSTEM
N01 Anaesthetics
No Generic Name
1 Ether Solvent
2
Desflurane Liquid
Cat Indications
Dosage
C To remove adhesive plaster Dose depending on the route and
from the skin
procedure
A
(Suprane)
Remark
RM28.53/unit
i) Induction and
maintenance of anaesthesia
in adult ii) Maintenance of
anaesthesia in infants &
children
ADULT: Induction , initially 3% in

oxygen or nitrous oxide/oxygen and
increased by 0.5%-1% every 2-3
breaths or as tolerated (up to 11%),
until loss of consciousness.
Maintenance: 2.5%-8.5% with or
without concomitant nitrous oxide
CHILD: maintenance, inhaled in
concentrations of 5.2%-10% with or
without concomitant nitrous oxide
RM492.00/240
ml
Borang E
Sevoflurane Liquid
A*
To be used only for

i) induction and
ii) maintenance of
anaesthesia
i) Up to 8% in oxygen or nitrous oxideoxygen mixture

ii) maintenance: 1 - 3%
RM338.40/
250ml
Fentanyl Citrate 50
mcg/ml Injection
Analgesia during operation,

relief of pain in the
immediate postoperative
period. Adjunct in
maintenance of general /
regional anaesthesia.
Dose should be individualized

according to age, body weight,
physical status, underlying
pathological conditions and type of
surgery and anaesthesia.
With spontaneous respiration, 50 200 mcg, then 50 mcg every 20 - 30
min as required.
With assisted respiration: 0.3 - 3.5 mg,
then 100-200 mcg as required up to
600 mcg. CHILD:Child with
spontaneous respiration: 3-5 mcg/kg,
then 1 mcg/kg as required. Child with
assisted ventilation : 10-15 mcg/kg,
then 1 - 3 mcg/kg as required
RM1.56/amp
Ketamine 50 mg/ml
Injection
Sole anaesthetic for short

IV - onset 30 sec : 2 mg/kg or
procedures or induction of IM - onset 3-4 min : 10 mg/kg
anaesthesia in certain types
of patients (e.g in shock
states)
Etomidate 20mg Injection
A*
Induction of general
CHILD > 10 yrs and ADULT: 0.15 - 0.3 RM15/unit
anaesthesia for
mg/kg
haemodynamically unstable ELDERLY: 0.15 - 0.2 mg/kg
KPK
patients
Propofol 1 % Injection
A*
Induction & maintenance of

general anaesthesia.
Sedation of ventilated ICU
patients
Induction: 1.5-2.5mg/ kg at the rate of

20-40 mg every 10 sec. CHILD > 8
yrs: usually 2.5mg/ kg. Maintenance:
IV 25-50 mg repeated according
response. IV infusion: 4-12mg/kg/hr;
CHILD > 3 yrs: 9-15 mg/kg/ hr.
Sedation: 0.3 - 4 mg/kg/hr up to 3
days
RM4.06/vial
For peripheral sympathetic

nerve and epidural
(excluding caudal)
anaesthesia and obstetrics
anaesthesia
Regional nerve block or epidural

block: 15 - 30 ml. Nerve block of finger
or toe: 2 - 6 ml. Max: 2 mg/kg in any 4
hrs period, equivalent to 25 - 30 ml in
adults of average weight
RM5.09/ea
Used for spinal anaesthesia ADULT: 2 - 4 ml. Not to exceed 2

mg/kg in a single dose
(Diprivan)
Bupivacaine 0.5 %
Injection
(Marcaine)
Bupivacaine 0.5 % Heavy

Injection
59
RM9.86/vial
RM17.01/ea
No Generic Name
10 Lignocaine 10 % w/w
Spray
Cat Indications
B For surface anaesthesia in
dental practice, in
otorhinolaryngology and
paracentesis
Dosage
Spray to affected part
Remark
RM35.41/
50ml
11
Lignocaine 2 % Jelly
Use for endotracheal tubes Apply to affected area 10 mins before

and instruments, painful
catheterization, etc
procedures in the ear, nose
and throat, burns, wounds,
abrasions, lacerations;
catheterisation of the male
and female urethra and for
symptomatic treatment of
cystitis and urethritis
RM3.94/tube
12
Lignocaine (Lidocaine)
HCl 2 % Injection
Local anesth by infiltration

IV regional anesthesia and
nerve block. Emergency
management of ventricular
arrhythmias particularly after
myocardial infarction and
cardiac surgery
Local anesthesia :
ADULT Max: 200 mg;
CHILD Max: 30 mg/kg
Cardiac arrhythmias : ADULT 50-100
mg IV. Max: 200-300 mg/hour;
CHILD LD: 0.8-1 mg/kg IV repeated if
necessary up to 3-5 mg/kg followed by
a continuous infusion of 10-50
mcg/kg/min
RM1.83/ea
13
Ropivacaine HCl 7.5

mg/ml Injection
A*
i) Surgical anaesthaesia
including obstetrics
ii) Acute pain management
RM25.20/ea
Dose adjusted according to patient
physical status and nature of
procedure.
i) Lumbar epidural: 15-25 ml of 7.5
mg/ml solution; Caesarean section, 1520 ml of 7.5 mg/ml solution in
incremental doses ( max total dose
150 mg).
ii) lumbar epidural: 10-20 ml of 2mg/ml
solution followed by 10-15 ml of 2
mg/ml solution at interval at of least 30
minutes. Labour pain 6-10 ml/hr of
2mg/ml solution
10 - 40 ml (0.25 %) or max : 2 mg/kg

in any 4 hrs period, equivalent to 25 30 ml of 0.5% solution
(Naropin)
RM20.20/amp
14
Bupivacaine 0.5 % with

Adrenaline 1:200,000
Injection
Regional nerve block or

epidural block.
15
Lidocaine 25mg and

Prilocaine 25mg Cream
Used for painless

Apply a thick layer under occlusive
venepunctures, radial artery dressing at least 1 hr before the
cannulations before
procedure
extradural/spinal and other
regional blocks in children
above 1 year old and adults.
Also used in chronic renal
failure patients for insertion
of A-V fistulas and shunts
for haemodialysis.
RM8.08/5gm
To produce local
anaesthesia or
vasoconstriction during
endoscopic nasal surgery,
turbinectomy septoplasty,
polypectomy etc
RM5.57/gm
(EMLA)
16
Cocaine 10% Solution
60
Max. total dose recommended for

application to the nasal mucosa in
healthy adult is 1.5 to 2 mg/kg of a
10% cocaine solution
No Generic Name
17 Ethyl Chloride Spray
N02 Analgesics
No Generic Name
1 Morphine HCl 10 mg/5ml
Solution
Cat Indications
C For minor surgical
procedures including
lancing boils, incision and
drainage of small
abscesses, pain due to
athletic injuries and pain
due to injection
administration
Dosage
Remark
Spray to affected area at a distance of RM10.49/can
about 30cm until a fine white film is
produced
Cat Indications
B For use in management of
moderate to severe pain
especially that associated
with neoplastic disease
Dosage
5 - 20 mg or more regularly every 4
hrs in terminal pain
Remark
RM8.70/g
Morphine Sulphate 10
mg/ml Injection
For moderate to severe pain ADULT: 10 - 20 mg/kg or more SC or RM1.14/amp

especially that associated
IM every 4 hrs in terminal pain. CHILD:
with neoplastic disease
Up to 1 mth: 0.15 mg/kg; 1-2 mths: 0.2
mg/kg; 1-5 yrs: 2.5 - 5 mg ; 6-12 yrs: 510 mg
Oxycodone HCl 5 mg
Immediate Release
Capsules
A*
i) As a second line drug in

the management of opioid
responsive, moderate to
severe chronic cancer pain
ii) As a step-down analgesic
drug in post-operative
procedures
Initially 5 mg every 4 to 6 hours,

increased if necessary according to
severity of pain, usual max. 400 mg
daily, but some patients may require
higher doses
RM0.80/tab
Surgical cancer pain,
PRN basis (6
pts/mth)
Ortho - max 3
days after
operation
Management of moderate to
severe chronic cancer pain
non-responsive to morphine
(in accordance with WHO
step-wise ladder of chronic
pain management)
ADULT, ELDERLY and CHILDREN >

18 yrs, opioid-naive patients: 10 mg
bd. Renal or hepatic impairment: 5 mg
bd. Titrate dose carefully, as
frequently as once a day if necessary,
to achieve pain relief
RM2.79/tab
For relief of moderate to

severe pain (medical and
surgical), pre-anaesthetic
medication and obstetrical
analgesia
ADULT: 0.5 - 2 mg/kg SC or IM every

3-4 hrs if necessary. CHILD: by IM 0.5
- 2 mg/kg. Up to 1 yr : 1-2 mg/kg IM, 15 yrs : 12.5 - 25 mg IM, 6-12 yrs: 2550 mg IM
RM1.11/amp
As a second line drug in the

management of chronic
cancer pain. The use is to
be restricted to pain
specialists, palliative
medicine specialists and
oncologists.
Patients who have not previously

received a strong opioid analgesic,
initial dose , one 25 mcg/hour patch to
be replaced after 72 hrs. Patients who
have received a strong opioid
analgesic, initial dose based on
previous 24 hrs opioid requirement
(oral morphine sulphate 90 mg over 24
hrs = one 25 mcg/hr patch). Not
recommended in children.
RM21.38/ea
(Oxynorm)
Oxycodone HCl 10 mg
Prolonged Release
Tablet (Oxycontin)
A*
Oxycodone HCl 20 mg
Prolonged Release
Tablet (Oxycontin)
A*
Pethidine HCl 50 mg/ml

Injection
Pethidine HCl 100 mg/2

ml Injection
Fentanyl 25 mcg/h
Transdermal Patch
A*
Tramadol HCl 50 mg
Capsule
(Tramal)
10
Tramadol HCl 50 mg/ml

Injection
(Tramal)
A/KK Post-operative pain, chronic 50 - 100 mg every 4 hrs. Max 400 mg

cancer pain, analgesia/pain daily. Not recommended in children
relief for patients with
impaired renal function
A
Post-operative pain, chronic

cancer pair and
analgesia/pain relief for
patients with impaired renal
function
61
ADULT: By IM / IV inj. (over 2-3 mins)

or by IV infusion. Initially 100 mg then
50 - 100 mg every 4 - 6 hours. Max:
600 mg daily. Child not recommended
RM5.37/tab
RM1.36/amp
RM0.06/cap
RM0.95/amp
No Generic Name
11 Acetylsalicylic Acid,
Soluble 300 mg Tablet
(Aspirin)
12 Paracetamol 120 mg/5 ml
Syrup
Cat Indications
C Mild to moderate pain
Mild to moderate pain and

pyrexia
Dosage
Remark
RM0.10/tab
300-900 mg every 4 - 6 hrs as
required. Max 4 g daily. Use in
children not recommended
CHILD: up to 1 yr: 6-120 mg. 1-5 yrs: RM2.49/60ml
120-240 mg. 6-12 yrs: 240-480 mg per
dose. Repeat every 4-6 hrs when
necessary. Max of 4 doses in 24 hrs
RM0.29/supp
13
Paracetamol 250 mg
Suppository
Symptomatic relief of fever

and post operative pain for
paediatric cases
CHILD 1-5 yrs: 125-250 mg; 6-12 yrs:

250-500 mg; 3-11 mths: 80 mg
inserted every 4 - 6 hrs if necessary,
max. 4 doses in 24 hrs. INFANTS
under 3 mths should not be given
Paracetamol unless advised by doctor;
a dose of 10 mg/kg (5 mg/kg if
jaundiced) is suitable
14
Paracetamol 500 mg
Tablet
Pizotifen 0.5 mg Tablet
Mild to moderate pain and

pyrexia
Prophylactic treatment of
vascular headache
ADULT: 500 - 1000 mg every 4-6 hrs, RM0.18/tab

max of 4 g dly
ADULT: 0.5 mg in the evening for first RM1.87/tab
2 days, then 0.5 mg mid-day and
evening for next 2 days, then 0.5 mg 3 Borang E
times daily. CHILD: Up to 1.5 mg daily
in divided doses
15
(Sandomigran)
N03 Antiepileptics
No Generic Name
1 Phenobarbitone 30 mg
Tablet
Cat Indications
B Epilepsy
Dosage
Remark
ADULT: 60-180 mg dly on. CHILD: Up RM0.11/tab
to 8 mg/kg dly
Phenobarbitone Sodium
200 mg/ml Injection
Status Epilepticus
ADULT: 10 mg/kg IV at a rate of not

faster than 100 mg/min. Initial max
dose does not exceeding 1 gm. Dly
maintenance of 1-4 mg/kg/day.
CHILD: 10-20 mg/kg/dose LD,
followed by repeated doses at 10
mg/kg/dose (strictly in ICU setting).
Maintenance 5 - 8 mg/kg/day
RM14.40/amp
Phenytoin Sodium 100

mg Capsule
Epilepsy
ADULT and CHILD > 6 yrs: 300-400

mg/day in 3-4 divided doses before
meals. Max: 600 mg/day. CHILD:
Initially 5 mg/kg/day in 2-3 divided
doses. Maintenance: 4-8 mg/kg/day.
Max: 300 mg/day
RM0.19/cap
Phenytoin Sodium 250

mg/5ml Injection
Status epilepticus
i) Status epilepticus: ADULT 10-15

mg/kg by slow IV. Max 50 mg/min.
Maintenance: 100 mg orally/IV tds qid. CHILD 15-20 mg/kg by slow IV.
Max: 1-3 mg/kg/min
ii) Neurosurgery 100-200 mg IM
approximately at 4 hrly interval
RM26.44/vial
Clonazepam 2 mg Tablet
i) Epilepsy
ii) Non-epileptic myoclonus
i) ADULT: Initially, 1 mg given at night

for 4 nights, gradually increased over
2-4 wk. Elderly: 500 mcg.
Maintenance: 4-8 mg dly. Max: 20
mg/day. CHILD: 5-12 yrs: Initially, 0.5
mg dly; 1-5 yrs: 0.25 mg dly.
Maintenance (given in 2-4 divided
doses): 5-12 yr: 3-6 mg dly; 1-5 yrs: 13 mg dly; infants: 0.5-1 mg dly. Max:
200 mcg/kg/day.
ii) ADULT: Initially, 250 mcg bd,
increased after 3 days up to 1 mg dly.
Max: 4 mg dly
RM0.20/tab
62
No Generic Name
6 Carbamazepine 200 mg
Tablet
Cat Indications
B i) Epilepsy
ii) Trigeminal neuralgia
(Tegretol)
Epilepsy
Dosage
Remark
RM0.30/tab
i) ADULT: 100-200 mg od - tds
increased gradually to usual dose of
0.8 - 1.2 g dly in divided doses.
CHILD: Up to 1 yr: 100-200 mg dly; 15 yrs: 200 - 400 mg dly; 5-10 yrs: 400 600 mg dly; 10-15 yrs: 0.6 - 1 g dly ii)
ADULT: Initially, 100 mg od or bd
gradually increased as necessary.
Maintenance: 400-800 mg dly in 2-4
divided doses. Max: 1.2 g dly
ADULT: Initial, 200 mg bd for the first
wk, may increase dosage by 200
mg/day at wkly intervals until optimal
response is obtained. Max: 1.6 g/day.
CHILD: usual max. dosage 1000
mg/day in children 12-15 yrs, 1200
mg/day in patients > 15 yrs
RM0.93/tab
CHILD: > 20 kg. Initially 400 mg/day

with spaced increases until control is
achieved (usually 20-30 mg/kg/day),
dose may be increased to 35
mg/kg/day. < 20 kg, 20 mg/kg/day.
Severe cases: 50 mg/kg dly
ADULT: Initially 600 mg/day in 2 - 3
divided doses, dose may be increased
by 200 mg at 3-day intervals to max
2.5 g/day. Usual maintenance dose: 12 g/day (20-30 mg/kg/day). CHILD: >
20 kg. Initially 400 mg/day with spaced
increases until control is achieved
(usually 20-30 mg/kg/day), dose may
be increased to 35 mg/kg/day. < 20 kg
20 mg/kg/day, in severe cases the
dose may be increased provided
plasma concentration can be
monitored
RM55.30/
300ml
Carbamazepine 200 mg
CR Tablet
Carbamazepine 400 mg
CR Tablet
Sodium Valproate 200

mg/5 ml Syrup
Epilepsy
Epilepsy
i) Adjunctive or
i) Up to 200 mg dly in single or divided
monotherapy for partial
dosage
seizures and generalised
ii) 25- 200 mg dly
tonic-clonic seizures not
satisfactorily controlled with
other antiepileptic drugs
ii) Prevention of mood
episodes in adult 18 years
and above with bipolar
disorder, predominately by
preventing depressive
episodes
RM0.28/tab
Management of seizures in
children aged 2-12 years
RM1.15/tab
(Epillim)
10
Sodium Valproate 200

mg Tablet
(Epillim)
11
Lamotrigine 50 mg Tablet
(Lamictal)
12
Lamotrigine 100 mg
Tablet
(Lamictal)
13
Lamotrigine 5 mg
Dispersible/ Chewable
Tablet
63
a) Add-on therapy in patients not

taking Valproate: wk 1 & 2: 2
mg/kg/day bd, wk 3 & 4: 5 mg/kg/day
bd. Maintenance: 5-15 mg/kg/day bd
b) Add-on therapy in patients taking
Valproate or other anti-epileptic drugs,
wk 1 & 2: 0.2 mg/kg/day as a single
dose (children < 25 kg may take 5 mg
on alternate days), wk 3 & 4: 0.5
mg/kg/day as a single dose.
Maintenance dose: 1 -5 mg/kg/day od
or bd
RM1.70/tab
RM0.21/tab
RM0.46/tab
No Generic Name
14 Topiramate 15 mg
Capsule Sprinkle
Cat Indications
A* Add-on therapy for
intractable partial epilepsy
15
Topiramate 25mg Tablet

(Topamax)
A*
16

(Topamax)
A*
17

(Topamax)
A*
Levetiracetam 500mg
Tab
A*
i) Monotherapy therapy in
the treatment of partial
onset seizures with or
without secondary
generalization in patients
from age 16 years of age
with newly diagnosed
epilepsy
ii) Adjunctive treatment in
partial onset seizures with
or without secondary
generalization in adults and
children from 4 years of age
with epilepsy; juvenile
myoclonic epilepsy and
idiopathic generalized tonic
clonic epilepsy from 12
years of age
i) Monotherapy ADULT & Adolescent RM1.53/tab

(from 16 yrs): starting dose: 250 mg
bd, increase dose to 500 mg bd after 2 Borang E
wk. Dose can be further increased by
250 mg bd every 2 wk depending
upon the clinical response. Max: 1500
mg bd
ii) ADULT > 18 yrs & Adolescent (1217 yrs) >50 kg: initially 500 mg bd may
be increased up to 1500 mg bd. Dose
changes can be made in 500 mg bd
increments or decrements 2-4 wkly.
CHILD (4-11 yrs) and Adolescent (1217 yrs) <50 kg: initially 10 mg/kg bd,
may be increased up to 30 mg/kg bd.
dose changes should not exceed
increments or decrements of 10 mg/kg
bd every 2 wks. CHILD >50 kg: Adult
dose
A*
i) Second line treatment of

neuropathic pain in patients
who do not response to first
line drugs
ii) Fibromyalgia
i) Initially, 75 mg bd. May be increased RM3.30/tab

to 150 mg bd after 3-7 days. Max: 600
Borang E
mg/day after an additional 7-day
interval
ii) Initially, 75 mg bd. May be
increased to 150 mg bd within 1 week
or 225 mg bd. Max: 450 mg/day
A*
i) Add-on therapy for

intractable partial epilepsy,
refractory to standard antiepileptic drugs
ii) Treatment of various
types of neuropathic pain,
both peripheral (which
includes diabetic
neuropathy, post-herpetic
neuralgia, trigeminal
neuralgia) in adult > 18 yrs
i) ADULT: 900-1800 mg/day in 3

divided doses. CHILD: 10-40
ii) ADULT: 900 mg/day in 3 equally
divided doses, max: 3600 mg/day.
Initiate therapy with 300 mg od on Day
1, 300 mg bd on Day 2, 300 mg tds on
Day 3. Thereafter, the dose may be
increased in 3 equally divided doses
up to max. 3600 mg/day
18
Pregabalin 75 mg
Capsule
(Lyrica)
20
Gabapentin 300 mg
Capsule
(Neurontin)
RM2.15/tab
Borang E
(Keppra)
19
Dosage
Remark
ADULT: 200 - 400 mg/day in 2 divided RM2.06/tab
Borang E
doses. Max:1600 mg/day.
CHILD: initial 25 mg (1-3 mg/kg/day),
RM2.27/tab
then titrated by 1-3 mg/kg/1-2 weeks
Borang E
in 2 divided doses. Maintenance 5-9
RM1.36/tab
Borang E
64
RM0.13/cap
N04 Anti-Parkinson Drugs

No Generic Name
1 Benzhexol 2 mg Tablet
Procyclidine HCl 10 mg/2

ml Injection
Cat Indications
B i) Parkinson's disease
ii) Drug induced
parkinsonism
iii) Dystonias
i) All forms of Parkinson's

disease (idiopathic paralysis
agitants), post-encephalitis
and arteriosclerosis
ii) To control troublesome
extrapyramidal symptoms
induced by neuroleptic
drugs including pseudoparkinsonism, acute
dystonic reactions and
akathisia
By IM injection 5-10 mg repeated if

necessary after 20 min.
Max: 20 mg dly.
By IV injection 5 - 10 mg
RM16.60/vial
Parkinson's disease
RM0.50/tab
Parkinson's Disease
Patients not receiving Levodopa

before, initially 100-125 mg tds - qid
adjusted according to response.
Maintenance: 0.75 -2 g in divided
doses. In patients previously treated
with Levodopa the dose should be
about 20 - 25% of the dose previously
being taken
Initial: 100/25 mg 1-2 times/day,
increase every 3-4 days until
therapeutic effect, optimal dosage:
400/100 mg to 800/200 mg/day
divided into 4-6 doses. Dose: 200/50
mg used only when maintenance
therapy is reached and not to exceed
levodopa 1000-1200 mg/benserazide
250-300 mg per day
(Kemadrin)
Levodopa 100 mg &

Carbidopa 25 mg Tablet
Dosage
Remark
RM0.03/tab
ADULT: Initially 1 mg dly.
Maintenance: 5-15 mg dly in 3-4
divided doses.
CHILD: 0.02 mg/kg/dose tds, gradually
increasing to 0.1 - 0.3 mg/kg/dose
(Sinemet)
KPK
RM1.06/cap
Levodopa 100 mg,

Benserazide 25 mg HBS
capsule (Madopar HBS)
Levodopa 200 mg,

Benserazide 50 mg
Tablet (Madopar)
Amantadine HCl 100 mg

Tablet
Parkinson's disease
RM0.75/tab
Initial dose: 100 mg daily and is
increased to 100 mg bd (not later than
4 p.m.) after a week. Elderly > 65 yrs: Borang E
< 100 mg or 100 mg at intervals of
more than 1 day
Pramipexole
Dihydrochloride 0.125 mg
Tablet
A*
Treatment for signs and

symptoms of advanced
idiopathic Parkinson's
disease. It may be used as
monotherapy or in
combination with levodopa
Dose escalation: 0.125 mg tds on wk 1 RM1.06/tab

then 0.25 mg tds wk 2 then 0.5 mg tds
on wk 3. Increase by 0.75 mg at wkly Borang E
intervals if needed up to max. of 4.5
mg/day. Patient on levodopa:
Reduced dose. Renal impairment:
Clcr: 20-50 ml/min: initially 0.125 mg
bd, Clcr < 20 ml/min initially 0.25 mg
dly as a single dose, max: 1.5 mg bd
(Sifrol)
RM0.80/tab
Selegiline HCl 5 mg
Tablet
A*
Only for treatment of late

5 mg bd at breakfast and lunch.
stage Parkinsonism with on Max: 10 mg/day
and off phenomenon
RM0.64/tab
Entacapone 200 mg
Tablet
Parkinson's Disease. An
adjunct to standard
levodopa/benserazide or
levodopa/carbidopa for use
in patients with parkinson's
disease and end of dose
motor fluctuations, who
cannot be stabilised on
those combinations
65
RM3.70/tab
(Comtan)
200 mg to be taken with each dly dose

of levodopa/dopa-decarboxylase
inhibitor. May be taken with or without
food
N05 Psycholeptics
No Generic Name
1 Chlorpromazine HCl 25
mg Tablet
Cat Indications
B Psychosis mania and
agitation
Dosage
ADULT : Initial dose - 25 mg tds
according to response up to 1 g dly.
PAEDIATRIC: Up to 5 yrs: 0.5 mg/kg
every 4-6 hrs (Max: 40 mg dly).
CHILD 6-12 yrs: A third to half adult
dose (Max: 75 mg dly)
Remark
RM0.17/tab
RM0.13/tab
Chlorpromazine HCl 100

mg Tablet
Fluphenazine Decanoate
25 mg/ml Injection
Long term management of

psychotic disorders
By deep IM : Test dose 12.5 mg (6.25

mg in ELDERLY), then after 4-7 days
12.5 mg-100 mg repeated at intervals
of 14-35 days, adjusted according to
response.
CHILD not recommended
RM0.87/amp
Perphenazine 4 mg
Tablet
Schizophrenia and other

psychoses
ADULT: Initially 4 mg tds adjusted

according to response, max: 24 mg
dly. ELDERLY: 1/4 to 1/2 adult dose.
CHILD not recommended
RM0.20/tab
Prochlorperazine
Mesylate 12.5mg/ml
Injection
(Stemetil)
i) Severe nausea and

vomiting
ii) Vertigo/labyrinthine
disorders
Deep IM injection, 12.5 mg repeated if

necessary after 6 hrs and then
followed by an oral dose. Not
recommended in children
RM1.50/amp
Prochlorperazine Maleate
5mg Tablet
i) Severe nausea and

vomiting
ii) Vertigo/labyrinthine
disorders
i) Injection IM 12.5 mg stat and

repeated if necessary after 6 hrs or
orally 20 mg stat followed by 10 mg
after 2 hrs. Prevention: 5 - 10 mg 2 - 3
times a day. CHILD (> 10 kg only) 250
mcg/kg bd - tds a day
ii) For labyrinthine disorders 5 mg tds,
gradually increased to 30 mg dly in
divided doses, then reduced after
several wks to 5-10mg dly. Not
RM0.03/tab
Psychotic disorder
ADULT: Initially 5 mg bd, increase by

5 mg after 1 wk, then at 3-day
intervals. Max: 40 mg/day.
CHILD up to 12 yrs: Initially up to 5 mg
dly in divided doses adjusted to
response, age and body weight
RM0.21/tab
(Stemetil)
Trifluoperazine HCl 5 mg
Tablet
(Stelazine)
Haloperidol 5 mg/ml
Injection
Acute psychoses and mania ADULT: IM or IV , 2-10 mg then every

4-8 hrs according to response to total
max. 18 mg dly. Use in child is not
recommended
Haloperidol 1.5 mg Tablet
Schizophrenia and other

psychoses
10
Haloperidol 5 mg Tablet
11
Flupenthixol Decanoate
Depot 20 mg/ml lnjection
Chronic psychoses
(Fluanxol)
66
RM310/amp
ADULT : 1.5 -5 mg bd - tds up to 30

mg dly. Paed : Initial: 0.05 mg/kg/day
or 0.25-0.5 mg/day given in 2-3
divided doses; increase by 0.25-0.5
mg every 5-7 days; max: 0.15
mg/kg/day. Maximum 10 mg
RM0.12/tab
By deep IM, initial test dose of 5-20

mg, then after at least 7 days. 20 - 40
mg repeated at intervals of 2-4 wks.
Max. 400 mg wkly. Usual maintenance
dose 50 mg every 4 wks to 300 mg
every 2 wks. ELDERLY, initially
quarter to half adult dose. CHILD not
recommended. Deep IM
recommended. Not for IV use
RM13.34/amp
RM0.03/tab
No Generic Name
12 Zuclopenthixol 20 mg/ml
Drops
Cat Indications
A* Only for psychoses with
insight or compliance
Dosage
Remark
RM34.39 20ml
Initial: 20-30 mg/day in 2-3 divided
doses. Max. 150 mg dly. Usual
maintenance dose 20-50 mg dly.
Elderly (or debilitated), initially quarter
to half adult dose. CHILD not
recommended. Oral: Zuclopenthixol
dihydrochloride: usual maintenance
dose: 20-40 mg/day; max.100 mg dly
A*
Only for treatment of

agitated and violent patients
suffering from schizophrenia
who are not responding to
the available standard drugs
50-150 mg repeated after 2-3 days if

necessary. Additional dose may be
needed 1-2 days after the first
injection. Max.cumulative dose 400
mg per course and max. 4 injections;
max. duration of treatment 2 wks.
Change to oral dose 2-3 days after the
last injection. Child not recommended
RM14.94/amp
A*
Only for treatment of

agitated and violent patients
suffering from schizophrenia
who are not responding to
the available standard drugs
By deep IM injection test dose 100 mg

followed after 7-28 days by 100 - 200
mg or more followed by 200-400 mg at
intervals of 2-4 wks adjusted
according to response. Max. 600 mg
wkly. Child not recommended
RM19.45/amp
Treatment of resistant
schizophrenia
Initial dose : 12.5 mg (od or bd) dly,

increase slowly in steps of 25-50 mg
up to 300 mg dly within 2-3 wks. Max.
900 mg/day
RM0.45/tab
(Clopixol)
13
Zuclopenthixol Acetate
50 mg/ml Injection
(Clopixol - Acuphase)
14
Zuclopenthixol
Decanoate Depot 200
mg/ml Injection
(Clopixol Depot)
15
Clozapine 25 mg Tablet
(Clozaril)
16
Clozapine 100 mg Tablet

(Clozaril)
17
Olanzapine 5 mg Tablet
(Zyprexa)
A*
18
Olanzapine 10 mg Tablet
(Zyprexa)
A*
19
Olanzapine 5mg
Disintegrating Tablet
(Zyprexa Zydis)
Olanzapine 10 mg
Disintegrating Tablet
(Zyprexa Zydis)
Quetiapine Fumarate 200
mg Extended Release
Tablet
A*
20
21
A*
Quetiapine Fumarate 300

mg Extended Release
Tablet
A*
i)Schizophrenia
ii) Moderate to severe manic
episodes in bipolar disorder
iii) Major depressive
episodes in bipolar disorder
A*
(Seroquel XR)
23
Sulpiride 200 mg Tablet

(Dogmatil)
i) 5-10 mg od, increase to 10 mg od

RM8.04/tab
within 5-7 days, adjust by 5-10 mg/day KBUK
at 1 wk intervals, max. 20 mg/day
RM14.86/tab
ii) 10-15 mg od, increase by 5 mg/day KBUK
at intervals of not less than 24 hrs.
RM7.42/tab
Maintenance 5-20 mg/day; max. 20
KBUK
mg/day
RM13.77/tab
KBUK
(Seroquel XR)
22
i) Acute and maintenance

treatment of schizophrenia
and other psychoses where
positive and or negative
symptoms are prominent
ii) Short-term use for acute
mania episodes associated
with Bipolar 1 disorder
RM1.33/tab
(clozaril RM2.73/tab)
Acute and chronic

schizophrenia, chronic
delusional psychoses
67
i) & ii) 300 mg od (Day 1) then 600 mg

(Day 2). Maintenance dose: 400 to
800 mg od. Max: 800 mg dly
iii) 50 mg (Day 1), 100 mg (Day 2),
200 mg (Day 3) and 300 mg (Day 4).
Recommended dly dose is 300 mg.
May be titrated up to 600 mg dly. In
elderly or hepatic impairment:Start
with 50mg/ day, may be increased in
increments of 50mg /day to an
effective dose.
RM5.71/tab
200-400 mg bd; 800 mg dly in

predominantly negative symptoms and
2.4 g dly in mainly positive symptoms.
Elderly, lower initial dose; increased
gradually according to response. Child
< 14 yrs not recommended
RM0.13/tab
RM10.43/tab
No Generic Name
24 Amisulpride 100 mg
Tablet
(Solian)
25
Amisulpride 400 mg
Tablet
(Solian)
Cat Indications
A* Treatment of psychoses,
particularly acute or chronic
schizophrenia disorders
characterized by positive
symptoms(e.g. delusion,
hallucinations, thought
disorders) and/or negative
A* symptoms(e.g. blunted
emotions, emotional and
social withdrawal) including
when the negative
symptoms predominate
Dosage
Remark
Predominantly negative episodes: 50- RM1.38/tab
300 mg od adjusted according to the
KBUK
patient's response.
Mixed episodes with positive and
negative symptoms: 400-800 mg/day
in 2 divided doses adjusted according
to the patient's response.
RM5.17/tab
Should be taken on an empty stomach
(Preferably taken before meals)
KBUK
RM0.34/tab
26
Lithium Carbonate 300

mg Tablet
i) Prophylaxis and treatment

of acute mania and
hypomania episodes
ii)Prophylaxis of manic
depression in bipolar illness
or bipolar depression and
recurrent depression
1800 mg/day in 2-3 divided doses,

desired serum lithium level ranging
between 0.4-1 mmol/litre.
Maintenance 900-1200 mg/day in 2-3
divided doses
27
Risperidone 1 mg/ml Oral

Solution
(Risperdal)
Psychoses and
schizophrenia
28
Risperidone 1 mg Tablet
(Risperdal)
29
Risperidone 2 mg Tablet
(Risperdal)
ADULT: 2 mg in 1-2 divided doses on RM143.07/

1st day then 4 mg in 1-2 divided doses 30ml
on 2nd day then 6 mg in 1-2 divided
KBUK
doses on 3rd day (slower titration
appropriate in some patients); usual
RM0.07/tab
range 4-8 mg dly; dose > 10 mg dly
only if benefit outweighs risk (max: 16
mg dly). Elderly (or in hepatic or renal
impairment): initially 0.5 mg bd
increased in steps of 0.5 mg bd to 1-2 RM0.12/tab
mg bd. Not recommended in children
< 15 yrs
30
Risperidone Long acting

25mg Injection
A*
Treatment of acute and

chronic schizophrenic
psychosis and other
psychotic conditions, in
which positive and negative
symptoms are prominent. It
also alleviates affective
symptoms associated with
schizophrenia
25 mg IM every 2 wks. Dose

increments (if required) to 37.5 mg or
50 mg can be considered after a
minimum of 4 wks on each dosage
RM335.89/ea
i) Treatment of acute
episodes of schizophrenia
and for maintenance of
clinical improvement during
continuation therapy.
ii) Treatment of acute manic
episodes associated with
bipolar I disorder
Schizophrenia: 10 or 15 mg/day.
Maintenance dose: 15 mg/day. Bipolar
mania: Starting dose: 15 or 30
mg/day. Dose adjustment should
occur at intervals of not less than 24
hr
RM4.54/tab
Second or third line

treatment of schizophrenia
ADULT 6 mg once daily in the

morning, adjusted if necessary; usual
range 3 -12 mg daily. Renal
impairment (Clcr between 10-50
mL/min) 3 mg once daily. Avoid if Clcr
< 10mL/min
RM13.41/tab
(Risperdal Consta)
31
Aripiprazole 10mg Tablet
A*
32
Aripiprazole 15mg Tablet
A*
33
Paliperidone 3 mg
Extended Released
Tablet
A*
(Invega)
68
KBUK
RM6.26/tab
No Generic Name
34 Diazepam 5 mg Rectal
Solution
35
Diazepam 10 mg/2 ml
Injection
Cat Indications
C Status epilepticus, skeletal
muscle spasm
i) Status epilepticus
ii) Skeletal muscle spasm
iii) Anxiety disorders
i) Muscle spasm of varied

i) ADULT: 2-10 mg tds - qid. CHILD 6
aetiology, including tetanus mths and older: 0.12 - 0.8 mg/kg daily
ii) Anxiety disorders
in divided doses, every 6-8 hrs
ii) ADULT : 2 mg tds, increased in
severe anxiety to 15-30 mg dly in
divided doses. ELDERLY (or
delibitated) half adult dose. CHILD
(night terrors), 1-5 mg at bedtime
(Valium)
36
Diazepam 5 mg Tablet
Dosage
Remark
Status epilepticus - ADULT: 0.5 mg/kg RM30.58/ea
repeated after 12 hrs if necessary.
CHILD (febrile convulsions, prolonged
or recurrent): 0.5 mg/kg (max.10 mg),
repeated if necessary. Not
recommended for children < 2 yrs
(Valium)
i) Slow IV: 5-10 every 10-15 min (rate

< 5 mg/min), to a total dose of 30 mg,
may repeat in 2 hr if needed. Infants
30 days to 5 yrs, 0.05-0.3 mg/kg/dose
given over 2-3 min, every 15-30 min to
a total dose of 5 mg, repeat in 2-4 hrs
if necessary. CHILD > 5 yrs, 1 mg by
slow IV, every 2-5 min, max.10 mg,
repeat in 2-4 hrs if necessary
ii) Slow IV or IM, 5-10 mg repeated if
necessary in 3-4 hrs. CHILD (tetanus):
30 days - 5 years, 1-2 mg IM or IV
slowly every 3-4 hrs as needed. 5 yrs
and above, 5-10 mg IM or IV slowly
every 3-4 hrs if needed
iii) Anxiety disorders, 2-10 mg by slow
IV (< 5 mg/min). Repeat if necessary
every 3-4 hrs
RM1.45/amp
RM0.36/tab
RM0.20/tab
i) 1-4 mg increase to 10 mg dly in
divided doses. ELDERLY (or
delibitated) half adult dose
ii) 1-2 mg at bedtime Not
3-18 mg dly in divided doses. 6-30 mg RM0.33/tab
dly (single or divided doses) in anxietyneurosis. Children not recommended
37
Lorazepam 1 mg Tablet
A/KK i) Severe anxiety

ii) Insomnia
38
Bromazepam 1.5 mg
Tablet
Anxiety disorders
39
Clobazam 10 mg tablet
A*
As adjunctive therapy in
patients with epilepsy not
adequately stabilised with
their basic medication.
RM0.69/tab
The initial dose in adults and
adolescents >15 yr should be low (5
to15mg daily), if necessary, increased Borang E
gradually to a maximum daily dose of
about 80mg. Doses of up to 30mg
may be taken as a single dose in the
evening. The initial dose in children
from 3 to15 yr is normally 5mg. A
maintenance dose of 0.3 to 1.0mg/kg
daily is usually sufficient.
Anxiety disorders
0.25 - 0.5 mg tds (elderly or delibitated

0.25 mg bd - tds), increased if
necessary to a total dose of 3 mg/day.
Not recommended for children
(Frisium)
40
Alprazolam 0.5 mg Tablet

(Xanax)
41
Alprazolam 1 mg Tablet
(Xanax)
69
RM0.39/tab
RM0.75/tab
No Generic Name
42 Hydroxyzine HCl 25 mg
Tablet
Cat Indications
A Allergic pruritus
(Atarax)
Dosage
Remark
RM0.12/tab
Initially 25 mg on, increased if
necessary up to 25 mg tds - qid.
ADULT and CHILD > 10 yrs : 50-75
mg; 6-10 yrs: 25-50 mg; 1-5 yrs: 12.5 25 mg; to be taken dly in divided
doses
i) ADULT : For induction 200-400 mg. RM6.20/vial
For repeat injection 3-5 mg/kg over 10 15 secs until desired depth of
anaesthesia is obtained. Not FDA
approved for use in pediatric patients
ii) 75-125 mg IV single dose; for localanaesthetic induced convulsion: 125 250 mg IV over 10 min
43
Thiopental Sodium 500

mg Injection
i) General anaesthesia,
induction
ii) Anticonvulsant for cases
resistant to conventional
anticonvulsants in the ICU
44
Chloral Hydrate 200 mg/5

ml Mixture
Preoperative sedation
ADULT : 0.5 -1 g (max 2 g) with plenty

of water at bedtime. CHILD : 30-50
mg/kg up to a max dose of 1 g
RM177.4/
500gm
45
Midazolam 5 mg/ml
Injection
Pre-operative sedation,
induction of general
anaesthesia, premedication
and sedation in ICU and
sedation for minor
procedures
Usual sedative range 2.5 - 7.5 mg

(about 70 mcg/kg by IV injection over
30 seconds). Premedication by IM
injection 70 - 100 mcg/kg 30 -60
minutes before surgery; ELDERLY: 1 1.5 mg/kg. Induction: Induction by
slow IV infusion 200 - 300 mcg/kg
(ELDERLY 100 - 200 mcg/kg. CHILD
over 7 years 150 - 200 mcg/kg);
Maximum: 0.35mg/kg. Sedation in ICU
0.03 - 0.2 mg/kg/hour
RM1.03/amp
ADULT: Usually 7.5 - 15 mg at

bedtime; or for premedication, 30-60
min before the procedure. For
ELDERLY, debilitated or impaired
liver/kidney function: 7.5 mg
RM1.10/tab
(Dormicum)
46
Midazolam 7.5 mg Tablet A/KK Pre and post-operative

sedation
(Dormicum)
N06 Psychoanaleptics
No Generic Name
1 Imipramine HCl 25 mg
Tablet
Cat Indications
B Depression
Clomipramine HCl 25 mg
Tablet
Depressive illness,
obsessive-compulsive
disorder
Amitriptyline HCl 10 mg
Tablet
Depression
Amitriptyline HCl 25 mg
Tablet
Dosage
Remark
RM0.05/tab
Initially up to 75 mg dly in divided
doses increased gradually to 150 200 mg (up to 300 mg in hospital
patients); up to 150 mg may be given
as a single dose at bedtime.
ELDERLY initially 10 mg dly;
increased gradually to 30-50 mg daily;
CHILD is not recommended
Initially 10 mg dly, increased gradually RM0.34/tab
as necessary to 30-150 mg dly in
divided doses or as a single dose at
bedtime; max 250 mg dly. ELDERLY
initially 10 mg dly increased carefully
over approximately 10 days to 30-75
mg dly; CHILD not recommended
Initially 75 mg. ADULT and ELDERLY
: 30-75 mg dly in divided doses or as a
single dose at bedtime, increase
gradually as necessary to 150-200
mg. CHILD < 16 yrs are not
recommended
70
RM0.11/tab
RM0.15/tab
No Generic Name
5 Dothiepin HCl 25 mg
Capsule
6
Dothiepin HCl 75 mg
Tablet
Fluoxetine HCL 20 mg
Capsule
(Prozac)
Sertraline HCL 50 mg
Tablet
Cat Indications
Dosage
Remark
A Depression of any aetiology Initially 75 mg (ELDERLY 50-75 mg) RM0.27/cap
dly in divided doses or single dose at
bedtime, increased gradually as
necessary to 150 mg dly (ELDERLY
RM0.34/tab
A
75 mg may be sufficient), up to 225
mg dly in some circumstances. CHILD
is not recommended
RM0.20/cap
A i) Depressive illness
i) 20 mg od increased after 3 wks if
ii) Obsessive-compulsive
necessary, usual dose 20-60 mg
disorder
(ELDERLY 20-40 mg) od, max 80 mg
od (ELDERLY max 60 mg od).
ii) Initially 20 mg od increased after 2
wks if necessary, usual dose 20-60
mg (ELDERLY 20-40 mg) od, max 80
mg (ELDERLY max 60 mg) od,
discontinue if no improvement within
10 wks. CHILD < 18 yrs are not
recommended
B
Major depression, obsessive-Depression, obsessive-compulsive

compulsive disorder (OCD), disorder: 50 mg/day. Panic disorder:
panic disorder
Initially 25 mg/day. After 1 wk,
increase dose to 50 mg/day. All dose
changes should be made at intervals
of more than 1 wk, max: 200 mg/day
RM0.18/tab
Depressive disorder
RM0.54/tab
(Zoloft)
For depression, initially 50-100 mg

daily in the evening, increased if
necessary to 300 mg dly (over 150 mg
in divided doses); usual maintenance
dose 100 mg dly. CHILD < 18 yrs not
recommended
Fluvoxamine 50 mg
Tablet
(Luvox)
10
Fluvoxamine 100 mg
Tablet
(Luvox)
11
Escitalopram 10mg
Tablet
A*
i) Treatment of major
depressive episodes
ii) Treatment of panic
disorder with or without
agoraphobia
i) 10 mg od; may be increased to max RM1.79/tab

20 mg dly.
ii) Panic disorder with or without
KBUK
agoraphobia :Initially 5 mg for the first
wk, thereafter increased to 10 mg dly.
May be further increased up to max 20
mg dly, dependent on individual
patient response. ELDERLY initially
half adult dose, lower maintenance
dose may be sufficient. CHILD < 18
yrs not recommended
A*
Treatment of depressive
syndrome
Initially 300 mg dly in divided doses.

Gradually to increase up to 600 mg dly
in divided doses depending on
response. Usual range 150-600 mg
dly. Not recommended in children
A*
Episodes of major
depression
Initially 15 mg dly at bedtime

RM4.18/tab
increased according to response up to KBUK
45 mg dly as a single dose at bedtime
or in 2 divided doses. CHILD < 18 yrs
not recommended
A*
i) Depression
ii) Generalized anxiety
disorder
iii) Social anxiety disorder
(social phobia)
iv) Panic disorder
i), ii) & iii) ADULT: 75 mg od. May

increase dose by 75 mg/day every 4
days to a max. 225 mg/day
iv) 37.5 mg/day for the first 4-7 days
after which the dose should be
increased to 75 mg od. CHILD < 18
yrs not recommended
(Lexapro)
12
Moclobemide 150 mg
Tablet
(Aurorix)
13
Mirtazapine 30mg
Orodispersible Tablet
(Remeron)
14
Venlafaxine HCl 75 mg
Extended Release
Capsule
(Efexor XR)
71
RM1.08/tab
RM2.41/tab
RM3.66/tab
KBUK
No Generic Name
16 Methylphenidate HCl 10
mg Tablet
Cat Indications
A Hyperkinetic disorder
(attention deficit
hyperactivity disorder)
(Ritalin)
17
Methylphenidate HCL
18mg Extended-release
Tablet
A*
(Concerta)
18
Piracetam 1.2 g Tablet
A*
(Nootropil)
19
Donepezil HCl 5 mg
Tablet
(Aricept)
20
Rivastigmine 3 mg
Capsule
Rivastigmine 9.5 mg/24hr

Transdermal Patch
Memantine HCI 10 mg
Tablet
(Ebixa)
CHILD > 6 yrs: od to be taken in the

RM5.19/tab
morning. Dose may be adjusted in
increments to a max. of 54 mg/day, at Borang E
wkly interval. Patient new to
methylphenidate: starting dose 18 mg
od. Patient currently using
methylphenidate: 18-36 mg. Max. 54
mg/day. Discontinue if no response
after 1 mth
Mild cognitive impairment, Initially 7.2 g dly in 2-3 divided doses, RM0.67/tab
post concussional head
increased according to response by
syndrome, head injury
4.8 g dly every 3-4 days to max.of 20
disorder, chronic vertigo and g dly. CHILD < 16 yrs not
myoclonus
recommended
Treatment of mild to
5 - 10 mg od at bedtime. Max 10 mg
moderate dementia in
dly
Alzheimer's disease, as well
as in patients with severe
Alzheimer's disease.
RM3.30/tab
KBUK
For psychiatrists and

neurologists only. Mild to
moderately severe dementia
associated with Alzheimer's
or Parkinson's disease
Initial dose 1.5 mg bd, may increase

RM3.83/cap
by 1.5 mg bd every 2 wks to max of 6
KBUK
mg bd. If treatment is interrupted for
several days, should be reinitiated at
the lowest dly dose
A*
Mild to moderately severe

dementia associated with
Alzheimer's or Parkinson's
disease
Initial, 4.6 mg/24 hr patch TOPICALLY RM8.74/ea

once daily; after a minimum of 4
weeks and good tolerability, increase KBUK
the dose to 9.5 mg/24 hour patch once
daily
A*
As monotherapy or as
adjunctive therapy with
cholinesterase inhibitors for
the symptomatic treatment
of patients with moderate to
severe Alzheimer?s
disease.
Adult Initially 5 mg/day on the 1st

week, 5mg bd on the 2nd week, then
15 mg/day (10mg in the morning and
5mg in the evening) on the 3rd week.
From the 4th week on, continue
treatment with maintenance dose of
20 mg/day (10mg bd). Max: 20
mg/day.
(Exelonpatch 10)
22
Attention deficit
hyperactivity disorder
(ADHD)
A*
(Exelon)
21
Dosage
Remark
RM1.71/tab
CHILD > 6 yrs, initially 5 mg od - bd,
increased if necessary at wkly
intervals by 5-10 mg dly to max. 60 mg
dly in divided doses; discontinue if no
response after 1 mth, also suspend
periodically to assess child's condition
(usually finally discontinued during or
after puberty)
72
RM5.71/tab
Borang E
N07 Other Nervous System Drugs

No Generic Name
Cat
1 Neostigmine
B
Methylsulphate 2.5 mg/ml
Injection
Pyridostigmine Bromide
60 mg Tablet
Indications
i) Myasthenia gravis
ii) Reversal of nondepolarising neuromuscular
blockade
Dosage
Remark
RM0.92/amp
i) ADULT: 1 - 2.5 mg at suitable
intervals by SC, IM or IV. Usual total
dly dose 5-20 mg. CHILD: 200-500
mcg at suitable intervals throughout
the day. NEONATE: 50-250 mcg every
4 hrs ii) By IV injection over 1 min, 5070 mcg/kg (max 5 mg) after or with
atropine sulphate 0.6-1.2 mg
Myasthenia gravis
ADULT: 30-120 mg at suitable

intervals throughout the day, total daily
dose 0.3 - 1.2 g. CHILD up to 6 yrs
initially 30 mg, 6-12 yrs initially 60 mg,
usual total dly dose 30-360mg
(Mestinon)
RM0.19/tab
Betahistine Mesylate 6
mg Tablet
Betahistine
Dihydrochloride 24 mg
Tablet (Betaserc)
A*
Vertigo, tinnitus and hearing 24 mg bd

loss associated with
Meniere's disease
RM1.04/tab
Cinnarizine 25 mg Tablet
(Stugeron)
Flunarizine HCl 5 mg
Capsule
Vestibular disorders
1 tablet tds
RM0.05/tab
i) Migraine prophylaxis
ii) Maintenance treatment of
vestibular disturbances and
of cerebral and peripheral
disorders
i) ADULT: 5-10 mg dly preferably at

night. ELDERLY > 65 yrs: 5 mg on.
Maintenance 5-day treatment at the
same daily dose
ii) 5-10 mg on. If no improvement after
1 mth, discontinue treatment
RM0.20/cap
(Sibelium)
A/KK Vertigo, tinnitus and hearing Given in doses of 8-16 mg orally tds
loss associated with
(total 24-48 mg/day) preferably with
Meniere's disease
food. CHILD not recommended
RM0.54/tab
73
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P01 Antiprotozoals
No Generic Name
1 Metronidazole 200 mg
Tablet
Cat Indications
B Anaerobic infection
Dosage
800 mg initially followed by 400 mg
tds. CHILD: 7.5 mg/kg tds
Remark
RM0.06/tab
Chloroquine Phosphate
250 mg Tablet (150 mg
Chloroquine base)
Treatment of malaria - acute ADULT 600 mg base stat, 300 mg 6 attack

8 hrs later and a further 300 mg on
each of 2 following days. CHILD 3-4
yrs : 150 mg base stat, 75 mg 6 hrs
later, then 75 mg dly for 2 days.
CHILD 5-8 yrs : 300 mg stat, 150 mg 6
hrs later, then 150 mg dly for 2 days
RM0.12/tab
Hydroxychloroquine
Sulphate 200 mg Tablet
i) SLE and mixed

connective tissue disease
for skin, joint and serosa
ii) Second line therapy for
acute rheumatoid arthritis
i) Initially 400 mg dly in divided dose.

Maintenance : 200-400 mg dly
ii) ADULT : 400-600 mg dly.
Maintenance: 200-400 mg dly.
CHILD : up to 6.5 mg/kg dly (max.
400mg dly)
RM1.76/tab
Primaquine 7.5 mg base

Tablet
i) Treatment of malaria
ii) Prophylaxis together with
a schizonticide such as
chloroquine
i) ADULT: 15 mg dly for 14 days.

CHILD: 0.3 mg/kg dly for 14 days
ii) ADULT: 30 mg once wkly.
CHILD: 0.5 mg once wkly
RM0.96/tab
Quinine Dihydrochloride
600 mg/2 ml Injection
Suppression or treatment of
chloroquine-resistant
Plasmodium Falciparum
malaria in conjunction with
other antimalarial agents
RM19.67/amp
By slow IV infusion (over 4 hrs).
ADULT : 20 mg/kg followed by 10
mg/kg tds. CHILD : 20 mg/kg followed Borang E
by 10 mg/kg every 12 hrs, initial dose
should be half in patients who have
received quinine, quinidine or
mefloquine during the previous 12 or
24 hrs
Quinine Sulphate 300mg

Tab
Suppression or treatment of
chloroquine-resistant
Plasmodium Falciparum
malaria in conjunction with
other antimalarial agents
300-600 mg dly. Treatment : 1.2 - 2 g

daily in divided doses. CHILD < 1 yr:
100-200 mg dly, 1-3 yrs: 200-300 mg
daily, 4-6 yrs: up to 500 mg dly, > 7 yrs
: up to 1 g dly. All above doses are
given for 7 days in 2-3 divided doses
RM0.21/tab
Sulfadoxine 500 mg &

Pyrimethamine 25 mg
Tablet
Treatment of Plasmodium
falciparum malaria in
patients in whom
chloroquine resistance is
suspected and malaria
prophylaxis for travellers to
areas where chloroquineresistant malaria is endemic
Treatment as single dose. ADULT: 2 3 tablet. CHILD > 45 kg: 3 tablets, 45

to 31 kg : 2 tablets, 30 to 21 kg : 1 and
half tablets, 20 to 11 kg : 1 tablet, 5 to
10 kg : one-half tablet
RM0.18/tab
A*
Acute uncomplicated
falciparum malaria
ADULT and CHILD >12 yrs, > 35 kg: 4 RM2.58/tab

tablets as a single dose at the time of
initial diagnosis, again 4 tablets after 8 Borang E
hrs and then 4 tablets bd (morning and
evening) on each of the following two
days (total course comprises 24
tablets).
INFANT and CHILD 5-35kg: A 6 dose
regimen with 1 to 3 tablets per dose,
depending on bodyweight
(Fansidar)
Artemether 20mg +
Lumefantrine 120mg
(Riamet)
74
No Generic Name
9 Pyrimethamine 25 mg
Tablet
P02 Antihelmintics
No Generic Name
1 Diethylcarbamazine
Citrate 50 mg Tablet
(DEC)
Cat Indications
Toxoplasmosis (is used
conjointly with a
sulfonamide, since
synergism exists with this
combination)
Dosage
Remark
RM2.94/tab
ADULT starting dose is 50 to 75 mg
daily, together with 1 to 4 g daily of a
KPK
sulfonamide of the sulfapyrimidine
type, e.g., sulfadoxine. This dosage is
ordinarily continued for 1 to 3 weeks,
depending on the response of the
patient and tolerance to therapy. The
dosage may then be reduced to about
one half that previously given for each
drug and continued for an additional 4 5 weeks.
CHILD: 1 mg/kg/day divided into 2
equal daily doses; after 2 to 4 days
this dose may be reduced to one half
and continued for approximately 1
month.
Cat Indications
B i) Bancrofti filariasis,
onchocerciasis, loasis,
creeping eruption
ii) Ascariasis
iii) Tropical eosinophilia
Dosage
Remark
RM0.09/tab
i) 1 mg/kg on the first day and
increased gradually over 3 days to 6
Borang E
mg/kg daily in divided doses. This
dosage is maintained for 21 days.
ii) 13 mg/kg once daily for 7 days.
CHILD : 6 - 10 mg/kg tds for 7 days iii)
6 mg/kg/day in 3 divided doses for 21
days
Albendazole 200 mg/5 ml

Suspension (Zentel)
Albendazole 200 mg
Tablet (Zentel)
i) Single or mixed
infestations of intestinal
parasites
ii) Strongyloides infection
i) ADULT and CHILD > 2 yrs : 400 mg

as a single dose
ii) 400 mg as a single dose for 3
consecutive days. CHILD 12-24 mths:
half adult dose
RM3.88/10ml
RM0.34/tab
P03 Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents

No Generic Name
1 Crotamiton 10 % Cream
(Eurax)
Cat Indications
A/KK i) Pruritus
ii) Scabies
iii) Insect bite reactions
Dosage
Remark
i) and iii) Massage into affected area RM2.80 /
15gm
until the medication is completely
absorbed. Repeat as needed. Apply
bd or tds
ii) Apply topically (do not rinse off),
apply a 2nd time and leave on skin for
24-48 hrs. For resistant scabies,
treatment (2 applications at 24 hr
interval) may be repeated after 1 wk
Gamma Benzene
Hexachloride 0.1 %
Lotion (Lindane)
Scabies
Apply lotion to entire body from neck

down for 8 to 12 hrs, then rinse
Benzyl Benzoate 12.5%

Emulsion (child)
Benzyl Benzoate 25%

Emulsion (Adult)
Scabies and pediculosis, for After bath, apply over the whole body,
child < 2 yrs
neck down and leave on for 24 hrs
then wash off. Reapply for another 24
hrs, the first repeat application should
be within 5 days of the initial
Scabies and pediculosis
application, a third application may be
required in some cases
75
RM18.28/L
RM0.94/
120ml
RM1.89/
120ml
RESPIRATORY SYSTEM
R01 Nasal Preparations

No Generic Name
1 Ephedrine 0.5% w/v
Nasal Drops
Cat Indications
A/KK Decongestion of the upper
respiratory tract
Dosage
2 drops tds. Max. use for 1 wk
Remark
RM0.50/ea
Oxymetazoline HCl
0.025% (Paed) Nasal
Spray
Acute colds, paranasal

sinusitis and otitis media
2 - 3 sprays into each nostril bd for

child > 1 yr
RM8.25/15ml
Oxymetazoline HCl
0.05% (Adult) Nasal
Spray
Acute colds, paranasal

sinusitis and otitis media
2 - 3 sprays into each nostril bd, max.

6 sprays per nostril/day
RM8.75/15ml
Beclomethasone
Dipropionate 50
mcg/dose Nasal Spray
ADULT and CHILD > 6 yrs : Apply 100

mcg (2 sprays) into each nostril bd or
50 mcg (1 spray) into each nostril 3 - 4
times/day. Max.400 mcg dly (8
sprays). When symptoms controlled,
reduce dose to 50 mcg (1 spray) into
each nostril bd
RM12.00/ea
A/KK Prophylaxis and treatment

of perennial and seasonal
allergic rhinitis and
vasomotor rhinitis
(Beconase)
Budesonide 50 mcg/dose
Nasal Spray
(Rhinocort )
Seasonal allergic, perennial ADULT and CHILD 6 yrs and older.

rhinitis and nasal polyposis Rhinitis : 2 spray into each nostril om
or 1 spray into each nostril bd.
Nasal polyps : 2 spray bd
RM16.20/ea
Mometasone Furoate 50
mcg Aqueous Nasal
Spray
A*
Allergic rhinitis
ADULT and CHILD > 12 yrs: 100

mcg/day (2 sprays) to each nostril od.
Max.200 mcg (4 sprays) od. Reduce
to 50 mcg (1 spray) od when control
achieved. CHILD 6-12 yrs: 50 mcg (1
spray) to each nostril od
RM27.37/ea
As directed for local use
RM170.40/kg
(Nasonex)
7
Menthol 1.6% in Ind.

Methylated Spirit
Inhalation
Decongestion of the upper

respiratory tract
Bismuth Subnitrate,
Iodoform & Liquid
Paraffin Paste
As a mild antiseptic for

As directed for local application
wounds and abscesses.
Sterile gauze impregnated
with paste for packing
cavities after otorhinological
surgery
RM0.37/gm
Decongestion of the upper

respiratory tract in common
cold, hay fever, allergic and
vasomotor rhinitis and
sinusitis
ADULT and CHILD > 12 yr: 10 ml.

CHILD 6-12 yr: 5 ml, 2-5 yr: 2.5 ml, 6
mths -2 yr: 1.25 ml. Doses to be taken
bd or tds. Not FDA approved in
children < 6 yrs
RM20.80/60ml
ADULT and CHILD > 12 yrs: 1 tablet

bd
RM1.12/tab
(BIPP)
9
Triprolidine HCl 1.25 mg

& Pseudoephedrine HCl
30 mg per 5 ml Syrup
(Actifed)
10
Loratadine 5 mg &
Pseudoephedrine
Sulphate 120 mg Tablet
(Clarinase)
R02 Throat Preparations

No Generic Name
1 Chlorhexidine Gluconate
0.2 % Mouthwash
2
Fusafungine 1% Nasal
Spray
(Locabiotal)
A/KK For treatment of allergic

rhinitis and allergic
dermatoses
Cat Indications
C As a gargle
A
Dosage
Rinse mouth with 10 ml for about 1
min bd
Local antibiotic, antiinflammatory treatment of

infectious and inflammatory
syndromes of the respiratory
mucosa
76
ADULT : 1 oral or 1 nasal inhalation 4

hrly, withdraw if no improvement after
7 days. CHILD : 1 oral or 1 nasal
inhalation 6 hrly, withdraw if no
improvement after 7 days
Remark
RM0.50
RM45.75/ea
R03 Drugs for Obstructive Airway Diseases

No Generic Name
Cat Indications
1 Salbutamol 100
B Asthma and other
mcg/dose Inhalation
conditions associated with
(Ventolin)
reversible airways
obstruction
Dosage
Remark
ADULT : 100-200 mcg up to tds - qid. RM7.51/ea
CHILD : 100 mcg increased to 200
mcg if necessary
Salbutamol 0.5 %
Inhalation Solution
(Ventolin)
Asthma and other

reversible airways
obstruction
2 ml may be inhaled up to qid over a

period of 3 min per inhalation (0.5 ml
diluted in 2.5 ml of normal saline by
inhalation over 5-15 min)
RM4.18/10ml
Terbutaline Sulphate 10
mg/ml Inhalation Solution
(Bricanyl)
Asthma and other

reversible airways
obstruction
ADULT : 5-10 mg bd - qid, additional

doses may be necessary in severe
acute asthma. CHILD up to 3 yrs : 2
mg, 3-6 yrs: 3 mg, 6-8 yrs: 4 mg, > 8
yrs : 5 mg bd - qid
RM28.88/
50ml
Ipratropium Bromide 20
mcg and Fenoterol 50
mcg/dose Inhalation
Management of symptoms
in chronic obstructive
airway disorders with
reversible bronchospasm
such as bronchial asthma
and chronic bronchitis with
or without emphysema
ADULT & CHILD >6 yrs; Acute asthma

2 puffs. Severe cases: if breathing has
not noticebly improved after 5 mins, 2
further puffs may be taken. Intermitent
and long-term treatment: 1-2 puffs for
each administration, up to max 8
puffs/day (average: 1-2 puffs tds)
RM15.20/ea
Management of reversible
bronchospasm associated
with obstructive airway
diseases
Acute attacks : 1 unit dose vial. In

severe cases not relieved by 1 unit
dose vial, 2 unit dose vials may
require, patient should consult a
doctor immediately. Maintenance : 1
unit dose vial tds - qid
RM0.85/ea
A/KK Regular treatment of

reversible obstructive
airways diseases including
asthma
ADULT and CHILD >12 yrs: 1-2 puff

bd. CHILD > 4 yrs : 1 puff bd
RM49.25/ea
(Berodual)
Ipratropium Bromide 0.5

mg & Salbutamol 2.5 mg
per UDV
(Duolin/ Combivent)
Salmeterol 50 mcg &

Fluticasone Propionate
250 mcg Inhalation
(Seretide Accuhaler)
Salmeterol 25mcg +
Fluticasone 125mg
Evohaler 120 Dose
(Seretide Evohaler)
A*
Budesonide 320 mcg and

Formoterol 4.5 mcg
Inhalation (Symbicort)
A*
Budesonide 160 mcg and

Formoterol 4.5 mcg
Inhalation (Symbicort)
10
Beclomethasone
Dipropionate 100
mcg/dose Inhalation
11
Budesonide 200
mcg/dose Inhalation
12
Budesonide 500 mcg/2

ml Nebulising Solution
KBUK
Regular treatment of
reversible obstructive
airways diseases including
asthma
ADULT and CHILD >12 yrs: 1-2 puff

bd. CHILD > 4 yrs : 1 puff bd
i) Regular treatment of
asthma where use of a
combination (inhaled
corticosteroid & long-acting
2-agonist) is appropriate.
ii) Symptomatic treatment of
patients with severe COPD
(FEV1
Asthma; Maintenance therapy: Adult RM88.00/ea

18 yr 160 mcg to 320 mcg bd. Some
KBUK
patients may require up to a max of
640 mcg bd. Adolescent 12-17 yr 160
mcg to 320 mcg bd. Childn 6-11 yr
RM103.4/ea
160 mcg bd,
KBUK
Prophylaxis of asthma
especially if not fully
controlled by
bronchodilators
Maintenance treatment of
asthma as prophylactic
therapy especially if not fully
controlled by
bronchodilators
Maintenance treatment of
asthma as prophylactic
therapy especially if not fully
controlled by
bronchodilators
ADULT : 100 mcg tds - qid or 200 mcg

bd. CHILD > 6 yrs : 50-100 mcg bd qid
RM14.51/ea
ADULT : 200-1600 mcg dly in 2-4

divided doses. Maintenance with bd
dosing. CHILD >7 yrs 200-800 mcg, 27 yrs 200-400 mcg. To be taken orally
in 2-4 divided doses
ADULT : Initially 1-2 mg bd. CHILD 3
mths -12 yrs: 500 mcg-1 mg.
Maintenance dose : half of the above
doses
RM27.26/ea
77
RM78.30/ea
KBUK
RM4.28/ea
No Generic Name
13 Fluticasone Propionate
125 mcg/dose Inhalation
Cat Indications
B Prophylactic treatment for
asthma
(Flixotide)
14
Ipratropium Bromide 20
mcg/dose Inhalation
(Atrovent)
15
Ipratropium Bromide
0.025 % Inhalation Soln
(250 mcg/ml)
(Atrovent)
16
Tiotropium bromide
Inhalation 18 mcg
Capsules & Handihaler
(Spiriva)
Dosage
Remark
RM27.37/ea
ADULT and CHILD >12 yrs
i) Mild asthma : 100-250 mcg bd
ii) Moderate asthma: 250-500 mcg bd
iii) Severe asthma: 500-1000 mcg bd.
Alternatively, the starting dose of
fluticasone dipropionate may be
gauged at half the total dly dose of
beclomethasone dipropionate or
equivalent administered by inhalation.
CHILD 4-11 yrs, 50 mcg bd
(max: 100 mcg bd)
RM11.86/ea
20-40 mcg tds - qid. In the early
treatment, up to 80 mcg tds - qid.
CHILD up to 6 yrs : 20 mcg tds,
6-12 yrs : 20-40 mcg tds
Only for treatment of : i)

Patients with chronic
bronchitis who have airway
obstruction and who do not
respond to Salbutamol or
Terbutaline ii) Patients with
ischaemic heart disease
who develop extrasystole
with Salbutamol or
Terbutaline
Only for treatment of : i)
ADULT : 500 mcg up to qid.
Patients with ischaemic
CHILD 5-12 yrs: 125-250 mcg up to
heart disease who develop qid, 12 yrs : 250-500 mcg up to qid
extrasystole with salbutamol
or terbutaline ii) Patients
with chronic bronchitis who
have airway obstruction and
who do not respond to
salbutamol or terbutaline.
Reversible airways
obstruction, particularly in
chronic obstructive
pulmonary disease
A/KK Long term maintenance

treatment of bronchospasm
and dypsnoea associated
with COPD. Tiotropium has
usually been added to
standard therapy (e.g.
inhaled steroids,
theophylline, albuterol
rescue)
RM1.15/ea
1 capsule od.
RM3.74/cap
Inhale the contents of capsule with the
handihaler device at the same time of KBUK
day.
Child and adolescent < 18 years, not
recommended
17
Ephedrine HCl 30 mg/ml

Injection
Treatment of bronchial
spasm in asthma, adjunct to
correct haemodynamic
imbalances and treat
hypotension in epidural and
spinal anaesthesia
By IM, SC or IV. Severe, acute

bronchospasm : 12.5-25 mg.
When used as a pressor agent :
ADULT 25-50 mg SC/IM. If necessary,
a 2nd IM dose of 50 mg or an IV dose
of 25 mg may be given. Direct IV
injection, 10-25 mg may be given
slowly. Max. parenteral ADULT dose:
150 mg in 24 hrs. CHILD : 3 mg/kg or
100 mg/m2 SC or IV dly, in 4-6 divided
doses
RM1.03/amp
18
Salbutamol 2 mg/5 ml
Syrup
(Ventolin)
Asthma and other

reversible airways
obstruction
CHILD 2-6 yrs: 1-2 mg tds - qid,

6-12 yrs: 2 mg tds - qid
RM1.15/60ml
78
No Generic Name
19 Salbutamol 0.5 mg/ml
Injection
(Ventolin)
Cat Indications
A Asthma and other
reversible airways
obstruction
20
A*
Prevention of uncomplicated Infusions containing 5 mg in 500ml (10

premature labour only
mcg/ml) at the rate of 10-45 mcg/min
increased at intervals of 10 min until
evidence of patient response as
shown by reduction of strength,
frequency or duration of contractions;
maintain rate for 1 hr after contractions
have stopped, then gradually reduce
by 50% every 6 hrs
RM39.65/amp
Asthma and other

reversible airways
obstruction
CHILD 2-6 yrs: 1-2 mg tds - qid,

6-12 yrs: 2 mg tds - qid.
CHILD >12 yrs and ADULT : 2-4 mg
tds - qid
RM0.015/tab
Bronchial asthma, chronic

bronchitis, emphysema and
other lung diseases where
broncoconstriction is a
complicating factor
SC, IM or slow IV : 250-500 mcg up to

qid. CHILD 2-15 yrs 10mcg/kg to a
max. of 300 mcg. Continuous IV
infusion, as a solution containing 3 - 5
mcg/ml, 1.5 -5 mcg/min for 8-10 hrs;
reduce dose for children
ADULT: 125 mg tds - qid after food,
increased to 250 mg if required.
CHILD: 1-15 yrs : 5 mg/kg/dose (up to
600 mg/ day) tds - qid
RM3.25/amp
Salbutamol 5 mg/5 ml
Injection
(Ventolin)
21
Salbutamol 2 mg Tablet
(Ventolin)
22
Terbutaline Sulphate 0.5

mg/ml Injection
(Bricanyl)
Dosage
Remark
500 mcg by SC/IM injection 4 hrly or RM1.66/amp
250 mcg by slow IV. If required, by IV
infusion, initially 5 mcg/min adjusted
according to response and heart rate,
usually in the range 3-20 mcg/min
RM0.02/tab
23
Theophylline 125 mg
Tablet
(Neulin)
Reversible airways
obstruction, acute severe
asthma
24
Theophylline 250 mg
Long Acting Tablet
(Neulin SR)
Reversible airways
obstruction and acute
severe asthma
ADULT: 250 mg bd. CHILD < 12 yrs:

Up to 10 mg/kg bd
RM0.16/tab
25
Aminophylline 25 mg / ml
Injection
Reversible airways
obstruction, acute severe
asthma
Deteriorating acute asthma not

previously treated with theophylline, by
slow IV injection over 20 min 250 - 500
mg (5 mg/kg), then as for acute severe
asthma.
Acute severe asthma by IV infusion :
500 mcg/kg/hr, adjusted according to
plasma-theophylline concentration.
CHILD : 6 mth-9 yrs: 1 mg/kg/hr,
10-16 yrs: 800 mcg/kg/hr
RM4.40/amp
26
Montelukast Sodium 4
mg Oral Granules
(Singulair)
A*
12 mths - 5 yrs: 1 packet of 4mg oral

granules dly at bedtime
RM3.98/ea
mg Chewable Tablet
(Singulair)
A*
Asthmatics, not controlled

on high dose inhaled
corticosteroids > 1600
mcg/day and with co-morbid
allergic disorders. Chronic
treatment of asthma
mg Tablet
(Singulair)
A*
27
28
KBUK
CHILD 6-14 yrs: One 5 mg chewable
tablet dly at bedtime
Chronic treatment of asthma CHILD > 15 yrs and ADULT: 10 mg

and relief of symptoms of
dly at bedtime
seasonal allergic rhinitis for
children > 15 yrs and adults
79
RM0.96/tab
KBUK
RM0.96/tab
KBUK
R05 Cough and Cold Preparations

No Generic Name
Cat Indications
1 Bromhexine HCl 4 mg/5
B Secretolytic therapy in acute
ml Elixir
and chronic
bronchopulmonary diseases
2 Bromhexine HCl 4 mg/2
A associated with abnormal
ml Injection
mucous secretion and
3 Bromhexine HCl 8 mg
B impaired mucous transport
Tablet (Bisolvon)
R06 Antihistamines for Systemic Use
No Generic Name
Cat Indications
1 Diphenhydramine HCl
C Cough
14mg/5ml & Ammonium
Chloride 135mg/5ml
Expectorant (Benadryl)
2 Dexchlorpheniramine
B Symptomatic treatment of
Maleate 2 mg/5 ml Syrup
allergic rhinitis
Dosage
Remark
ADULT & CHILD > 12 yrs: 10 ml tds, 6- RM0.92/60ml
12 yrs : 5 ml tds, 2-6 yrs: 2.5 ml tds, <
2 yrs: 1.25 ml tds
RM0.92/amp
4 mg SC, IM or IV bd - tds
ADULT & CHILD > 12 yrs: 8 mg tds, 612 yrs: 4 mg tds, 2-6 yrs: 4 mg bd
Dosage
ADULT : 5 - 10 ml bd - tds.
CHILD : 2.5 - 5 ml bd - tds.
RM0.02/tab
Remark
RM3.36/90ml
CHILD 2-5 yrs : 0.5 mg every 4-6 hrs;

6-11 yrs : 1 mg every 4-6 hrs
RM1.30/60ml
ADULT : 2 mg tds.
CHILD 1-12 yrs : 2 mg tds
RM0.02/tab
Dexchlorpheniramine
Maleate 2 mg Tablet
(Polaramine)
allergic rhinitis and allergic
dermatoses
Chlorpheniramine
Maleate 2 mg/5ml Syrup
(Piriton)
CHILD 1-2 years : 1 mg bd, 2-5 yrs : 1
allergic conditions
mg every 4-6 hrs (max 6 mg dly), 6-12
responsive to antihistamine yrs : 2 mg every 4-6 hrs (max 12 mg
dly)
RM3.01/ 60ml
Chlorpheniramine
Maleate 10 mg/ml
Injection
Allergic conditions
RM0.27/amp
Chlorpheniramine
Maleate 4 mg Tablet
(Piriton)
ADULT : 4 mg every 4-6 hrs. Max 24
allergic conditions
mg dly. CHILD 1-2 yrs : 1 mg bd, 2-5
responsive to antihistamines yrs: 1 mg every 4-6 hrs (max. 6 mg
dly), 6-12 yrs: 2 mg every 4-6 hrs
(max. 12 mg dly)
RM0.03/tab
Promethazine HCl 5 mg/5

ml Syrup (Phenergan)
Allergic conditions
CHILD 2-5 yrs: 5-15 mg dly,

5-10 yrs : 10-25 mg dly
RM3.01/60ml
Promethazine HCl 25
mg/ml Injection
Allergic conditions
By deep IM: ADULT: 25-50 mg, max.

100 mg. CHILD: 5-10 yrs: 6.25 - 12.5
mg. By slow IV: 25 - 50 mg in a
solution of 2.5 mg/ml in water for
injection. Max 100 mg
RM2.90/amp
Cetirizine HCl 10 mg
Tablet
(Zyrtec)
A/KK Urticaria, allergic

dermatoses (insect bites,
atopic eczema), perennial
rhinitis, allergic rhinitis
ADULT and CHILD > 6 yrs:10 mg dly

or 5 mg bd. Child 2-6 yrs: 5 mg od or
2.5 mg bd
RM0.05/tab
10
Loratadine 1 mg/ml Syrup

(Clarityne)
ADULT and CHILD >6 yrs: 10 mg od.

CHILD 2-6 yrs: 5 mg od
RM1.67/60ml
11
Loratadine 10 mg Tablet
(Clarityne)
Allergic rhinitis, chronic

urticaria and other allergic
dermatological disorders
Desloratadine 5 mg
Tablet
(Aerius)
A*
Allergic rhinitis and chronic

idiopathic urticaria
ADULT & CHILD more than 12 years :

5 mg once daily. CHILD: 6-11 yr: 2.5
mg; 1-5 yr: 1.25 mg; 6-11 mth: 1 mg.
Doses to be taken once daily
10-20 mg IM or SC, repeated if

required. Not to exceed 40 mg in 24
hrs. 10-20 mg over 1 min by slow IV
80
RM0.13/tab
RM1.01/tab
R07 Other Respiratory System Products

No Generic Name
Cat Indications
Dosage
1 Beractant Intratracheal
A* Treatment of newborn baby 100 mg/kg (4 ml/kg) via endotracheal
Suspension (200 mg
with birth weight of 700 g or tube every 6 hrs (1 - 4 doses)
phospholipids in 8 ml.
greater undergoing
vial)
mechanical ventilation for
(Survanta)
syndrome, whose heart rate
and arterial oxygenation are
continuously monitored
81
Remark
RM1555.60/
vial
SENSORY ORGANS
S01 Ophtalmologicals
No Generic Name
1 Amphotericin-B 0.15%
Eye Drops
Cat Indications
A Fungal infection of the
cornea
Dosage
1 drop hrly or 2 hrly
Remark
RM22.02/ea
Chloramphenicol 0.5%
Eye Drops
Broad spectrum antibiotic in 1 - 2 drops every 3-4 hrs

superficial eye infections
RM0.98/ea
Chloramphenicol 1% Eye
Ointment
Conjunctivitis and other

superficial eye infection
RM1.11/ea
Gentamicin 0.3% Eye

Drops
Gentamicin 3% Fortified
Eye Drops
Gentamicin 0.3% Eye

Ointment
Fusidic Acid 1% Eye

Ointment
A/KK Broad spectrum antibiotic in 1 - 2 drops every 4 hrs, in severe

infection dosage may be increased up
and also for Pseudomonas to 2 drops every hr
aeruginosa
A
Oxytetracycline with
Polymyxin B Sulphate
Eye Ointment
RM2.67/ea
Broad spectrum antibiotic in Dose according to the needs of the

patient
and also for Pseudomonas
aeruginosa
A/KK Conjunctivitis, blepharitis,

blepharo-conjunctivitis,
keratitis,
keratoconjunctivitis,
episcleritis, dacrocystitis,
corneal ulcers, styes and
infected eye socket
Apply into the conjunctival sac tds qid
RM2.95/ea
1 drop in conjunctival sac bd. To be

continued for 2 days after the eye
appears normal. On the first day of
treatment, may be applied more
frequently : 1 drop 4 hrly. Surgical
prophylaxis : 1 drop bd, 24-48 hrs
before operation
RM14.90/ea
For staphylococcal
infections
Conjunctivitis,
Apply into the conjunctival sac qid
dacryocystitis,
blepharoconjunctivitis,
keratitis, trachoma,
blepharitis, pre-op
prophylaxis against infection
RM1.33/tube
RM23.80/tube
(Fucithalmic)
Apply 1/2 inch of ointment every 3-4

times into the conjunctival sac
(Terramycin)
Acyclovir 3% Eye
Ointment
A*

herpes simplex keratitis
10
Ciprofloxacin HCl 0.3%

Ophthalmic Solution
(Ciloxan)
A*
i) For corneal ulcer

i) 2 drops every 15 min for first 6 hrs,
ii) For bacterial conjunctivitis then 2 drops every 30 min for the rest
of the day. 2nd day : 2 drops every hr.
Subsequent days (3rd - 14th day) : 2
drops every 4 hrs. ii) 1-2 drops 2 hrly
into the conjunctival sac while awake
for 2 days and 1-2 drops 4 hrly while
awake for the next 5 days
RM5.00/ea
11
Betamethasone Disod
Phos 0.1% Eye Drops
Non-infected inflammatory
conditions of the eyes
1 - 2 drops every 1 - 2 hrs until

controlled then reduce frequency
RM2.18/ea
12
Fluorometholone 0.1%
Ophthalmic Suspension
(Flarex)
A*
Treatment of steroid
responsive ocular
inflammation
1-2 drops bd - qid
RM5.43/ea
82
Apply 1 cm 5 times dly. Continue for at

least 3 days after healing
No Generic Name
13 Ketorolac Tromethamine
0.5% Eye drop
(Acular)
Cat Indications
A i) Ocular itching due to
allergic conjunctivitis
ii) Prophylaxis and reduction
of inflammation and
associated symptoms
following ocular surgery
A
Remark
RM15.30/ea
1-2 drops hrly for severe cases and 46 hrly for mild infection
RM6.28/ea
Apply 2-3 drops tds - qid
RM11.71/ea
14
Dexamethasone &
Neomycin Sulph &
Polymyxin B Sulph
Ophthalmic Suspension
(Maxitrol)
15
Framycetin Sulp 0.5%,

A/KK Otitis externa
Dexamethasone 0.05% &
Gramicidin 0.005% Ear
Drops (Sofradex)
16
Gentamicin Sulphate &

Betamethasone Disod
Phosphate Eye Drops
(Garasone)
17
Betamethasone Disod
Phos & Neomycin Sulp.
0.5% Eye Drops
(Betnesol-N)
Infected inflammatory
conditions of the eyes
2-3 drops every 2-3 hrs
RM2.78/bot
19
Pilocarpine 2% Eye
Drops
Miotics in chronic openangle glaucoma
1 drop od - qid
RM6.69/ea
20
Pilocarpine 4% Eye
Drops
21
Carbachol 0.01%
Intraocular Solution
For intraocular use for

miosis during surgery
22
Acetazolamide 500 mg
Injection
RM62.00/ea
23
Acetazolamide 250 mg
Tablet
Reduction of intra-ocular
250 - 500 mg given by IM or IV
pressure in open-angle
glaucoma, secondary
glaucoma and peri250 - 500 mg dly
operatively in angle-closure
glaucoma
24
hypromellose 0.3% Eye

Drops
A*
All glaucoma patients where

beta-blockers are
contraindicated and when
intraocular pressure is not
well controlled by other
drugs
Monotherapy: 1 drop tds.

Adjunctive therapy with an ophthalmic
beta-blocker: 1 drop bd. When
substituting for another ophthalmic
antiglaucoma agent with this product,
discontinue the other agent after
proper dosing on one day and start
Trusopt on the next day. If more than
1 topical ophthalmic drug is used, the
drugs should be administered at least
10 mins apart
RM48.70/ea
Elevated intraocular
pressure, chronic open
angle galucoma
Initially, 1 drop of 0.25% bd, if clinical

response is not adequate, 1 drop of
0.5% bd
RM19.45/ea
A/KK Inflammatory and allergic

2 drops tds - qid
conditions involving
superficial eye structures
and when bacterial infection
is present : conjunctivitis,
blepharitis, keratitis,
episcleritis, dacryocystitis,
hordeolum, meibomianitis,
injuries involving anterior
segment of the eye
(Artificial Tears)
25
Timolol Maleate 0.5%

Eye Drops
Treatment of ocular
inflammation when
concurrent use of an
antimicrobial is judged
necessary
Dosage
i) 1 drop qid
ii) 1 drop qid starting 24 hrs postoperation, continue for 2 wks
RM2.67/ea
RM10.24/ea
83
Instill not more than 1/2 ml gently into

the anterior chamber
RM16.75/vial
KPK
RM0.01/tab
No Generic Name
26 Betaxolol 0.25% Eye
Suspension
(Betoptic)
Cat Indications
A Chronic open-angle
glaucoma, ocular
hypertension
Dosage
1-2 drops in the affected eye(s) bd
27
A*
Reduction of elevated
intraocular pressure in
patients with open-angle
glaucoma
1drop (1.5 g) in the affected eye(s)

od in the evening. If more than one
topical ophthalmic drug is being used,
the drugs should be administered at
least 5 min apart
RM16.50/ea
A*
Reduction of elevated
intraocular pressure in
patients with open angle
glaucoma or ocular
hypertension.
1drop in the affected eye(s) od in the

evening.
RM5.31/ea
Latanoprost 0.005% Eye

Drops
(Xalatan)
28
Travoprost 0.004% Eye

Drops
(Travatan)
Remark
RM22.54/ea
KPK
29
Atropine Sulphate 1%
Eye Drops
Determination of refraction,
strabismus, iritis and
iridocyclitis, after extra or
intracapsular extraction of
lens
Preoperative Mydriasis: 1 drop of a

1% solution supplemented with 1drop
of 2.5 or 10% phenylephrine prior to
surgery. Anterior Uveitis or
Posoperative Mydriasis: 1 drop of a
1% or 2% solution up to tds
RM6.39/ea
30
Cyclopentolate 1% Eye
Drops
Mydriasis and cycloplegia
1-2 drops several times a day.

Refractory procedures, ADULT : 1
drop of 0.5% solution. CHILD 6-12 yrs
: 1 drop of 1% solution. CHILD < 6 yrs
: 1-2 drops of 1% solution
RM19.45/ea
1-2 drops several times a day
RM19.87/ea
Mydriasis and vasoconstriction: 1 drop

of 2.5% or 10% solution, repeated in 1
hour if necessary. Chronic mydriasis:
1 drop of a 2.5% or 10% solution 2-3
times a day. Uveitis with posterior
synechiae (treatment) or synechiae,
posterior (prophylaxis): 1 drop of a
2.5% or 10% solution, repeated in 1
hour if necessary, not to exceed 3
times a day. Treatment may be
continued the following day, if
necessary
RM8.72/ea
(Cyclogyl)
31
Tropicamide 1% Eye
Drops
(Mydriacyl)
32
Phenylephrine HCl 2.5%

Eye Drops
A/KK Topical use to produce

cycloplegic refraction for
diagnostic purposes
B
(Mydfrin)
For pupillary dilation in

uveitis, for refraction without
cyclopegic. For fundoscopy
and other diagnostic
procedures
33
Antazoline HCL,
Tetrahydrozoline HCL &
Benzalkonium Cl Eye
Drops (Spersallerg)
A/KK Hay fever, conjunctivitis,

ADULT : Instill 1 drop tds - qid, into the
allergic conjunctivitis, vernal lower eyelid.
keratoconjunctivitis and
CHILD 2-12 yrs : Instill 1 drop od - bd
eczematosa
RM5.80/ea
34
Sodium Cromoglycate
2% Eye Drops
A/KK Prevention and treatment of 1 or 2 drops qid

allergic conjunctivitis
including seasonal and
perennial allergic
conjunctivitis and vernal
keratoconjunctivitis
RM6.88/ea
(Opticorm)
35
Proparacaine HCL 0.5%

Ophthalmic Drops
Topical anaesthesia in
ophthalmic procedures
(Alcaine)
84
Deep anaesthesia, 1 drop in each eye

every 5-10 min for 5-7 doses.
Superficial anaesthesia, 1-2 drops in
each eye before surgery or diagnostic
procedure. Tonometry and/or
tonography procedure, 1-2 drops in
each eye before procedure
RM8.50/15ml
No Generic Name
36 Fluorescein 1 mg
Ophthalmic Strip
(Fluorets)
Cat Indications
B Diagnostic fluorescein
angiography or angioscopy
of the fundus and of the iris
vasculature
Dosage
Moisten tip with tear fluid from lower
fornix, sterile water or ophthalmic
solution and gently stroke across the
conjunctiva
Remark
RM0.57/ea
37

Eye Drops
Irrigation of conjunctival sac 1-2 drops every 3-4 hrs
RM2.56/ea
38
Hypromellose 0.3% Eye

Drops
Symptomatic relief of severe Instill 1-2 drops in affected eye(s) as

dry eye conditions and as
needed
lens lubricant during
ophthalmic diagnostic
procedures
RM3.74/10ml
Eyes disorders e.g. burns,

scalds, ulcers, prevention
and treatment of radiation
dermatitis, traumatic and
ischaemic wound
RM13.60/
20gm
(Artificial Tears)
39
Protein Free
Haemodialysate 20 %
Eye Gel
(Solcoseryl)
S02 Otologicals
No Generic Name
1 Ofloxacin 0.3% Otic
Solution
(Tarivid)
Cat Indications
A Acute otitis media with
tympanostomy tubes,
chronic suppurative otitis
media with perforated
tympanic membranes and
otitis externa
Instill 1 drop tds - qid
Dosage
Remark
RM0.96/ea
CHILD: 1-12 yrs: 5 drops bd for 10
days. ADULT and CHILD > 12 yrs: 6 10 drops bd and remain in the ear
about 10 min
Clotrimazole 1% Ear drop
Otomycosis; concomitant
4 to 5 drops 3 to 4 times daily
therapy with antibiotics and
corticosteroid ear drops
RM3.25/ea
Chloramphenicol 5% w/v
Ear Drops
Acute otitis media, otitis

externa with perforation
2-3 drops bd - tds. Not to be used for

long term
RM4.06/ea
Polymyxin B Sulph
10,000 U, Neomycin Sulp
5 mg & Hydrocortisone
10 mg Ear Drops
(Pocin-H / Otosporin)
Treatment of bacterial
infection and inflammation
of the external auditory
meatus
3 drops tds - qid. External auditory

meatus and canal to be thoroughly
cleansed and dried before each
application but soap should not be
used as the antibiotics may be
inactivated by it
RM5.80/ea
Olive Oil Ear Drops
Impacted wax softener
3-4 drops 3-4 or as directed
RM0.50/ea
Sodium Bicarbonate 5%
w/v Ear Drops
To soften the impacted ear

wax
2-3 drops tds - qid
RM0.50/ea
Dosage
2-3 drops every 2-3 hrs, reduce
frequency when relief obtained
RM2.18/ea
S03 Ophthalmological and Otological Preparations

No Generic Name
Cat Indications
1 Betamethasone Disod
B Non-infected inflammatory
Phos 0.1% Ear Drops
conditions
(Betnesol)
2
Betamethasone Disod
Phos & Neomycin Sulp
0.5% Ear Drops
(Betnesol-N)
Allergic dermatosis in the

ear
85
2-3 drops tds - qid, reduce frequency

when relief obtained
Remark
RM2.78/ea
VARIOUS
V03 All Other Therapeutic Products

No Generic Name
Cat Indications
1 Fuller's Earth 30 %
C Adsorbent in pesticide
Suspension
poisoning
Dosage
200-500 ml of Fuller's Earth together
with magnesium sulphate or mannitol
every 2 hrs for several days
Remark
RM61.50/
500gm
Pralidoxime 0.5g/20 ml
Injection
Antidote in the treatment of

organophosphorus
insecticide poisoning and in
the control of overdosage by
anticholinergic drugs used
in the treatment of
myasthenia gravis
1-2 g by IV infusion in 100 ml saline

over 15-30 min or slow IV injection
over 10 min as 5 % solution. In water,
followed after 1 hr by a second dose
of 1-2 g. CHILD: 20-40 mg /kg, may be
given depending on the severity and
response to treatment
RM73.19/amp
Protamine Sulphate
50mg/5ml inj
Heparin overdose and

following cardiac or arterial
surgery or dialysis
procedures when required
to neutralize the effects of
heparin administered during
extracorporeal circulation
RM33.66/ea
Naloxone HCl 0.4 mg/ml

(Adult) Injection
For the complete/partial

reversal of narcotic
depression including
respiratory depression
induced by opioids such as
natural and synthetic
narcotics. Diagnosis of
suspected acute opioids
overdosage
5 ml slow IV injected over 10 min. If

administered within 15 min of heparin
dose, 1 mg will neutralise
approximately 100 units of heparin. If
longer time has elapsed, less
protamine is required. Not more than
50 mg should be injected at any one
time
Initially 0.4 - 2 mg IV repeated at
intervals of 2-3 min according to
patient's needs
Methylene Blue 1%
Injection
For treatment of idiopathic

and drug-induced
methaemoglobinemia
1 to 2 mg/kg (0.1 to 0.2 mL/kg of a 1%

solution) IV very slowly over several
min
RM17.86/ea
Acetylcysteine 200 mg/ml

Injection
A*
Antidote for paracetamol

poisoning
Diluted with dextrose 5% and infused

IV. Initial, 150 mg/kg IV in 200 ml over
60 min, then 50 mg/kg IV in 500 ml
over 4 hrs, followed by 100 mg/kg IV
in 1000 ml over 16 hrs. Total dose:
300mg/kg in 20 hr
RM8.24/ea
Desferrioxamine B
Methanesulphonate 0.5 g
Injection
i) Acute iron poisoning in

children
ii) Investigation and
treatment of
haemochromatosis
iii) Diagnosis and treatment
of aluminium toxicity in
patients with renal failure
and dialysis
iv) Chronic iron toxicity or
overload
i) 2 g by IM immediately and 5 g by
mouth after gastric lavage
ii) 0.5 - 1.5 g by IM injection dly
iii) Diagnosis: 5 mg per kg by slow IV
infusion during the last hr of
haemodialysis. Treatment: 5 mg per
kg once a wk by slow IV infusion
during the last hr of dialysis
iv) 30-50 mg/kg
RM10.42/vial
Deferiprone 500mg
Tablet (Ferriprox)
A*
Treatment of iron overload 25 mg/kg tds for total daily dose of 75

mg/kg. Doses greater 100 mg/kg are
in patients with
not recommended
thalassaemia major for
whom desferrioxamine
therapy is contraindicated or
inadequate. Add on therapy
to desferrioxamine for
thallasaemia patients with
cardiac complication
86
RM2.32/amp
RM0.99/tab
BORANG E
No Generic Name
9 Deferasirox 125 mg
Dispersible Tablet
(Exjade)
10
Deferasirox 500 mg
Dispersible Tablet
(Exjade)
Cat Indications
A* Treatment of chronic iron
overload due to blood
transfusions (transfusional
haemosiderosis) in adult
A*
and pediatric patients aged
2 years and above
Dosage
Remark
Initial 20 mg/kg/day. Starting dose can RM23.14/tab
also be based on transfusion rate and
Borang E
existing iron burden. Max is 30
mg/kg/day
RM92.61/tab
Borang E
Flumazenil 0.5 mg/5 ml

Injection
i) Diagnosis and/or
management of
benzodiazepine overdose
due to self-poisoning or
accidental overdose
ii) Reversal of sedation
following anaesthesia with
benzodiazepine
12
Calcium Polystyrene
Sulphonate Powder
(Kalimate)
Hyperkalemia resulting from 15-30g dly in 2-3 divided doses. Each

acute or chronic renal failure dose should be suspended in 30 50ml of water and administered orally
RM1.59/5gm
13
Mesna 400mg/4ml
Injection
For prevention of urotoxic

effects of
oxazaphosphorines e.g.
ifosfamide and
cyclophosphamide
IV injection at a dosage of 20% of the

corresponding oxazaphosphorine
dose at the times 0 hr (concurrently
with the oxazaphosphorine), 4 hrs and
8 hrs thereafter. CHILD: Dose given at
greater frequency (e.g. 6 times) and a
shorter intervals (e.g. 3 hrs)
RM7.88/vial
i) Biochemical modulator for

5-Fluorouracil in the
treatment of colorectal
cancer
ii) As rescue for high dose
methotrexate
iii) Gestational trophoblastic
disease
i) 20 mg/m2 dly for 5 days before 5Fluorouracil or 200 mg/m2 IV infusion

over 2 hrs prior to 5-Fluorouracil on
Day 1 & Day 2 or 500 mg/m2 IV Day 1
wkly (refer to specific protocol)
ii) Starting 24-42 hrs of methotrexate
administration, doses usually 15-30
mg/m2 every 6 hrs for 8-12 doses
depending on protocol and serum
methotrexate levels
iii) 6-12 mg exactly 30 hrs after each
dose of methotrexate. In EMA-CO
regime for high risk gestational
trophoblastic disease, use 30 mg IM
RM11.60/vial
(Uromitexan)
14
Leucovorin Calcium
(Calcium Folinate) 50 mg
Injection
87
i) Initial, 0.2 mg IV over 30 secs; if

desired level of consciousness not
obtained after an additional 30 secs,
give dose of 0.3 mg IV over 30 secs;
further doses of 0.5 mg IV over 30
secs may be given at 1-min intervals if
needed to max. total dose of 3 mg;
patients with only partial response to 3
mg may require additional slow
titration to a total dose of 5 mg; if no
response 5 min after receiving total
dose of 5 mg, overdose is unlikely to
be benzodiazepine and further
treatment with flumazenil will not help
ii) 0.2 mg IV over 15 secs; if desired
level of consciousness is not obtained
after waiting 45 secs, a 2nd dose of
0.2 mg IV may be given and repeated
at 60-secs intervals as needed (up to
a max of 4 additional times) to a max
total dose of 1 mg; most patients
respond to doses of 0.6-1 mg; in the
event of resedation, repeated doses
may be given at 20-min intervals if
needed; for repeat treatment, no more
than 1 mg (given as 0.5 mg/min)
should be given at any one time and
no more than 3 mg should be given in
any one hr
RM35.00/amp
11
No Generic Name
15 N-Acetylcysteine 600mg
Tablet
V04 Diagnostic Agents

No Generic Name
1 Dextrose Powder
2
Tuberculine PPD
Injection
Cat Indications
Dosage
Prevention of contrast
For each course is 600mg BD x 3/7
induced nephropathy in high
risk group patients
Cat Indications
B Use as a diagnostic agent
for diabetes
B
For routine Mantoux

(tuberculin sensitivity) test
Remark
RM2.55/tab
KPK
Dosage
75 g stat
RM5.64/kg
10 units is injected intradermally
RM74.58/ea
V07 All Other Non-Therapeutic Products

No Generic Name
Cat Indications
Dosage
1 Water for Injection
C As a diluent and vehicle for According to the needs of the patient
the administration of
medications
Remark
Remark
RM0.28/10ml,
RM2.27/
500ml
Sodium Hypochlorite
10% Solution
Low-level disinfectant and

antiseptic
Antiseptic: less than 0.5%.

Disinfectant: 5%
RM2.94/kg
Sodium
Dichloroisocyanurate 2.5
g Tablet
Low and medium level

disinfectant
50 - 10,000 ppm av chlorine
RM0.37/tab
Hydroxyethyl Cellulose
Jelly (KY Jelly)
For lubricating purpose
Apply sufficiently for lubricating

purpose
RM3.20/ea
88
INDEX
A
Acarbose Tablet
Acetazolamide Tablet, Injection
82
Acetylcysteine Injection
85
Acetylcysteine Tablet
87
Acetylsalicylic Acid + Glycine Tablet
10
Acetylsalicylic Acid Soluble Tablet
62
Acitretin Capsule
24
Acriflavine Lotion
26
Actinomycin D Injection
50
Acyclovir Tablet, Injection
42
Acyclovir Eye Ointment
81
Acyclovir Cream
25
Adefovir Dipivoxil Tablet
44
Adenosine Injection
17
Adrenaline Acid Tartrate Injection
17
Albendazole Tablet, Suspension
75
Alcohol Solution
26
Alendronate Sodium and Cholecalciferol Tablet
58
Alfacalcidol Capsule, Drops, Injections
6,7
Alfuzosin HCI Tablet
30
Allopurinol Tablet
58
Alprazolam Tablet
69
Alprostadil Injection
17
Amantadine Tablet
65
Amikacin Injection
39
Amino Acids Injection
13
Amino Acids with Electrolytes Injection
14
Amino Acids with Taurine Injection
13
Aminophylline Injection
79
Amiodarone Injection
16
Amiodarone Tablet
16
Amisulpride Capsule
68
Amitriptyline HCl Tablet
70
Amlodipine Tablet
20
Amlodipine & Valsartan Tablet
22
Amoxicillin & Clavulanate Syrup, Injection, Tablet
35
Amoxicillin Capsule, Suspension
34
Amphotericin B Injection
40
Amphotericin-B Eye Drops
81
Ampicillin & Sulbactam Suspension, Tablet, Inj
35
Ampicillin Sodium Injection
Anastrozole Tablet
54
Antazoline HCL, Tetrahydrozoline HCL &

Benzalkonium Cl Eye Drops
83
Anti RhD Gamma Globulin Injection
45
Antivene Serum Snake Polyvalent Injection
45
Antivenene Malaysian Pit Viper Injection
45
Antivenene Serum (Cobra) Injection
45
Antivenene Serum (Sea snake) Injection
45
Aqueous Cream
23
Aripiprazole Tablet
68
Artemether + Lumefantrine
74
Ascorbic Acid Tablet
Atenolol Tablet
19
Atorvastatin Tablet
22
Atracurium Besylate Injection
57
Atropine Sulphate Eye Drops
83
Atropine Sulphate Injection
Azathioprine Tablet
55
Azithromycin Injection
38
Azithromycin Tablet
38
34
89
Bacampicillin Tablet
34
Baclofen Tablet
57
Balanced Salt Solution
14
BCG.Freeze-dried Vaccine Injection
46
Beclomethasone Dipropionate Inhalation
77
Beclomethasone Dipropionate Nasal Spray
76
Benzalkonium & Cetrimide Cream
26
Benzathine Penicillin Injection
34
Benzhexol Tablet
65
Benzoic Acid Compound Ointment
23
Benzoin Compound Tincture
26
Benzoyl Peroxide Gel
27
Benzydamine HCl Solution
Benzyl Benzoate Emulsion
75
Benzylpenicillin Injection
34
Beractant Intratracheal Suspension
81
Betahistine Tablet
73
Betamethasone 17 - Valerate Cream, Ointment
25
Betamethasone & Neomycin Ear Drops
84
Betamethasone & Neomycin Eye Drops
82
Betamethasone Disod Phos Ear Drops
84
Betamethasone Disod Phos Eye Drops
81
Ceftriaxone Injection
36
Betaxolol Eye Suspension
83
Cefuroxime Axetil Suspension
35
Bicalutamide Tablet
54
Cefuroxime Sod Injection, tablet
36
Bisacodyl Suppository, Tablet
Celecoxib Capsule
56
Bismuth Subgallate & Benzyl Benzoate Supp
18
Cephalexin Monohydrate Syrup, Capsule
35
Bismuth Subnitrate, Iodoform & Liq Paraffin Paste
76
Cetirizine HCl Tablet
80
Bisoprolol Fumarate Tablet
19
Cetrimide Lotion
26
Bleomycin HCl Injection
51
Charcoal, Activated Tablet, Granules
Bromhexine HCl Injection, Elixir, Tablet
80
Chloral Hydrate Mixture
70
Bromazepam Tablet
69
Chlorambucil Tablet
47
Bromocriptine Mesylate Tablet
28
Chloramphenicol Eye Drops, Eye Ointment
81
Budesonide & Formoterol Inhalation
77
Chloramphenicol Ear Drops
84
Budesonide Inhalation
77
Chlorhexidine Gluconate Mouthwash
76
Budesonide Nasal Spray
76
Chlorhexidine Gluconate Solution
26
Budesonide Nebulising Solution
77
Chloroquine Phosphate Tablet
74
Bupivacaine Heavy Injection
59
Chlorpheniramine Maleate Injection, Syrup
80
Bupivacaine Injection
59
Chlorpheniramine Maleate Tablet
80
Bupivacaine with Adrenaline Injection
60
Chlorpromazine Tablet
66
Chlortetracycline Cream
24
Cinnarizine Tablet
73
Calamine Cream, Lotion
24
Ciprofloxacin Injection, Tablet
39
Calamine with Precipitated Sulphur Lotion
24
Ciprofloxacin HCl Ophthalmic Solution
81
Calcipotriol Ointment
24
Cisplatin Injection
51
Calcipotriol + Betamethasone Ointment
24
Clarithromycin Tablet
38
Calcitonin Nasal Spray, Injection
33
Clindamycin HCl Capsule
38
Calcitriol Capsule
Clindamycin Phosphate Injection
38
Calcium Carbonate Tablet
Clobazam Tablet
69
Calcium Gluconate Injection
Clobetasol Propionate Cream, Ointment
25
Calcium Lactate Tablet
Clobetasone Butyrate Cream, Ointment
25
Calcium Polystyrene Sulphonate Powder
86
Clomifene Citrate Tablet
30
Capecitabine Tablet
49
Clomipramine HCl Tablet
70
Captopril Tablet
20
Clonazepam Tablet
62
Carbachol Intraocular Solution
82
Clopidogrel Tablet
Carbamazepine Tablet
63
Clotrimazole Cream
23
Carbimazole Tablet
33
Clotrimazole vaginal Tablet
28
Carboplatin Injection
51
Clotrimazole ear drop
84
Carboprost Tromethamine Injection
28
Cloxacillin Sodium Capsule, suspension
34
Carvedilol Tablet
20
Cloxacillin Sodium Injection
34
Caspofungin Acetate Injection
41
Clozapine Tablet
67
Cefepime Injection
36
Coal Tar Solution
24
Cefoperazone & Sulbactam Injection
36
Cocaine Solution
60
Cefoperazone Sodium Injection
36
Cocois Co. Ointment
24
Cefotaxime Injection
36
Colchicine Tablet
58
Ceftazidime Injection
36
Colistin (Polymyxin E)
39
90
Conjugated Oestrogens Tablet, Cream
29
Doxazosin Mesylate CR Tablet
18
Crotamiton Cream
75
Doxorubicin HCl Injection
51
Cyanocobalamin Injection, Table
12
Doxycycline Capsule
34
Cyclopentolate Eye Drops
83
Dutasteride Capsule
30
Cyclophosphamide Injection, Tablet
47
Dutasteride + Tamsulosin Capsule
30
Cyclosporin Capsule Microemulsion
55
Dydrogesterone HCI Tablet
29
Cytarabine Injection
49
E
D
Efavirenz Capsule, Tablet
44
Dabigatran capsule
10,11
Emulsificants Ointment
23
Dacarbazine Injection
48
Enalapril Tablet
20
Danazol Capsule
30
Enoxaparin Sodium Injection
Dapsone Tablet
41
Entacapone Tablet
65
Deferasirox tablet
86
Eperisone HCl Tablet
57
Deferiprone Tablet
85
Ephedrine HCl Injection
78
Desferrioxamine B Methanesulphonate Injection
85
Ephedrine Nasal Drop
76
Desflurane Liquid
59
Epirubicin Injection
51
Desloratadine tablet
80
Erlotinib tablet
52
Desmopressin Tablet, Nasal Spray
31
Erythromycin Ethylsuccinate Tablet, Suspension
37
Dexamethasone & Neomycin Sulph & Polymyxin B

Sulph Ophthalmic Suspension
Erythromycin Lactobionate Injection
38
82
Dexamethasone Tablet
Dexamethasone Sodium Phosphate Injection
31
Erythropoietin Human Recombinant Prefilled

Syringes (Eprex).
13
32
Escitalopram Tablet
71
Dexchlorpheniramine Maleate Tablet, Syrup
80
Esomeprazole Tablet
Dextrose Injection
14
Essential Phospholipid Capsules
Dextrose Powder
87
Estradiol & Estradiol with Dydrogesterone 10mg
29
Diazepam Injection
69
Estradiol Valerate Tablet
28
Diazepam Tablet
69
Estradiol Valerate & Norgestrel 0.5mg Tablet
29
Diclofenac Emulgel
57
Ethambutol HCl Tablet
41
Diclofenac Sodium Tablet, Injection
56
Ether Solvent
59
Diethylcarbamazine Citrate tablet
75
Ethyl Chloride Spray
61
Digoxin Tablet, Injection
16
Etomidate Injection
59
Diltiazem HCl Tablet
20
Etoposide Injection
50
Dinoprostone Vaginal Tablet
28
Etoricoxib Tablet
56
Diosmin & Hesperidin Tablet
19
Exemestane tablet
54
Diphenhydramine HCl & Ammonium Chloride

Expectorant
Ezetimibe tablet
22
80
Diphenoxylate with Atropine Sulphate Tablet
Dipyridamole Tablet
10
Dobutamine HCl Injection
17
Docetaxel Injection
50
Domperidone Tablet
Donepezil HCl Tablet
72
Dopamine HCl Injection
16
71
Dothiepin HCl Capsule, Tablet
91
Factor VIII Injection
12
Fat Emulsion 20% for IV Infusion
13
Felodipine Tablet
20
Fentanyl Transdermal Patch
61
Fentanyl Citrate Injection
59
Ferric Ammonium Citrate Paed Mixture
12
Ferrous Fumarate Tablet
12
Gliclazide Tablet
Filgrastim (G-CSF) Injection
54
Glycerin
Finasteride Tablet
30
Glycerin & Sodium Chloride Disposable Enema
Flecainide Acetate Tablet
16
Glyceryl Trinitrate Tablet, Injection
17
Fluconazole Capsule
40
Goserelin Depot Injection
54
Fluconazole Injection
40
Granisetron HCl Injection
Fludrocortisone Acetate Tablet
31
Flumazenil Injection
86
Flunarizine HCl Capsule
73
Fluorescein Ophthalmic Strip
84
Fluorometholone Ophthalmic Suspension
81
Fluorouracil Injection
48
Fluoxetine HCL Capsule
71
H
Haemophilus Influenzae Type B Conjugate Vaccine
46
Haloperidol Tablet
66
Heparin Injection
Heparin Sodium in Sodium Chloride Injection
Hepatitis B Immunoglobulin (Human) Injection
45
Hepatitis B Vaccine Injection
46
Human Albumin Injection
13
Hydralazine Injection
18
Hydrochlorothiazide Tablet
18
Hydrocortisone Cream, Ointment
25
Hydrocortisone Enema
82
Hydrocortisone Tablet
32
Frusemide Injection, Tablet
18
Hydrocortisone Sodium Succinate Injection
32
Fuller's Earth Suspension
85
Hydrogen Peroxide Solution
26
Fusafungine Nasal Spray
76
Hydroxychloroquine Sulphate Tablet
74
Fusidic Acid Eye Ointment
81
Hydroxyethyl Cellulose Jelly
87
Fusidic Acid Cream
25
Hydroxyethyl Starch Injection
13
Fusidic Acid in Betamethasone Valerate Cream
26
Hydroxyurea Capsule
53
Fusidic Acid Tablet, Injection
39
Hydroxyzine HCl Tablet
70
Hyoscine N-Butylbromide Tablet, Injection
Hypromellose Eye Drops
82,84
Flupenthixol Decanoate Depot lnjection
66
Fluphenazine Decanoate Injection
66
Fluticasone Propionate Inhalation
78
Fluvoxamine Tablet
71
Folic Acid Tablet
12
Fondaparinux Injection
Framycetin Sulp, Dexamethasone & Gramicidin Ear
Drops
11
G
Gabapentin Capsule
64
Gamma Benzene Hexachloride Lotion
75
Ganciclovir Sodium Injection
42
Ibandronic Acid Tablet
58
Gefitinib Tablet
52
Ibuprofen Tablet
56
Gemcitabine HCl Injection
49
Ifosfamide
47
Gemeprost Pessary
28
Imipenem & Cilastatin Injection
37
Gemfibrozil Capsule
22
Imipramine HCl Tablet
70
Indinavir Sulphate Capsule
43
Gentamicin Eye Drops, Eye Ointment, Fortified Eye

Drop
81
Indomethacin Capsule
56
Gentamicin Beads
38
Insulin Aspart
Gentamicin Sulphate & Betamethasone Disod

Phosphate Eye Drops
82
Insulin Glargine
Gentamicin Sulphate Injection
39
Insulin Recombinant Synthetic Human, Intermediate

-acting vial Penfill and Refill
Glibenclamide Tablet
Gliclazide Modified Release Tablet
Insulin Recombinant Synthetic Human, Pre-mixed

Penfill
92
Lignocaine Injection
16
Insulin Recombinant Synthetic Human, short-acting

Penfill and Refill
Iodine & Potassium Iodide Solution
33
Lignocaine, Aluminium Acetate, Zinc Oxide &

Hydrocortisone Suppository
18
Ipratropium Inhalation,Inhalation Solution
78
Liquid Paraffin
Ipratropium Bromide & Salbutamol Inhalation
77
Lithium Carbonate Tablet
68
Ipratropium Bromide and Fenoterol Inhalation
77
Lopinavir and Ritonavir Tablet, Solution
43
Irbesartan Tablet
21
Loratadine Syrup, Tablet
80
Irinotecan HCl Trihydrate Injection
53
Loratadine & Pseudoephedrine Sulphate
76
Iron Dextran Injection
12
Lorazepam Tablet
69
Isoniazid Tablet
41
Losartan Tablet
21
Isosorbide Dinitrate Tablet
17
Losartan Potassium & Hydrochlorothiazide Tablet
21
Isosorbide Mononitrate SR Capsule
17
Lovastatin Tablet
22
Isotretinoin Capsule
27
L-Thyroxine Sodium Tablet
31
Itopride HCL Tablet
Itraconazole Capsule
40
Ivabradine Tablet
17
Magnesium Sulphate Injection
15
Magnesium Trisilicate Mixture
Magnesium Trisilicate Tablet
Ketamine Injection
59
Mannitol Injection
14
Ketoconazole Shampoo
23
Mebeverine HCL Tablet
Ketoconazole Tablet
40
Mecobalamin Tablet
58
Ketorolac Tromethamine Eye drop
82
Medroxyprogesterone Acetate Tablet
29
Mefenamic Acid Capsule
56
Meloxicam Tablet
56
L
Labetalol HCl Injection, Tablet
19
Memantine Tablet
72
Lactulose Liquid
Meningococcal A, C, Y, W135 Vaccine Injection
46
Lamivudine Oral Solution
44
Menthol in Ind. Methylated Spirit Inhalation
76
Lamivudine Tablet
44
Meropenem Injection
36
Lamotrigine Tablet
63
Mesna Injection
86
Lamotrigine Dispersible/ Chewable Tablet
63
Metformin & Glibenclamide Tablet
L-Aspariginase Injection
52
Metformin HCl Tablet
Lapatinib Tablet
53
Methotrexate Injection, Tablet
48
Latanoprost Eye Drops
83
Methoxsalen Capsule
24
Letrozole Tablet
54
Methyl Salicylate Ointment
57
Leucovorin Injection
86
Methyldopa Tablet
17
Leuprolide Acetate Injection
54
Methylene Blue Injection
85
Levetiracetam Tablet
64
Methylphenidate HCl Tablet, Extended Release Tab
72
Levodopa & Carbidopa Tablet
65
Methylprednisolone Sodium Succinate Injection
32
Levodopa, Benserazide HBS capsule
65
Metoclopramide HCl Tablet, Injection
Levodopa, Benserazide Tablet
65
Metoprolol Tartrate Tablet
19
Levonorgestrel Releasing Intrauterine System
28
Metronidazole Tablet
74
Levothyroxine Tablet
32
Metronidazole Injection
39
Lidocaine and Prilocaine Cream
60
60
Miconazole Cream
23
Midazolam Injection, Tablet
70
Lignocaine HCl Injection, Jelly, Spray
93
Minoxidil Tablet
18
Mirtazapine Orodispersible Tablet
71
Paclitaxel Injection
50
Mitomycin-C Injection
51
Paliperidone Extended Release Tablet
68
Moclobemide Tablet
71
Pamidronate Disodium Injection
58
Modified Fluid Gelatin Injection
13
Pantoprazole Tablet, Injection
Mometasone Cream
25
Paracetamol Syrup, Suppository, Tablet
62
Mometasone Furoate Aqueous Nasal Spray
76
Paraffin, White Soft
23
Monobasic Sodium Phosphate, Dibasic Sodium

Phosphate
Parecoxib Sodium Injection
56
Pentoxifylline Tablet
18
Montelukast Sodium Tablet, Oral Granule, Chewable

Tablet
79
Morphine HCl Solution
61
Morphine Sulphate Injection
61
Multivitamin Syrup, Injection
Mupirocin Ointment
25
Mycophenolate Mofetil Tablet
55
N
Naloxone HCl (Adult) Injection
85
Naproxen Tablet
56
Neomycin Cream
25
Neostigmine Methylsulphate Injection
73
Nevirapine Tablet
44
Nifedipine Tablet
20
Noradrenaline Bitartrate Injection
16
Nystatin Cream
23
Nystatin Suspension
O
Octreotide Injection
31
Ofloxacin Otic Solution
84
Ofloxacin Tablet
39
Olanzapine Tablet
67
Olive Oil Ear Drops
84
Omeprazole Capsule, Injection
Oral Rehydration Salt
Oxaliplatin Injection
52
Oxycodone Tablet
61
Oxycodone Immediate Release Tablet
61
Oxymetazoline HCl Nasal Spray (Paed), (Adult)
76
Oxytetracycline with Polymyxin B Sulphate Eye

Ointment
81
Oxytocin Injection
31
Oxytocin 5 units & Ergometrine Maleate Injection
28
94
Perindopril Tablet
21
Peritoneal Dialysis with Glucose Solution
14
Perphenazine Tablet
66
Pethidine HCl Injection
61
Phenobarbitone Tablet, Injection
62
Phenoxymethyl Penicillin Tablet, Suspension
34
Phenylephrine HCl Eye Drops
83
Phenytoin Sodium Capsule
62
Phenytoin Sodium Injection
62
Phosphate Sandoz
15
Pilocarpine Eye Drops
82
Piperacillin & Tazobactam Injection
35
Piracetam Tablet
72
Pizotifen Tablet
62
Pneumococcal Vaccine (Polyvalent)
46
Polymyxin B Sulphate, Neomycin Sulphate &

Hydrocortisone Ear Drops
84
Polyethylene Glycol/ Macrogol 4000 Powder
Potassium Chloride (SR) Tablet
Potassium Chloride Injection
14
Potassium Chloride Mixture
Potassium Citrate & Citric Acid Mixture
Potassium Dihydrogen Phosphate Injection
15
Potassium Permanganate Solution
26
Povidone Iodine Solution
26
Pralidoxime Injection
85
Pramipexol Tablet
65
Pravastatin Sodium Tablet
22
Prazosin HCl Tablet
17
Prednisolone Tablet
32
Pregabalin Capsule
64
Primaquine base Tablet
74
Procaine Benzylpenicillin Aqueous Injection
34
Prochlorperazine Maleate Tablet, Injection
66
Procyclidine HCl Injection
65
Prolase Tablet
58
Selegiline HCl Tablet
65
Promethazine HCl Injection, Syrup
80
Selenium Sulphide Shampoo
27
Proparacaine HCL Ophthalmic Drops
83
Sertraline HCL Tablet
71
Propofol Injection
59
Sevoflurane Liquid
59
Propranolol HCL Tablet
19
Silver Sulphadiazine Cream (SSD)
25
Propylthiouracil Tablet
32
Simvastatin Tablet
22
Protamine Sulphate Injection
85
Sodium Bicarbonate Ear Drops
84
Protein Free Haemodialysate Jelly
24
Sodium Bicarbonate Injection
14
Protein Free Haemodialysate Eye Gel
84
Pyrazinamide Tablet
41
Sodium Bicarbonate, Citric Acid, Sodium Citrate and

Tartaric Acid
14
Pyridostigmine Bromide Tablet
73
Sodium Bicarbonate, Magnesium Carbonate,

Tincture Cardamom Compound Mixture
Pyridoxine HCl (Vitamin B6) Tablet
Sodium Biphosphate & Sodium Phosphate Enema
Pyrimethamine Tablet
75
Sodium Chloride (Half Strength) Injection
15
Sodium Chloride with Dextrose Injection
15
Q
Quetiapine Fumarate (Extended Release) Tablet
67
Quinine Dihydrochloride Injection
74
Quinine Sulphate Tablet
74
R
Rabies Human Diploid Cell Vaccine (Lyophilised)
Injection
46
Raloxifene HCl Tablet (Evista)
30
Ramipril Tablet
21
Ranitidine Tablet
Sodium Chloride Eye Drops
84
Sodium Chloride Injection
15
Sodium Citrate, Citric Acid Mixture
14
Sodium Cromoglycate Eye Drops
83
Sodium Dichloroisocyanorate Tablet
87
Sodium Hypochlorite Solution
87
Sodium Lactate Compound
15
Sodium Tetradecyl Sulphate Injection
19
Sodium Thiosulphate Solution
23
Sodium Valproate Tablet, Syrup
63
Somatropin Injection
31
Spironolactone Tablet
18
Stavudine Capsule
43
Stavudine & Lamivudine & Nevirapine Tablet
44
Ranitidine Injection
Riboflavine Tablet
Rifampicin Capsule
41
Risperidone Tablet, Oral Solution
68
Streptokinase Injection
10
Risperidone Long Acting Injection
68
Streptomycin Sulphate Injection
38
Ritonavir Capsule
43
Sucralfate Tablet
Rivastigmine Capsule
72
Sulfadoxine & Pyrimethamine Tablet
74
Rivastigmine Transdermal Patch
72
Sulfamethoxazole & Trimethoprim Suspension
37
Sulfamethoxazole & Trimethoprim Tablet, Inj
37
Sulpiride Tablet
67
Rocuronium Bromide Injection
57
Ropivacaine HCl Injection
60
Suxamethonium Chloride lnjection
57
Synthetic Vitamin K1 Injection
11
Salbutamol Inhalation Solution
77
Salbutamol Injection, Tablet, Syrup
78,79
Tacrolimus Tablet
55
Salbutamol Inhalation
77
Tamoxifen Citrate Tablet
54
Salicylazosulphapyridine (Sulphasalazine) Tablet
Tamsulosin Tablet
30
Salicylic Acid Ointment, Cream
23
Tar, Coal Tar and Oleyl Alcohol Liquid
24
Salmeterol & Fluticasone Evohaler
77
Telmisartan Tablet
21
Telmisartan & Hydrochlorothiazide Tablet
22
Telmisartan & Amlodipine Tablet
22
Salmeterol & Fluticasone Propionate Inhalation
77
95
Tenecteplase Injection
10
Tuberculine PPD Injection
87
Tenofovir Tablet
43
Typhoid Vaccine Injection
46
Tenofovir + Emtricitabine (Truvada) Tablet
44
Terazosin HCl Tablet
30
Terbinafine HCL Tablet
23
Urea Cream
23
Terbutaline Sulphate Injection
79
Urokinase Injection
10
Terbutaline Sulphate Inhalation Solution
77
Ursodeoxycholic Acid Capsule
Testosterone Injection
28
Tetanus Immunoglobulin, Human Injection
45
Tetanus Toxoid Injection
46
Valsartan & Hydrochlorothiazide Tablet
Theophylline Tablet
79
Valsartan Tablet
21
Theophylline Long Acting Tablet
79
Vancomycin HCl 500 mg Injection
39
Thiamine Mononitrate Tablet
Vecuronium Bromide Injection
57
Thiopental Sodium Injection
70
Venlafaxine Hydrochloride Extended Release Cap
71
Thymol Compound Gargle
Verapamil HCl Tablet, Injection
20
Tibolone Tablet
29
Vinblastine Sulphate Injection
49
Ticlopidine HCl Tablet
10
Vincristine Sulphate Injection
49
Timolol Maleate Eye Drops
82
Vinorelbine Injection
50
Tiotropium Bromide Inhalation Cap & Handihaler
78
Vitamin B Complex Tablet
Tolterodine L-Tartrate Tablet
30
Vitamin B1, B6, B12 Tablet
Topiramate Tablet
64
Topiramate Capsule Sprinkle
64
Trace Elements and Electrolytes (Adult) Solution
15
Warfarin Sodium Tablet
Trace Elements and Electrolytes (Paed) Solution
15
Water for Injection
87
Tramadol HCl Capsule, Injection
61
Tranexamic Acid Injection, Capsule
11
22
Travoprost Eye Drops
83
Zidovudine Injection
43
Tretinoin Gel, Cream
27
Zidovudine Syrup, Capsule
43
Triamcinolone Acetonide In Dental Paste
Zidovudine + Lamivudine (Combivir) Tablet
44
Triamcinolone Acetonide Injection
32
Zinc Oxide Ointment
23
Trifluoperazine HCl Tablet
66
Zoledronic Acid Injection
58
Trimetazidine Tablet
17
Zuclopenthixol Drops
67
Trimethoprim Tablet
37
Zuclopenthixol Acetate Injection
67
Triprolidine HCl & Pseudoephedrine HCl Syrup
76
Zuclopenthixol Decanoate Depot Injection
67
Triptorelin Injection
54
83
Tropicamide Eye Drops
96

APPENDIX 1
Adverse Drug Reactions (ADR) Reporting Form

Please report all suspected ADRs that may be related to a drug, or a combination of drugs using the form
below. Do not hesitate to report if some details are not known. ADR forms can be obtained from Pharmacy
Department. Please send the completed form to Drug Information Unit, Pharmacy Department or submit the
report online via the internet at www.bpfk.gov.my.
97

APPENDIX 2
BORANG PERMOHONAN KAD ALAHAN UBAT

99
(DRUG ALLERGY CARD
REQUEST FORM)
JABATAN FARMASI HOSPITAL PAKAR SULTANAH FATIMAH, MUAR

A. MAKLUMAT PESAKIT
Nama : _________________________________________________
Jantina : Lelaki / Perempuan
R/N:________________
Bangsa : ________________
No Kad Pengenalan
Alamat : ___________________________________
No. Telefon - (Rumah) : __________________
__________________________________
- (Bimbit) : __________________
__________________________________
__________________________________
Alamat e-mel : _________________________
Jika warganegara asing, sila isi maklumat berikut:

No. Passport: ______________________
Warganegara: _____________ Umur: __________
B. JENIS PERMOHONAN
. MAK
PERMOHONAN KAD BARU
PERMOHONAN TAMBAHAN MAKLUMAT PADA KAD

No. Siri Kad Alahan Ubat : DAC _________________________
Tarikh kad dikeluarkan
Bil.
Nama Ubat Yang Terlibat
Reaksi Alahan
1.
2.
C. MAKLUMAT PEMOHON
Nama dan tandatangan
Nombor telefon
Wad / Unit
Hospital/ Klinik
Alamat
Cop Jawatan
Tarikh
: _____________________________
98
D. UNTUK KEGUNAAN FARMASI

No. Siri Kad
: DAC_________________________
Tarikh Kad dikeluarkan
: _____________________________
Nama dan tandatangan

Pegawai Farmasi
Cop Jawatan
Tarikh
LULUS
TOLAK
Nyatakan sebab: __________________________________________
________________________________________________________
________________________________________________________
E. PENGESAHAN PENERIMAAN OLEH PESAKIT
pesakit/penjaga
Saya
nombor
kad
pengenalan
dengan ini telah menerima kad
alahan dan telah diberi penerangan sewajarnya berkaitan keperluan memaklumkan atau menunjukkan kad
alahan tersebut apabila berjumpa pegawai perubatan, pegawai farmasi, pegawai pergigian atau anggota
kesihatan lain.
Tandatangan
Pesakit / Penjaga :
Tandatangan dan cop

Pegawai Farmasi
Tarikh
Tarikh
99

Drug Formulary 2013

Uploaded by

Copyright:

Available Formats

Drug Formulary 2013

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Drug Formulary 2013

Uploaded by

Copyright:

Available Formats

HOSPITAL PAKAR SULTANAH FATIMAH, MUAR

MESRA BERSAMA MEMBINA KEUNGGULAN

HOSPITAL PAKAR SULTANAH FATIMAH

Drug Information Unit

Hospital Drug Formulary, Hospital Pakar Sultanah Fatimah 2013

= Consultant / Specialist for specific indication only

= Consultant / Specialist / Family Physicians Specialist

DR. SELAHUDDEEN BIN ABD. AZIZ

Hospital Drug Formulary, Hospital Pakar Sultanah Fatimah 2013

Hospital Drug Formulary, Hospital Pakar Sultanah Fatimah 2013

Pharmacy Telephone Directory

Drive Through Pharmacy

Cytotoxic Drug Reconstitution (CDR)

Total Parenteral Nutrition (TPN)

Therapeutic Drug Monitoring (TDM)

Drug Information Service (DIS)

Hospital Drug Formulary, Hospital Pakar Sultanah Fatimah 2013

Pharmacy Telephone Directory

ALIMENTARY TRACT AND METABOLISM

AND BLOOD FORMING ORGANS

GENITO URINARY SYSTEM AND SEX HORMONES

Hospital Drug Formulary, Hospital Pakar Sultanah Fatimah 2013

SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

ANTIINFECTIVES FOR SYSTEMIC USE

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Hospital Drug Formulary, Hospital Pakar Sultanah Fatimah 2013

2. Drug Allergy Card Request Form

Hospital Drug Formulary, Hospital Pakar Sultanah Fatimah 2013

ALIMENTARY TRACT AND METABOLISM

A01 Stomatological Preparations

Benzydamine HCl 0.15 %

For relief of painful condition Used as a 30 seconds gargle or rinse, RM11.05/

For sore throat and minor

A02 Drugs For Acid Related Disorders

To be gargled tds - qid

Heartburn, for rapid relief of ADULT 10-20 ml tds

i) Benign gastric/ duodenal

i) ADULT: Slow IV injection of 50 mg

Ranitidine 150 mg Tablet

Ranitidine 300 mg Tablet

i) 150 mg bd (om & on) or 300 mg on

i) Benign gastric and

Only for : i)Reflux

Hospital Drug Formulary, Hospital Pakar Sultanah Fatimah 2013

i) 40 mg bd in combination with any of

i)Gastro-oesophageal reflux i)20mg daily for 4-8 weeks ii)40mg

i) Benign gastric and

A03 Drugs For Functional Gastrointestinal Disorders

i) 2 g bd or 1 g qid for 4-6 weeks or in

i) ADULT 300-600 mcg IM/SC 30-60

Gastrointestinal tract and

ADULT 10-20 mg tds.

Itopride HCl 50 mg Tablet

Hospital Drug Formulary, Hospital Pakar Sultanah Fatimah 2013

A04 Antiemetics and Antinauseants

A05 Bile And Liver Therapy

A/KK Nutritional supplement in

Chronic dyspepsia ADULT 10 mg 3

i) Constipation ii) Bowel